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Abstract
The transmissible spongiform encephalopathies (TSEs) are a group of progressive
neurological diseases of unknown cause. Infection is associated with an abnormal
form of a host protein designated 'prion protein'. Previous studies have shown that
lymphoid tissues are involved in the peripheral pathogenesis of TSEs prior to
neuroinvasion. Using immunoelectron microscopy, disease specific PrP (PrPd)
accumulation was demonstrated within the spleens of scrapie-infected mice where it
was found in association with the plasmalemma and extracellular space around
follicular dendritic cell (FDC) processes (dendrites), and in the lysosomes of tingible
body macrophages (TBMs). In light zones of secondary follicles, almost all FDCs at
the terminal stages of disease form hypertrophic labyrinthine glomerular complexes.
Within these labyrinthine complexes PrPd is consistently seen on the plasmalemma
of adjacent dendritic profiles and in association with abundant electron dense
material held between dendrites. The latter was interpreted as excess trapped antigen-
antibody complexes. Contrary to previous dogma, these results show that a
pathological response within the immune system follows murine scrapie infection.
The nature of these changes is similar irrespective of the strain of agent used. To help
determine the significance of these changes, scrapie-infected mice were inoculated
with cytokines that alter the biology of secondary follicles. Tumour necrosis factor
receptor fusion protein (Hu-TNFR:Fc) or Lymphotoxin P receptor fusion protein
(LTPR:Fc), have been reported to induce de-differentiation of FDCs and heighten B
cell apoptosis. However, in this study, mature FDCs were present 3 and 35 days after
treatment with LTpR:Fc and retained PrPd accumulation. The mechanisms by which
xii
these cytokines modulate incubation period were not determined. To ensure that the
pathology of experimental disease is similar to that occurring in natural disease,
ovine scrapie tissue samples were examined. The results presented suggest that
natural scrapie is closely similar to that of experimental murine scrapie. Further
technique refinement is still necessary to give comparable levels of sensitivity and
tissue preservation in ovine tissue.
1. INTRODUCTION
1.1. Scrapie and other TSEs
Scrapie, a disease that has been present naturally in British sheep and goats for many
centuries, belongs to a group of neurodegenerative diseases known as the
transmissible spongiform encephalopathies (TSEs) or prion diseases, and following
its experimental transmission to rodents is the most extensively studied of the group.
The disease is now endemic to many other countries throughout the world and its
control and potential eradication poses a problem worldwide.
1.1.1. Animal and human TSEs
TSEs affect both animals and humans and are invariably fatal. Bovine Spongiform
Encephalopathy (BSE) of cattle and exotic ungulates was first identified in a Nyala
(Jeffrey & Wells 1988), and subsequently in cattle (Wells et al. 1987)1. It is
considered to have arisen as a result of scrapie agent contamination of inadequately
rendered scrapie-infected sheep offal. The TSE agent contaminated meat and bone
meal produced by the rendering process was then used as a nutritional supplement in
cattle feed with subsequent mutation or amplification of the BSE agent (Wilesmith et
al. 1988; Wilesmith et al. 1991). Other TSE infections related to BSE include: Feline
Spongiform Encephalopathy (FSE), which is thought to have emerged as a result of
similar dietary exposure to contaminated food supplements, Transmissible Mink
1 Published out of sequence relating to case occurrence.
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Encephalopathy (TME), a disease of captive mink in the United States which is
thought to have originated from the consumption of scrapie affected sheep carcasses,
and chronic wasting disease or CWD, a scrapie like disease of mule deer and elk, the
origins of is completely unknown (Williams et al. 2002).
Human forms of the disease exist as infectious, inherited or sporadic disorders.
Creutzfeldt-Jacob disease (CJD) and Kuru are infectious forms of the disease and can
occur through horizontal transmission. Iatrogenic transmission of CJD occurs rarely,
for example through intake of contaminated growth hormone or neurosurgery using
non-sterile instruments (Brown 1998; Blattler 2002). Kuru has been attributed to
ritualistic cannibalism and is restricted to the Fore tribe in Papua New Guinea. It is
thought to have arisen from a single case of sporadic CJD (Knight & Collins 2001).
Fatal Familial Insomnia (FFI), familial CJD and Gertsman-Straussler-Scheinker
syndrome (GSS) are inherited disorders in which there are germ line mutations in the
protein-coding region of the prion protein gene. The causative agent of sporadic
human TSEs remains unknown, however, it has been hypothesised that the disease
may occur as a result of spontaneous conversion of the normal prion to the infectious
agent, or that a somatic mutation may arise in the protein coding gene (Gajdusek
1977; Prusiner 1989). More recently, variant CJD has been diagnosed, presumptively
a result of transmission of BSE to humans by the consumption of brain or spinal cord
of BSE infected cattle (Ironside 1996; Will et al. 1996; Bruce et al. 1997).
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1.1.2. Experimental TSEs
In the 1930s, experimental sheep to sheep scrapie transmission was achieved by
Cuille and Chelle, demonstrating the infectious nature of the agent (Cuille & Chelle
1936). This was further shown by the infection of 10% of a sheep flock with scrapie
as a result of total flock vaccination with a scrapie contaminated louping ill vaccine
(original report: Gordon et al. (Gordon 1946)). However, much of the current
information concerning scrapie is derived from rodent experimental models, first
transmitted successfully from homogenised sheep brain in 1961 (Chandler 1961).
Subsequent studies have characterised many different murine scrapie strains based
on neuropathological changes and incubation period (Fraser & Dickinson 1973;
Dickinson 1976). Primarily the murine Sine gene, short for scrapie incubation, which
encodes a specific PrP sequence, determines incubation period. The difference
between s7 and p7 Sine genes lies in the amino acid sequence at two positions in the
protein; if it has leucine at position 108 and threonine at 189 it is designated Sine s7,
whereas if it has proline at position 108 and valine at 189, it is Sine p7 (Bostock,
2000). This difference in amino acid sequence exerts consistently different scrapie
incubation periods between the 2 genotypes, and the s7 or p7 sequences determine
whether a short or prolonged incubation period occurs respectively (Westaway et al.
1987; Hunter et al. 1992). These alleles can alter incubation period of a specific
scrapie strain by up to 400 days (Dickinson et al. 1968). Route of infection is also
known to regulate incubation period. The most efficient route of transmission is via
intracerebral (i.e.) inoculation, although alternative routes such as intraperitoneal
(i.p.), intravascular, oral, intraneural, subcutaneous and intraoccular inoculation have
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also proved efficient (Kimberlin & Walker 1979a; Bruce & Fraser 1981; Kimberlin
& Walker 1986). The species barrier is an important factor in disease transmission
with interspecies transmission being considerably less efficient than transmission
within the same species. However, those animals that do develop disease following
interspecies transmission are readily able to transmit disease within their own species
(Scott et al. 2000).
The introduction of transgenic mouse models led to the discovery that the species
barrier was regulated by amino acid differences between the donor and host prion
protein (Prusiner et al. 1990). Introduction of a donor prion gene to the host species
greatly increased the likelihood of developing the disease from the donor species,
and also reduced the incubation period. These results suggest that PrPd replication
occurs optimally if both the inoculated PrPd and PrPc of the recipient animal share the
same primary structure.
1.1.3. TSE pathology and the molecular properties of PrPc / PrPd
Prion diseases are generally characterised in the later stages of disease by the
development of lesions within the central nervous system (CNS). Vacuoles develop
within regions of the CNS, astrocytes become hypertrophic, while neurones
degenerate (Fraser 1993). These CNS changes co-localise with the accumulation of
the abnormal disease-specific form of a cell surface glycoprotein, designated PrPd or
PrPres. When compared with the normal form of PrP found at the cell surface of
neurons, the abnormal form of PrP is partially pro tease-resistant in nature. This
abnormal form of PrP also accumulates in the peripheral nervous system and
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lymphoreticular tissues of some naturally occurring diseases and many animal
experimental models. The normal cellular form of this protein (PrPc or PrPsen) is
sensitive to protease digestion and is expressed abundantly at the membrane of many
CNS cells (Manson et al. 1992; Ford et al. 2002), but also at lower levels in many
peripheral tissues (Oesch et al. 1985). However, it was noted that TSE pathology
could be present without the detection of protease-resistant PrP (Collinge et al.
1995). Similarly, protease-resistant PrP can be detected in the absence of infectivity
(Riesner et al. 1996) suggesting there may be a variety of forms of PrP associated
with infection that differ from PrPc or PrPsen. As a result of this ambiguity, the term
PrPc will be used to indicate the normal form of the prion protein in the absence of
pathology. Similarly, the use of PrPres implies the molecule has been tested for
Proteinase K (PK) sensitivity. This test is not possible using resin post embedding
methods, however, it is impossible to visualise PrPc in normal resin embedded
tissues, which would imply that the harsh processing involved in preparation of
tissues for ultrastructural study renders the normal form of PrP unobtainable. PK
treatment prior to immunohistochemical labelling of paraffin embedded TSE infected
tissues can determine whether the PrP present is sensitive or resistant to PK digestion
(Stack et al. 1996). The term "PrPsc" has also been used to describe disease-specific
PrP, which has been tested for PK sensitivity and the presence of (3 pleated sheet. In
this thesis PrPd will be used to indicate a form of the molecule that has not been PK
tested but coincides with infection.
Whether abnormal PrP is the causative agent of the TSEs or whether it is a by¬
product of an unconventional viral infection is still a contentious issue. Early studies
demonstrated that the TSE agents were highly resistant to UV radiation, which may
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therefore imply that they are devoid of nucleic acid (Alper et al. 1967). In addition,
no viral-like agent containing a nucleic acid genome has been discovered. However,
the interpretation of the original UV inactivation data has now been shown to be
erroneous (Rohwer 1991; Somerville 2002). If nucleic acids are present in infectious
extracts, they may be small, present in small amounts, and well protected by protein.
The "protein only" hypothesis initially proposed by Griffith (Griffith 1967), and later
updated (Prusiner 1989) was therefore advanced to explain this absence of nucleic
acid. The "protein only", or prion hypothesis has continued to gain ground over
recent years. In this hypothesis it is suggested that the causative agent is the altered
form of the normal cellular PrP protein. Infection is thought to occur as a result of
introduction of a conformationally modified form (the disease-specific form) of PrP
into the organism, inducing the additional formation of the same conformer of the
protein from the normal cellular precursor protein. The exact mechanism for this
conversion remains unclear, however, PrPc has been shown to be rich in a helices
while virtually devoid of (3 pleated sheets (Pan et al. 1993). In contrast, both Pan et
al. and Caughey et al. (Caughey et al. 1991) demonstrated that PrPd has a high (3
sheet content and a low a helix content, suggesting the conversion of normal PrP
into an abnormal disease-specific form appears to involve unfolding of the molecule
and refolding into (3 pleated sheets.
Normal prion protein function is unknown (Bueler et al. 1992; Sakaguchi et al. 1996;
Aguzzi & Weissman 1997; Ford et al. 2002); however, its location on the cell surface
indicates a role in signalling, cell adhesion or transport functions (Rieger et al. 1997).
Mice devoid of PrP develop and reproduce normally. It has however been suggested
that this may be due to the organisms compensation for the loss of the gene by over
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expression of others, or manipulation of alternative developmental pathways (Bueler
et al. 1992; Manson et al. 1994). More recently, Long-term Potentiation (LTP) of the
synapses of neurones within the CA1 region of the hippocampus was found to be
inhibited in mice devoid of PrP (Collinge et al. 1994), while altered circadian
rhythms (Tobler et al. 1996) and defects in copper metabolism have also been
identified in these mice (Brown et al.1997).
PrP-knockout mice do not develop experimental prion disease (Bueler et al. 1993),
demonstrating that the normal PrP molecule is necessary for infection to take place.
In addition, heterozygous mice carrying a single copy of the PrP gene are only
partially susceptible to disease with a considerably longer incubation period than
wild type mice, indicating availability of PrPc may be a rate-limiting factor in disease
progression (Manson 1996). Subsequent investigations involving neurografts in
transgenic and knockout mice further demonstrate the necessity for PrPc in prion
propagation within the CNS (Brandner et al. 1996 and reviewed by Aguzzi &
Weissman 1997). A similar study involving reconstitution of PrP-null (PrP"/_ or
PrP0/0) mice with wild type lymphohaemopoietic cells resulted in wild type levels of
prion titre within the spleen following scrapie inoculation, but no scrapie pathology
within the PrP expressing neurograft, again indicating PrPc is also required for
neuroinvasion (Blattler et al. 1997).
1.2. Peripheral stages of infection.
Peripheral infection of the lymphoreticular system (LRS) and Enteric Nervous
System (ENS) occurs in some TSEs. For example, the emergence of variant CJD
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(vCJD), presumably from the oral uptake of BSE contaminated foodstuffs, results in
infection of the PNS and ENS. The infectious agent although ultimately targeting
cells of the CNS, may initially infect peripheral organs in some forms of TSEs.
1.2.1. Lymphoreticular system involvement and neuroinvasion.
Bioassays of rodents and sheep experimentally infected by the peripheral route, show
initial infectivity is detected in tissues of the LRS, (Fraser & Dickinson 1970;
Kimberlin & Walker 1979; Bueler et al. 1993). In murine models of scrapie initial
neuroinvasion occurs via the splanchnic nerves that innervate the spleen (Kimberlin
& Walker 1988). Intragastric inoculation of 139A in mice leads to initial
accumulation of the infectious agent in intestinal Peyer's patches (Kimberlin &
Walker 1988), with CNS neuroinvasion occurring at two sites, one via the splanchnic
nerve and the other via the vagus (McBride et al. 2001). In naturally occurring sheep
scrapie, initial infection may be detected in the Peyer's patches, but initial sites of
replication can also be detected in the tonsils, retropharyngeal lymph nodes and the
spleen (Jeffrey et al. 2001b). Abnormal forms of PrP detected by
immunohistochemistry (IHC) can be identified in the peripheral nervous system in
both naturally affected (Van Keulen et al. 2000) and intraperitoneally inoculated
sheep scrapie (Groschup et al. 2000). Studies of natural sheep scrapie indicated more
specifically that sympathetic noradrenergic fibres might be responsible for the
transport of infectivity from the spleen to the CNS (Bencsik et al. 2001). However,
as not all sheep infected with TSE show evidence of peripheral PrPd accumulation, it
8
is possible that other routes may be involved . This will be discussed later in section
3.2.4.
1.2.2. Scrapie-specific cellular targeting within the lymphoreticular system
Many studies have indicated the importance of the LRS in TSE pathogenesis. Those
TSEs known to have a peripheral phase will show PrPd accumulation in LRS
components at an early stage of infection, however, until recently, accumulation
seemed to occur in the absence of an integrated immune response, with no
recognition of antigens by specific antibodies or previously sensitized lymphocytes.
As PrPd is a conformationally altered form of the normal cell surface protein, this is
not particularly surprising (Porter et al. 1973). It was considered likely that although
PrP antibodies are able to recognise conformational determinants of self-proteins, the
protein may be altered in such a way as to mask the abnormal part of the molecule,
or, alternatively, the abnormal form may be similar to another self-protein. Following
immunisation with purified protein, Prusiner at al. synthesised polyclonal antibodies
against prion protein in PrP-null mice (Prusiner et al. 1993), while more recently,
PrP-null mice were used to generate monoclonal antibodies against prion proteins
(Krasemann et al. 1996; Krasemann et al. 1999).
I.p. inoculation allows early detection of the infectious agent in the LRS
Subsequently, this route has been studied extensively in transmission experiments of
rodent scrapie. For many years, investigators have attempted to identify the cells
necessary for prion propagation within the LRS. Genetic asplenia, or surgical
splenectomy shortly before of after peripheral challenge increases the incubation
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period of TSE models, while genetic athymia or surgical thymectomy have no effect
(Fraser & Dickinson 1978). Whole body gamma irradiation before or after infection
also failed to alter scrapie incubation periods (Fraser & Farquhar 1987). Cell
fractionation techniques have demonstrated that, when separated into pulp and
stroma, a greater concentration of infectivity was observed in the stromal fraction
(Clarke & Kimberlin 1984). Taken together, these studies indicate a population of
radio-resistant cells, present in the splenic stromal fraction and not derived from the
thymus or bone marrow, are responsible for scrapie replication in the FRS. Based on
these findings, follicular dendritic cells (FDCs) have been proposed as the cells
necessary for prion propagation within the FRS (Fraser & Farquhar 1987). Using
immunohistochemical techniques, it was demonstrated cells morphologically similar
to FDCs with an immune trapping function also immunolabelled with antibodies to
PrP (McBride et al. 1992).
Studies involving severe combined immunodeficient (SCID) mice have further
indicated an important role for FDCs in FRS prion replication. These mice are
resistant to both i.e. and peripheral scrapie infection and have no functional B or T-
lymphocytes to influence the maturation of FDCs. This defect can be reversed by
reconstitution with immunocompetent bone marrow (Kapasi et al. 1993). In this
study, no PrPd accumulations were associated with FDCs in SCID mice, which
remained resistant to infection via peripheral inoculation. Similarly, SCID mice are
resistant to the ME7 strain of scrapie following peripheral infection with a moderate
dose of scrapie brain homogenate (10"2 or 10"3) (Fraser et al. 1996). However,
peripheral infection with a highly concentrated dose results in a 100% disease
incidence rate. It is likely that infection of peripheral nerves occurs directly without
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LRS involvement at high concentrations (Kimberlin & Walker 1988a). Direct i.e.
inoculation with either CJD or scrapie results in levels of i.e. infection in SCLD mice
similar to that found in the brain of comparable immunocompetent mice, while
immunocompetent bone marrow reconstitution of SCED mice also gives scrapie
incubation periods similar to that of immunocompetent control mice (Fraser et al.
1996).
In contrast to the above studies that implicate FDCs in peripheral infection and
replication of TSE agents, Klein et al. (Klein et al. 1997) suggested B cells play a
primary role in neuroinvasion of scrapie. Using a series of immunodeficient mice
lacking T cells, B and T cells, and B cells only, i.e. inoculation with the Rocky
Mountain Laboratory (RML) scrapie isolate resulted in the development of clinical
scrapie with similar incubation periods to that of immunocompetent controls. I.p.
inoculation only caused clinical scrapie in those mouse models that did not have B-
lymphocyte disruption. As no mature FDCs are present in B cell deficient models
(Klein et al. 1997), further investigation to demonstrate whether the resistance of B
cell deficient mouse models to peripherally inoculated scrapie is due to the lack of B
cells or mature FDCs, was necessary.
Although PrPc expression is necessary for the neuroinvasion of infectivity (Blattler et
al. 1997), it was later shown that B cells which lack PrPc do not impair scrapie
neuroinvasion in reconstituted SCID mice (Klein et al. 1998). This indicates that B
cells are not directly responsible for accumulation and transport of infectivity.
FDC maturation is dependent on cytokine signalling from B cells (Chaplin & Fu
1998). Tumor Necrosis Factor a (TNFa) and Lymphotoxin a (LTa) are structurally
related, secreted proteins, and can each interact and activate two defined TNF
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receptors, designated TNFRI and TNFRII. Lymphotoxin P (LTP) was later
discovered and exists in a membrane bound hetrotrimeric formation with one LTa
chain (LTa / P). This molecule does not show an affinity for TNF receptors but binds
through the LT P receptor (LTpR) (Fu et al. 1999). If the gene for TNFa or LTa is
deleted, follicles do not develop and FDC are absent (Pasperakis et al.1996;
Matsumoto et al 1997). Similar results are obtained if TNFRI is deleted, and in
addition, the defect cannot be corrected by reconstitution with wild type bone
marrow (Matsumoto et al 1997). In contrast, if TNFRII is deleted, FDCs and follicles
mature normally (Le Hir et al.1996). Deletion of the gene for LTP leads to partial
follicular alterations, while deletion of the LTpR has a similar affect to that of LTa
deletion (Rennert et al.1997).
When TNFa null (or TNFa7") mice and interleukin 6-null (IL67 ) mice were i.p.
challenged with the ME7 strain of scrapie, most TNFa "" mice failed to develop
scrapie up to 503 days post scrapie injection, while all IL-67" mice succumbed to
disease at the same timepoint as wild type mice. High levels of PrPd were also
detected in association with FDCs in the spleens of IL67"mice, while TNFa 7" mice
showed no PrPd accumulation. The authors concluded that mature FDCs are essential
for replication of the scrapie agent in lymphoid tissues and that in their absence,
neuroinvasion following peripheral challenge is impaired (Mabbott et al. 2000a).
FDC maturation can also be inhibited by lack of signal or by blocking the FDC
signal receptor. In the TNFa R1-deficient model, B and T cells remain fully mature.
Clinical scrapie has been observed in RML inoculated TNFa R1 -deficient mice, with
an incubation period similar to that of wild type control mice, following peripheral
inoculation with this strain of agent (Klein et al. 1997; Prinz et al. 2002). The authors
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of these studies suggested that B cells or macrophages and not FDCs as previously
suggested, play a pivotal role in scrapie pathogenesis. However, as splenic infectivity
titre was not measured in the TNFaRl -deficient mice, it cannot be excluded that due
to the high titres of infectivity used in the inoculum, disease entered the PNS, and
subsequently the CNS, without a LRS replication phase. Following treatment with
LT(3R:Ig, which is known to inhibit FDC development in a similar way to that of
TNF, neuroinvasion of the RML scrapie isolate after i.p. inoculation was impaired
(Montrasio et al. 2000; Prinz et al. 2002). However, it was demonstrated that lymph
node development was more severely impaired in LT than in TNF deficient mice,
which may imply the effect of TNF depletion is more easily overridden by a high
scrapie dosage than LT depletion (Fu & Chaplin 1999).
In addition to FDCs, macrophages of the LRS have been identified as reservoirs of
the TSE infectious agent. In some studies these cells have been shown to retain more
infectivity than lymphoid cells (Carp et al. 1994). In an in vitro system, mouse
peritoneal macrophages exposed to scrapie infection for prolonged periods were
demonstrated to produce longer disease incubation periods following re-inoculation
into indicator mice when compared to those cells exposed to infectious agent for a
shorter time period (Carp & Callahan 1982). In the early stages of scrapie
pathogenesis in the spleen, studies indicated that macrophages play the role of
scavenger cells. Using a cell suicide technique to transiently deplete all splenic
macrophage populations, the author's demonstrated accelerated replication of the
scrapie agent in the early stages of scrapie pathogenesis (Beringue et al. 2000). Both
studies indicate macrophages participate in the clearance of scrapie inoculum.
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1.2.3. Follicular Dendritic Cell involvement in scrapie pathogenesis.
To clarify the role of FDCs and B-lymphocytes in scrapie pathogenesis, Brown et al.
produced chimaeric mice by crossing SCID with PrP-knockout (SCID / PrP0/0) or
PrP wild type (SCID / PrP+/+) mice (Brown et al. 1999). The two models were
reconstituted with bone marrow from PrP+/+ or PrP0/0 mice respectively. Bone
marrow grafting is known to replace only B and T cells from the graft tissue itself,
while the presence of mature B cells allows host-derived immature FDCs to develop
normally (Brown et al. 1999). Subsequently, SCID / PrP+/+ mice reconstituted with
PrP0/0 bone marrow will express PrP on FDCs but not B or T cells, while SCID /
PrP0/0 mice reconstituted with bone marrow from wild type mice will express PrP on
B and T cells but not FDCs. Following peripheral infection with the ME7 strain of
mouse scrapie, SCID / PrP+/+mice reconstituted with PrP0/0 or PrP+/+ bone marrow
had high splenic levels of infectivity. Infectivity was not detectable in the spleens of
SCID / PrP0/0 reconstituted with PrP+/+bone marrow, thus indicating LRS
involvement in scrapie pathogenesis is directly dependent on PrP expressing FDCs,
and indirectly upon B cells which are required for FDC maturation.
Further investigation using the RML scrapie isolate as inoculum, has demonstrated
that reconstitution of PrP0/0 mice with PrP+/+ bone marrow results in high levels of
infectivity within the spleen, indicating replication of the RML scrapie isolate is
dependent on haemopoietic derived cells (Klein et al. 1998). This finding again
implies that different scrapie strains target different cells in the LRS, as occurs in the
CNS (Fraser 1976).
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The exact mechanism by which infection reaches lymphoid follicles and FDCs
remains unclear. However, as will be discussed in section 1.3.2.3, FDCs are
responsible for the trapping and retention of antigens in association with antibodies
on their cell surface. This trapping is initiated by the interactions of complement and
cellular complement receptors (Nielsen et al. 2000). A prolonged incubation period
of ME7 scrapie following peripheral infection in mice deficient in complement
components C3 or Clq, which are known to be critical for complex retention by
FDCs (Nielsen et al. 2000), was demonstrated (Mabbott et al. 2001). This suggests
that the complement system is involved in the initial trapping of the infectious agent
in lymphoid follicles.
1.2.4. Scrapie pathogenesis of sheep.
Although the TSEs have been extensively studied in rodent models, studies of TSEs
within sheep flocks remain at an early stage, with the pathogenesis of the natural
disease remaining relatively unclear.
Initial problems with studying the disease in sheep included difficulty in identifying
preclinical cases and the laborious nature of scrapie infectivity detection methods.
Sheep genotype was also identified as an important factor in susceptibility and
disease progression. Many of the early studies of natural disease were performed
without the knowledge of the PrP genotype of affected and exposed sheep (e.g.
(Hadlow et al. 1982).
However, in the mid 1990's, the study of ovine TSEs intensified. An
immunohistochemical method for the preclinical detection of PrPd in the tonsil of
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scrapie-infected sheep was identified (Schreuder et al. 1998; Van Keulen et al. 2000),
while studies of the effects of PrP genotype on scrapie susceptibility and incubation
period were being undertaken by a number of groups (Belt et al. 1995; Bossers et al.
1996; Elsen et al. 1996; Hunter 1996a).
More recently, immunoblotting techniques have become commonly used for large-
scale TSE surveillance and diagnosis. This technique detects the presence of a
protease-resistant form of PrP, which is present only in diseased animals (Katz et al.
1992; Beekes et al. 1995; Schaller et al. 1999). Nevertheless, immunohistochemical
methods remain a useful method for the detection of a range of different forms of
disease-specific PrP present in the tissues of infected animals. In particular,
immunohistochemical techniques have the added advantage of allowing accurate
cellular localisation of the agent (Gonzalez et al. 2003; Jeffrey et al. 2003).
Following ovine necropsy, immunohistochemical studies have shown that PrPd
accumulation occurs in the CNS and all lymph nodes of clinically affected animals
(Van Keulen et al. 1996). Histopathological studies have shown some variation in
intensity of neuropathological vacuolation, with the dorsal motor nucleus of the
vagus and the thalamic nuclei most commonly affected (Begara-McGorum et al.
2002; Ligios et al. 2002). Recognised PrPd labelling patterns within the brain
included intraneuronal, perivascular and neuropil associated, the profile or patterns
of which are scrapie strain specific (Gonzalez et al. 2002). The study also confirms
previous findings which suggested PrP genotype and sheep breed influenced the
susceptibility to disease and rate of PrPd accumulation within the brain (Bossers et al.
1996; Hunter 1996b; Hunter et al. 1997).
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The route of transmission of natural scrapie remains unknown to date; however,
extensive studies involving natural and experimentally infected flocks have
postulated many possible routes. The apparent early involvement of the alimentary
tract in some breeds of sheep has made the oral route a likely candidate (Jeffrey et al.
2001c).
Using a sheep genotype known to be highly susceptible to natural scrapie, it was
demonstrated that scrapie infection of the CNS occurs following initial PrPd
detection in the ENS. Histopathology results from sequential necropsies indicate that
the ENS acts as the initial entry point for disease to neural tissues, followed by
spread through the autonomic nervous system (ANS) firstly to the spinal cord and
then to the medulla oblongata (Van Keulen et al. 2000).
This study does not eliminate the possibility that other routes of CNS infection
follow natural scrapie infection, for example, a sympathetic noradrenergic
involvement following splenic PrPd accumulation (Bencsik et al. 2001). Lymphoid
tissues are infected at an early stage of disease and may act as an initial entry site for
infection to the CNS. However, a lymphoreticular phase of infection is not common
to all sheep genotypes (Van Keulen et al. 1995; Van Keulen et al. 1996).
Within lymph nodes of scrapie susceptible sheep, virtually all secondary follicles
showed PrPd accumulation. Labelling of CD21, which is known to be expressed on
FDC membrane surface and on B cells (Zabel & Weis 2001), co-localised with PrPd
immunolabelling only on cells morphologically similar to FDCs. This FDC pattern
of labelling was found in the light zone of the secondary follicle, while Tingible
Body Macrophage (TBM) type labelling was observed in the light, dark, mantle and
paracortical zone (Jeffrey et al. 2001b). PrPd labelling has also been detected within
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mononuclear cells of the periarteriolar lymphoid sheath (PALS) and within the
marginal zone (Heggebo et al. 2002). Although cell types involved in PrPd
accumulation have tentatively been identified as both TBMs and FDCs,
ultrastructural study is required in order to conclusively verify the association
between the disease-specific form of the protein and these cell populations.
1.3. The secondary lymphoid tissues
The secondary lymphoid organs are located at strategic sites within the body where
foreign antigens can be intercepted. Antigens in the blood are intercepted by the
spleen but localised antigenic challenges arising from individual tissues and external
sources are usually first dealt with in lymph nodes. Although lymph nodes and the
spleen are morphologically dissimilar, they share some common features that provide
the necessary microenvironment for the cellular interactions needed to remove
unwanted pathogens efficiently, and the subsequent development of immune
responses.
In this section, the spleen will primarily be discussed, with particular reference to
rodent spleen, as LRS involvement in scrapie pathogenesis has been most
extensively studied in this model.
1.3.1. Structure of the spleen.
The spleen, one of the largest lymphoid organs in mammals, is separated into two
major components, the red and white pulp, and is enclosed by a capsule of
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connective tissue. The red pulp consists of sinuses and cords and areas of capillaries,
venules and connective tissue. Sinusoids are lined by endothelial cells, supported by
reticulin fibres and separated by cords of Billiroth. The function of the cords is to
provide a blood supply to the sinuses from terminal arteries. Circulating monocytes
that differentiate into macrophages are also located within the cords. In addition,
these cords contain many transitory cells such as red blood cells, plasma cells, and
CD8+T cells, which are randomly scattered amongst macrophages (Weiss 1983;
Wilkins 1997).
The white pulp is organised around branches of the splenic artery and consists of
three highly organised compartments: the marginal zone, PALS, and the follicles
(van Ewijk et al. 1977). The marginal zone separates the red pulp from the PALS and
follicles, and is readily apparent due to the numerous, large memory B-lymphocytes
that have a distinctive open nuclei with little chromatin (Steiniger & Barth 2000). It
is also the pathway for B and T cell entry into the white pulp. This cellular region is
characterised by memory B cells expressing high levels of IgM and low levels of IgD
on the cell surface (Liu et al. 1988). The PALS region primarily contains CD4+ T
cells and some interdigitating dendritic cells, and forms a cylinder that encapsulates
the secondary follicle (Wilkins 1997). T cells can be morphologically identified as
small densely packed cells with little cytoplasm and small, very dark nuclei. This T
cell dominant area can be immunohistochemically detected by applying antibodies
against T-lymphocyte cell surface proteins such as alpha/beta T cell antigen receptor
(TCR) or CD5. Interdigitating cells are of a similar size, while the nuclei contain less
chromatin and are therefore less dark in routine histological preparations. They are
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characterised by their high levels ofMHC class II antigen expression (Steiniger &
Barth 2000).
Primary follicles are small groups of B-lymphocytes within a meshwork of
immature FDCs, and are usually attached to one side of the PALS region. Immature
FDCs, or their precursors, have no cytoplasmic extensions, while the cytoplasm is
limited and contains few organelles (Rademakers 1992). Upon antigenic stimulation,
their capacity to produce matrix elements is lost, while adhesion molecules,
complement and specific surface antigens, are created in turn (Heinen et al. 1995).
Primary follicular B-lymphocytes are characterised by their simultaneous expression
of both IgM and IgD, and by their expression of the high molecular weight form of
leukocyte common antigen (CD45R) (Steiniger & Barth 2000).
Immune stimulation of primary follicles leads to the development of germinal
centre-containing secondary follicles, as a result of the deposition of antigen /
antibody complexes on the surface of FDCs (Thorbecke et al. 1994). The function of
these germinal centres is B cell proliferation, selection and heavy chain switch.
Germinal centres consist of a light and dark zone; the dark zone of the follicle is
adjacent to the T cell compartment. It is populated by predominantly round, large,
tightly packed B blast cells with an irregular nucleus, which may contain up to three
peripheral nucleoli, while the cell cytoplasm contains large amounts of
polyribosomes and scarce cell organelles. These cells are known as centroblasts, and
undergo extensive mitosis. Non-differentiating centrocytes are the primary cell type
in the light zone of the follicle, and are less densely packed (Thorbecke et al. 1994).
They are irregularly shaped and have a small ring of cytoplasm containing free
ribosomes, coated vesicles and mitochondria, surrounding an indented nucleus.
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Centrocyte nuclei contain heavy marginal chromatin, an inconspicuous nucleolus and
occasional nuclear pockets (Rademakers 1992). An area rich in FDCs expressing
high levels of immune complexes supports this zone. FDC networks spread
throughout the germinal centre but are much denser in the light zone than in the dark
zone. Surrounding the germinal centre is the mantle zone that consists of small re¬
circulating B cells.
1.3.2. Lymphocyte circulation within the spleen.
The passage of lymphocytes through the spleen is essential to allow antigenic
surveillance, optimal cellular interactions within the spleen, and to maintain whole
body immunity. Unlike most other lymphoid tissues, the spleen lymphocyte entry
and exit is blood-borne and does not involve the lymphatic vessels. In rodents,
circulating lymphocytes initially enter the white pulp via the marginal zone (van
Ewijk et al. 1977). They arrive in the marginal zone either via the marginal sinus or
from capillaries (Weiss 1983; van Ewijk & Nieuwenhuis 1985). B-lymphocytes
move into the secondary follicle from the marginal zone, while T cells move into the
PALS. To leave the white pulp, both B and T cells can enter a side branch of the
central arteriole known as a marginal zone bridging channel which crosses the
marginal zone, and enter the red pulp (Liu & Banchereau 1996). The precise exit
route from the white pulp via these bridging channels has yet to be investigated.
Although lymphocyte recirculation within the white pulp of rodent spleen has been
extensively categorised, that of the exit route of lymphocytes from the white pulp
and subsequent red pulp recirculation remains equivocal (Steiniger & Barth 2000).
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1.3.3. Splenic function
Again, knowledge concerning both immunological and blood related functions of the
spleen have been acquired almost entirely from studies of rodents. Immunological
reactions including antibody production have been thoroughly studied, while the
spleen has been found to play an essential role in blood circulation and processing.
1.3.3.1. Red pulp
The red pulp is essentially a filtration unit for the blood but contains both filtering
and non-filtering areas. Blood from the splenic artery reaches the sinuses either
directly from the finest splenic arterioles, or indirectly from arterioles via splenic
cords. These two routes constitute the "closed" and "open" parts of splenic
circulation respectively.
The main filtration function of the spleen occurs within the cords which are
composed of reticular fibres, and are associated with many cell types; the most
important of these cells are macrophages which are thought to be responsible for the
removal of unwanted debris and effete red blood cells (erythrophagocytosis). The
walls of the sinuses themselves are also thought to have a filtering function (Steiniger
& Barth 2000). Antibody synthesis by plasma cells also occurs primarily within the
splenic cords that also contain large numbers of T-lymphocytes.
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1.3.3.2. The white pulp and immunological response to antigenic challenge.
Production of antibody can be induced in the spleen as a result of exposure to "T cell
independent "and "T cell dependent" antigens. Antigens which are composed of
glycoproteins, glycolipids and polymeric polysaccharides, such as are found on
viruses or bacterial capsules, are processed by T cell independent pathways
(Humphrey 1985; Mond et al. 1995). The antibody response by marginal zone B
cells to T independent antigens can occur in the absence of germinal centres and
memory cells, with non-T cell signals decisive in promoting antibody production.
However, studies have shown that under certain circumstances, specific memory
cells of the marginal zone can be provoked. This finding correlates with the fact that
T cell help during the antibody response to T independent antigens is reduced, but
not totally lacking (Mond et al. 1995). The mechanism of marginal zone B cell
stimulation by T cell independent antigens remains unclear. It has been suggested
that they may be stimulated directly by the T independent antigen via immune
complexes and / or complement receptors (van den Eertwegh et al. 1992).
Alternatively, some authors suggest marginal zone macrophages that accumulate
antigen play an important role marginal zone B cell stimulation (Humphrey 1981).
The T cell dependent pathway processes antigens rich in protein. The primary role of
white pulp of the spleen is in B cell reactions against protein antigens. These cellular
responses occur in different white pulp compartments and occur sequentially.
During the immunological response to antigenic challenge, the function and
morphology of germinal centres change markedly. Primary follicles are areas of the
white pulp that serve as recirculation sites for B-lymphocytes to survey FDC for
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specific attached antigen. If their cognate antigen is encountered, the B-lymphocyte
will remain in the follicle, proliferate and hypermutate. The life span of a germinal
centre depends on the amount of antigen present.
The first stage of a primary germinal centre reaction involves the activation of naive
CD4+ T helper cells in the T cell zone by antigen presenting cells (APCs), which
express antigenic peptide in association with MHC class II molecules (Figure 1.1).
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Figure 1.1. Diagrammatic representation of the sequence of events leading to
the activation and proliferation of T helper cells.
* Following MHC-II / antigen binding to the TCR molecule, co-stimulation of
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Figure 1.3. Diagrammatic representation of the signals involved in the initial
stages of B cell activation
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The attachment of the antigen peptide, in association with the MHC class II molecule
to the T helper cell receptor molecules (TCR), initiates activation of the nai've T
helper cell. In addition, the T cell CD4 molecule binds to the a and [3 chains of the
MHC class II molecule on the APC. The most important molecules for co-
stimulation of T cells by APCs, are two membranes receptor ligand pairs: the CD28
molecule on T cells which binds to the B7 ligands on the APC, and the CD40 ligand
on T cells which binds to the CD40 molecule on the APC (Steiniger & Barth, 2000).
Interleukin-1 (IL-1) receptor on the T cell also receives stimulation in the form of IL-
1 from APCs. Finally, IL-2 receptor is induced on stimulated T cells, and IL-2
signals serve to self-stimulate and induce T cell proliferation (Figure 1.2). In the
outer PALS region, the primed T helper cells meet antigen specific B cells. These B
cells have bound and internalised their specific antigen through cell surface
immunoglobulin receptors, and presented it together with MHC class II molecules on
the B cell surface. Antigen presented in this way is able to induce primed T cell help
in the form of CD40 ligand interaction, B cell B7 molecule and T cell CD28
molecule interaction, and IL secretion by B cells, while they pass through the outer
PALS region. The interaction of the B cell CD40 molecule and CD40 ligand on the
T helper cell, signal the B cell to activate transcription factor NFkB, and increase
surface expression of intracellular adhesion molecule 1 (ICAM-1). Thus, the bonds
between B cells and T helper cells are strengthened. A signal produced in the T
helper cell causes the secretion of cytokines including IL-4, which is essential for B
cell proliferation. T cell stimulation induces B cells to differentiate into short-lived
plasma cells that migrate to the cords of the red pulp (Figure 1.3). As these plasma
cells have not passed through a germinal centre, secreted immunoglobulin will be of
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low affinity (Ford 1975). If the antibody secreted by these cells then encounters its
specific antigen, immune complexes form, which localise on the FDC cell surface
attached to Fc or complement receptors (Tew et al. 1997). Subsequently, B cells
move into the primary follicle still attached to their cognate CD4+T helper cells,
which are also essential fro the formation of the germinal centre. As they divide, they
become large, metabolically active centroblasts, which become increasingly close
packed and form the dark zone of the follicle. The germinal centre or secondary
follicle reaction contains morphologically distinct light and dark zones constituting
the centrocyte and centroblast rich areas of the germinal centres, respectively. As a
result of T cell cytokine stimulation, centroblasts within the germinal centre
hypermutate to form non-dividing centrocytes with mutated surface immunoglobulin
within the light zone of the follicle. After hypermutation, the surface
immunoglobulin expressed by an individual centrocyte can have an affinity for its
specific antigen that is higher or lower that the un-mutated immunoglobulin. Thus,
the population of centrocytes in a germinal centre express immunoglobulins with a
range of affinities for a specific antigen. Survival of these centrocytes depends on
whether their surface immunoglobulin is bound to antigen retained by FDCs, i.e.
those centrocytes with high antigen affinity will preferentially bind antigen. These
antigens, in the form of immune complexes, are shed by FDCs and taken up by
centrocytes via their cell surface immunoglobulin. Antigenic peptides, derived from
the internalised immune complex, are presented on the centrocytes in association
with MHC class II molecules, and are then presented to primed T helper cells.
Subsequently, T cell CD40 ligand interaction occurs. (Figure 1.4). This induces the
centrocyte to express the Bcl-xL protein, which prevents apoptosis. If this process
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does not occur, centrocytes are programmed to die by apoptosis. T helper cells are
then stimulated to proliferate in the germinal centre, and can transmit signals in the
form of direct cell surface interactions or of cytokines, to the specific centrocyte sub-
population, allowing them to survive and switch expression of the low affinity IgM
to IgG by a process of somatic hypermutation. The particular isotype to which the
immunoglobulin switch is made depends on the cytokines secreted by the T helper
cell. Predominantly, IL-4, IL-5 and TGF-P are secreted. Somatic hypermutation is
the process by which DNA base changes occur during the lifetime of a B cell.
Immunoglobulin polypeptide mutations occur as a result of the recombination of the
variable (V) regions of the immunoglobulin gene. The mutated surface
immunoglobulin has an affinity for its specific antigen, and those centrocytes that
express immunoglobulin of low affinity are prone to apoptosis (Steiniger & Barth,
2000). Centrocytes with the greatest specific IgG survive longest in the germinal
centre. As the amount of antigen on FDCs decreases during the course of an immune
reaction, competition amongst centrocytes for this antigen increases. Only
centrocytes with a high expression of antigen will be "helped" by T cells.
Centrocytes that do not receive adequate T helper stimulation will eventually die
close to the dark zone. Centrocytes / FDC interactions are also necessary for
centrocyte survival (see section 1.3.3.3).
Surviving centrocytes then perform a number of different tasks. Centrocytes can
leave the germinal centre and redistribute around the body to locally differentiate
into plasma cells. Other centrocytes can develop into memory B cells to spread
specific immunity around the body. In this way the affinity of antibodies for a
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specific antigen increases during the course of an immune response and
subsequent exposures to the same antigen.
Cell surface antibody IgM switch to IgG
-Stimulated by IL secretion
FDC














BcI-Xl secretion No Bcl-xL secretion
Centrocyte survival Centrocyte apoptosis
Figure 1.4. Diagrammatic representation of the signals and cellular
interactions involved in the proliferation and immunoglobulin class switch of
centrocytes in the secondary follicle.
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It has further been speculated that centrocytes can move to the dark zone to revert to
centroblasts (MacLennan et al. 1997). The mechanism for differentiation of a
centrocyte into a memory B cell remains unclear. However, the B cell surface
receptor CD40 must react with the T helper ligand CD40, in order for this
differentiation to occur. In the absence of this CD40 interaction (Liu & Banchereau
1997), it has been shown that centrocytes maintained in vitro, terminally differentiate
into antibody-secreting plasma cells. There is generally a lack of consensus relating
to whether antibody-secreting cells are located at extrafollicular or germinal centre
sites. However, plasma cells may persist in the follicle under certain conditions such
as pre existing memory B cells or an excess of antigen (Steiniger & Barth 2000).
Unlike other lymphoid organs, splenic white pulp contains the marginal zone that
selectively retains IgM-positive memory B cells for certain types of T cell
independent antigens. In addition, the marginal zone also contains memory B-
lymphocytes to T cell dependent antigens. The marginal zone therefore plays a vital
role in the initial response to infection by some viral or bacterial pathogens.
1.3.3.3. Origin, function and morphology of FDCs
The exact origin of FDCs has yet to be established. Several studies on the ontogeny
of FDCs have indicated that they may be derived from the bone marrow, while others
suggest a stromal-derived origin (Heinen et al. 1995). Following the study of antigen
transport and bone marrow chimeras in SCID mouse models, it was concluded that
FDCs were of a bone marrow origin, hypothesising that Antigen Transporting Cells
(ATCs) are the precursor of FDCs (Kapasi et al. 1994; Yoshida et al. 1994; Kapasi et
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al. 1995). The location of ATCs within the lymph node indicated an origin outwith
the node itself. These cells appeared monocytic in morphology. Investigators also
noted that ATCs seemed to alter in morphology as they travelled along the pathway
from subcapsular sinus to the follicle, ultimately closely resembling the FDC (Kapasi
et al. 1994). Parallel in situ antigenic phenotyping demonstrated both cell types had a
similar phenotype, further supporting the conclusion that ATCs are the FDC
precursors. FDCs from bone marrow reconstituted SCID mice were also found to be
of donor phenotype, indicating bone marrow contained FDC precursors (Kapasi et al.
1994).
Following a SCED bone marrow reconstitution experiment similar to that described
above, FDCs were found to express the SCID host phenotype suggesting they were
not of a bone marrow origin (Imai et al. 1993). Ultrastructural studies highlighting
the structural similarities between the FDC and fibroblasts outlined the structural
characteristics of a population of cells morphologically similar to both fibroblasts
and FDCs, known as Fibrohistiocytoid Cells (FH). Their studies indicated that FDCs
might be derived from fibroblasts, while FH cells may be the intermediate between
the two cell types (Heusermann et al. 1980; Imai et al. unpublished data cited in
(Imai & Yamakawa 1996)). Although this matter remains an issue for contention, it
is generally accepted that FDCs are not bone marrow derived.
The regulation of the humoral immune response depends directly on lymphocyte and
accessory cell population interactions, during which FDCs play an important role.
The primary function of FDCs within the lymphoid follicles is the trapping and
retention of immune complexes via the C3b and Fc cell surface receptors. Complexes
are retained at the cell surface without undergoing endocytosis (Heinen et al. 1985;
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Radoux et al. 1985b; Tew et al. 1990), where they may remain from several months
or even years (Tew et al. 1997). FDCs trap antigen via complement receptors only
when it is complexed with an antibody and complement (Klaus & Humphrey 1977;
Radoux et al. 1985a). Ferritin was not observed in conjunction with FDCs in mice
that were not pre-immunised with this antigen, but, instead, was localised in large
quantities in macrophages. In contrast, after a secondary immunisation with ferratin,
sub-cellular analysis revealed accumulation of this antigen in the electron-dense
material surrounding FDC dendritic processes (Radoux et al. 1985a). In addition, the
ferritin antigen / antibody complex seemed to localise within the extracellular space
between adjacent dendrites, resulting in an almost uniform spacing between
dendrites. This arrangement could be due to the fixation of the antigen / antibody
complex on adjacent dendrites, the complex thus acting as a bridge. Antigen /
antibody complexes retained by the FDC may be involved in the periodic re-
stimulation of B, and perhaps, T cells (Heinen et al. 1995). In studies with aged mice,
it has been demonstrated that functional FDCs are required for the development of
antibody-forming cells, and subsequent secondary response (Kosco et al. 1989). This
study concluded that in young mice, FDCs readily attach antigen / antibody complex,
and subsequently stimulate the proliferation of centrocytes into antibody-forming
cells. However, in aged mice, it was observed that FDCs retained little antigen, and
released no immune complex coated bodies; thus, few antibody-forming cells were
formed. It was concluded that failure of old mice to respond to antigen was due to the
lack of functional FDCs and resulted in the absence of germinal centres (Szakal et al.
1990). This was further shown in aged mice that were unable to induce a normal
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secondary antibody response in the absence of released immune complex coated
bodies, termed "ICCOSOMES" (Szakal et al. 1989; Burton et al. 1991).
It is possible that circulating B cells trap antigen, move towards the germinal centre
where they present immune complex to FDCs (Heinen et al. 1986), however the
involvement of B cells at this stage remains controversial. The alternative hypothesis
now considered more likely, involves the binding of secreted low affinity antibodies
at extrafollicular sites to the respective antigen, which complex and finally localise
on the FDC in the primary follicle, although exactly how the complexes reach the
FDC in the spleen remains unclear (Tew et al. 1997). The major accessory cell role
of the FDC is in the stimulation of B cells. Antigen encountered within the primary
follicle leads to the induction of the germinal centre, where B cells rapidly proliferate
and divide. Immune complex-retaining FDCs can create a microenvironment for
centrocytes within the light zone of the follicle. The FDC-expressed antigen is then
believed to interact with specific immunoglobulin receptors on the centrocytes, thus
inducing proliferation into antibody-producing or memory B cells (Petrasch et al.
1991). B cells which are not surrounded, or "emperipolesed" by the FDC, are
considerably more likely to undergo apoptosis (Kosco & Gray 1992). The exact
mechanism for the inhibition of apoptosis by FDC emperipolesis, and also by T cell
stimulation was also investigated (Findhout et al. 1995). The primary characteristic
of apoptosis is the fragmentation of DNA by an endogenous endonuclease.
Following FDC interaction, endonuclease activity within B cells of the germinal
centre is irreversibly blocked. Both FDCs and T cells provide stimuli to B cells that
prevent apoptosis, and promote differentiation into memory or plasma cells. In
addition to Fc and complement receptors, many adhesion molecules are expressed on
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germinal centre FDCs, and also on B cells. These receptor molecules have been
shown to mediate cell to cell, or cell to the extracellular matrix binding and play an
important role in the interactions between these two cell types (Koopman et al. 1991;
Bosseloir et al. 1995). Stimulation of B cell adhesion molecules, cross linking of
immunoglobulin receptors by antigen associated with FDCs, and cross-linking of the
T cell CD40 ligand with B cell CD40, have been shown to prevent apoptosis of B
cells within the germinal centre (Koopman et al. 1997). It was later demonstrated that
FDCs are responsible for both the maintenance of anamnestic responses as a result of
antigen presentation, and, along with T cells (Kosco et al. 1992; Burton et al. 1995),
for co-stimulatory signals to induce B cell proliferation. FDCs also play an
important role in the induction of B cell response to chemotactic factors that induce
migration.
FDC complex retention relies on activation of complement. If activation does not
occur, complexes will not be retained on the FDC cell surface and ultimately,
memory B cells and antigen specific antibody will not be produced (Imai &
Yamakawa 1996). Complement receptors expressed by the FDC are necessary for
binding immune complexes, and the presence of complement receptors such as CD21
are essential for the production of antibodies against both T cell dependent and
independent antigen during the primary immune response. CD21 is also essential for
the long-term retention of immune complex within the germinal centre.
The expression of adhesion molecules by FDCs also plays an important role in B cell
binding to create the B cell / FDC network (Kosco et al. 1992; Ogata et al. 1996). In
addition, cytoplasmic processes of the FDC have been demonstrated to bind to
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extracellular fibres. This mechanism is thought to play an important role in the
creation of a three dimensional framework within the follicle.
In 1948, Marshall et al. reported metallophillic cells in germinal centres which were
later given the name "Dendritic reticular cells" due to their abundance of dendritic
extensions (Maruyami et al. in (Heinen 1995)). The morphological features of these
cells, later termed follicular dendritic cells, have been thoroughly described. FDCs
frequently have a large, clear, bi- or multi-lobed nucleus, delineated peripherally with
only a thin line of chromatin along the lamina densa. These features and the
restricted distribution of the cell to one pole of the light zone of the follicle assist the
morphological identification at the light microscopical level. Mature FDCs bear well-
developed cytoplasmic dendritic profiles, which extend between many lymphocytes
within the germinal centre of the follicle. Desmosomal junctions between dendrites
serve to maintain the convoluted dendritic network. The cytoplasm is sparse and
contains limited organelles. FDCs of the germinal centre were sub-divided into seven
distinct morphological types (Rademakers 1992). These categories were
distinguished on the basis of cell organelle content, cellular extension morphology,
the presence of plasmalemmal-associated electron-dense deposit, and the occurrence
of intermediate filaments. The distribution of FDC subtypes differs between the dark
and light zone, with the more primitive types predominantly located in the dark zone,
and more differentiated types appearing in the light zone.
S
37
1.3.3.4. Origin, function and morphology of TBMs
TBMs, so named due to their dark-staining, phagocytosed nuclear remnants in their
cytoplasmic vesicles, are normal constituents of the germinal centres of secondary
lymphoid tissues (Smith et al. 1998; Steiniger & Barth 2000). These cells are large
with indented nuclei and well-developed Golgi complexes, while many other cellular
organelles are present in small quantities. Many electron-dense granules, thought to
be lysosome precursors are also present, while the cytoplasm of activated
macrophages contains multiple developed lysosomes. This group of macrophages are
a subset of the long-lived mononuclear phagocytic cells, which are derived from
bone marrow, and after differentiation into blood monocytes, finally settle in a
specific tissue, which, in the case of TBMs, is the germinal centre of the spleen.
Macrophages may finally come to reside at many different locations. Their specific
function is partly determined by the microenvironment in which they are located
(Smith et al. 1998). Within the germinal centres of the follicles, B cells which fail to
produce functional immunoglobulin receptors by affinity selection (see section 1.3 2.
2.) undergo apoptosis and are removed by TBMs. This occurs via a mechanism
known as endocytosis, which can be divided into phagocytosis and pinocytosis,
depending on the size of the endocytosed vesicles. Pinocytosis occurs in most cells
and involves the ingestion of pieces of their plasma membrane in the form of small
pinocytic vesicles. These vesicles are formed from specialised invaginated areas of
the cell membrane, which are coated in proteins, predominantly clathrin. A dynamin
ring forms around the neck of the invagination to cause 'budding' of the vesicle into
the cell (Hill et al. 2001). As soon as the intracellular vesicle is formed, the clathrin
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and associated proteins dissociate from the membrane, and return to the plasma
membrane. The vesicle is then able to fuse with endosomes, where unless their
contents are specifically retrieved, will finally be digested by hydrolytic enzymes
within lysosomes. The movement of endosome contents from peripheral to
perinuclear endosomes and subsequently lysosomes remains unclear (Brown et al.
1986).
Macrophages are capable of ingesting many apoptotic cells, up to twenty have been
observed in a single macrophage (Ghadially 1982). Apoptotic B cells are engulfed by
TBMs by the process of phagocytosis. The apoptotic cells first attach to the
macrophage membrane; however, the receptors for this process are unknown.
Pseudopodia are extended around the dying cell and phagosomes are formed, the
diameter of which is determined by the size of the particle being ingested, and at this
stage, some components of the phagocytosed cellular plasma membrane are recycled
to the macrophage membrane, where they are presented in complexes with major
histocompatibility complex glycoproteins. This presentation then serves to stimulate
T helper cells to mount an immune response. However, TBM-enriched preparations
were shown to be poor antigen presenters and therefore were determined not to be
involved in the regulation of the germinal centre reaction (Smith et al. 1998). In
addition to the cell-scavenging role of TBMs, it has been suggested that these cells
are a major determinant of interleukin 2 suppression, thereby serving as regulatory
cells by downregulating the germinal centre reaction (Smith et al. 1998). As in
pinocytosis, endocytosed vesicles fuse with lysosomes, where the contents are
digested. Indigestible materials remain within the lysosomes to form residual bodies,
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while digested material is expelled into the cell cytosol where it is excreted or
reutilised by the cell (Bainton 1981).
Although it has been suggested that TBMs are resident germinal centre macrophages
(Kotani et al. 1982), it seems more likely, due to the transient nature of germinal
centres that these macrophages migrate to the germinal centre as a result of
immunological stimulation. Ultrastructural studies by Szakal et al. (unpublished data)
suggest they migrate into the germinal centre from the sub-capsular sinus. This is
supported by the findings of Smith et al. who failed to immunolabel macrophages
within primary follicles (Smith et al. 1988).
The kinetics of the TBM response have also been investigated, and it was
demonstrated that proliferation of B cells as a result of an immune reaction, directly
correlated with an increase in TBM numbers, and the ratio of B cells to TBM
remained relatively constant throughout germinal centre development (Smith et al.
1991).
1.4. Project background
Initial sub-cellular investigations of scrapie-infected tissues were undertaken in
murine brain (Jeffrey et al. 1994a; Jeffrey et al. 1995; Jeffrey & Goodsir 1996;
Liberski et al. 1996). These studies determined the sub-cellular localisation of PrPd
and its relationship to the pathological changes associated with disease in brain
tissue.
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More recent light microscopical studies have suggested follicular dendritic cells and /
or B cells of the LRS play a vital role in the peripheral pathogenesis of scrapie
(McBride et al.1992; Klein et al. 1997; Brown et al. 2000).
The investigations detailed in this thesis attempt to verify the hypotheses that PrPd is
located both intracellularly and extracellularly within the LRS, FDCs are intrinsically
involved in the accumulation of PrPd, and that sub-cellular pathology of the LRS
occurs following TSE infection.
1.5. Project aims
Light microscopical immunohistochemical and morphological analysis of TSE
infection within the LRS has been well documented during the past decade, however,
ultrastructural analyses have, to date, been limited.
This thesis will investigate aspects of scrapie infection within the lymphoreticular
system of mice and, to a lesser extent, sheep.
The principal aims of the study can be divided into technical, structural and
pathogenesis.
Technical development
To determine methods for the fixation of lymphoid tissues and labelling of PrPd. This
should permit both high quality preservation of cellular structure, while retaining




To determine the structure of the secondary follicles of murine spleen and sheep
lymph node in normal and scrapie-infected animals. Morphologic changes will be
sought from early in the incubation period through to the development of clinical
disease.
Pathogenesis
To determine the sub-cellular location of PrPd accumulation, and to relate this to the
pathogenesis of disease.
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2. MATERIALS AND METHODS
2.1. Experimental animals
2.1.1. Murine - C57B1 mice: ME7 inoculation (intracerebral - i.e.).
All experimental mice were maintained under specific pathogen free conditions at
the Institute of Animal Health (IAH) Neuropathogenesis Unit (NPU) in Edinburgh.
The ME7 strain of scrapie was used in the majority of experiments, as it is one of the
best-characterised strains. It has been established that i.e. ME7 scrapie inoculation
causes peripheral infection, therefore, due to the short incubation period, this
inoculation route was used for the initial experiments. As limited tissues were available,
either i.e. or intra-peritoneal (i.p.) inoculations were used for each of the other
experimental models. It was therefore impossible to directly compare experimental
models, however, this was taken into consideration when results were analysed.
C57B1 mice, infected with the ME7 scrapie strain by i.e. injection of 20 p.1 of a 1%
brain homogenate, were available for study. An average of 40 spleen tissue blocks
were taken from each of two scrapie-infected mice at day 70, and an average of 33
spleen tissue blocks were taken from each of three scrapie-infected mice at terminal
stages of the disease (mean incubation period approximately 170 days following i.e.
injection). From two age-matched (70 dpi) normal brain (NB) inoculated control
mice, 70 blocks of spleen tissue were available for examination, while 90 tissue
blocks were available from the NB inoculated control group at 170 dpi. At least 5
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tissue blocks were studied from each animal. An average of three white pulp areas
were present within each of the blocks studied.
2.1.2. Murine - Sheep red blood cell inoculation (SRBC).
C57B1 mice were challenged by i.p. injection with a 10"2 dilution of ME7 scrapie
brain or a homogenate consisting of normal mouse brain. I.p. ME7 inoculation gives
a mean incubation period of 270 days.
One group of ME7 infected, and one group of NB mice were given one
immunization of SRBC (1 x 107 SRBC in sterile saline in a total volume of lOOpl) or
saline, followed by a boost 21 days later (approximately 63 days post infection
(dpi)). A duplicate set of mice were immunologically challenged with SRBC or
saline at 240 dpi, followed by a boost 21 days later (approximately 261 dpi) (see
table 2.1). These mice were allowed to become terminally diseased. From each
experimental group, at least 5 tissue blocks containing white pulp areas were studied.
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Number of animals (average no. tissue blocks per animal)
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Table 2.1. Scrapie and SRBC innoculation. Table shows numbers of animals
/tissue blocks (numberwithin bracket) from each experimental group.
2.1.3. Murine - strain / agent studies. 139A. 79A, ME7, 87V. Scrapie inoculation
Phenotypic properties of different scrapie strains were analysed ultastructurally
within the spleen. Initial PrPd detection, incubation periods and cellular targeting
differences between TSE strains were compared. All mice were challenged i.e. with
a 10"2 dilution of the TSE agent.
Tissues from each of the inoculated groups were collected 5 weeks after scrapie
infection, 10 weeks after scrapie infection and finally at terminal disease (see table
2.2). At lease 5 tissue blocks containing white pulp were identified from each group
for study.
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The ME7 scrapie strain was originally isolated from a Suffolk sheep with naturally
acquired scrapie. Maintenance of the strain is achieved by serial passage in C57B1
mice.
The 79A scrapie strain was originally isolated from a goat which had been inoculated
experimentally with the SSBP / 1 scrapie strain. Passage was undertaken in C57B1
mice.
139A scrapie was isolated form a murine source that originated from the same
caprine source as 79A scrapie. The strain was maintained in C57B1 mice.
87V scrapie was originally isolated from a Cheviot / Border Leicester cross sheep
which had natural scrapie. Passage was achieved in a VM strain of mice.
Scrapie strain
(mouse strain) Number of animals (average No. of tissue blocks)
5weeks 10 weeks Terminal
ME7 (C57BI) 2 (29) 2(35) 2 (32)
79A (C57BI) 2(31) 2(35) 2 (30)
139A (C57BI) 2 (30) 2 (28) 2 (34)
87V (VM) 2 (36) 2(27) 4(35)
Table 2.2. Number of animals / average number of tissue blocks per scrapie
strain group at 3 different timepoints.
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2.1.4. Murine - cytokine inoculation
Signalling between lymphocytes and FDCs by cytokines is essential in the formation
of the germinal centre and maintenance of FDC networks (Matsumoto et al. 1997;
Pasperakis et al. 1996). These studies investigate the effect of the inhibition of
specific cytokine signals from B-lymphocytes on the sub-cellular localisation of
PrPd, and transmission of scrapie infectivity to the CNS.
2.1.4.1. Murine - Tumour Necrosis factor fusion protein inoculation
C57B1 mice (8 -12 weeks old) were treated i.p. with Human Tumour Necrosis Factor
Receptor Fusion protein (huTNFR: Fc) or human Immunoglobulins (hu-Ig) at either
14 or 38 days after i.p. injection, with 20 pi of a 1% dilution of brain homogenate
from a terminally affected scrapie mouse. Mice were sacrificed 7 days after
huTNFR:Fc / hu-Ig treatment. The experimental animals are detailed in Table 2.3.
Significant numbers of tissue blocks were processed and examined in each case.
These were examined by toluidine blue, initially to determine the structure of the
spleen, and in order to locate several secondary follicles in appropriate stages of
development and orientation. At least 5 tissue blocks were studied from each animal,
however, follicles were sparse in blocks from huTNFR:Fc treated animals.
Subsequently, many more blocks were studied from these animals. The precise
number of follicles detected varied from animal to animal and between experiment
groups.
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Table 2.3. Number of animal / average number of tissue blocks (number
within bracket) per treatment group.
2.1.4.2. Murine - Lymphotoxin [3 fusion protein inoculation
C57B1 mice were i.p treated with human Lymphotoxin (3 Receptor immunoglobulin
Fusion protein (LT|3R: Ig) or hu-Ig, at either 42 or 70 days after i.p. injection with
ME7 scrapie (20 pi of a 1% dilution of brain homogenate from a terminally affected
scrapie mouse). Mice were then sacrificed either 3 or 35 days after treatment.
At least 5 tissue blocks were studied from each animal from each experimental







Number of animals (Average No. tissue blocks per
animal)
hu-lg LTPR-Ig
42 (45) 4(27) 2 (23)
42 (77) 3 (23) 2 (20)
70 (73) 3(19) 2(21)
70 (105) 2(18) 2(19)
Table 2.4. Number of animal / average number of tissue blocks (number
within bracket) per treatment group.
2.1.5. Ovine studies.
For all ovine studies, mesenteric lymph node (MLN) from clinically affected Suffolk
sheep were used. Tissues were obtained from sheep of the most susceptible
genotype: prpARQ/AR(2. MLN was studied due to the consistency of infection and ease




2.2.1. Tissue fixation technique
2.2.1.1.Murine
Following a previously established animal perfusion technique protocol (see
Appendix 6.l.a), mice were anaesthetised and perfused with one of two aldehyde-
based fixatives (see Appendices 6.1.b and 6.1.C for fixative recipes). Spleen tissue
was chosen due to both the vast abundance of literature available regarding splenic
involvement in murine scrapie, and due to ease of tissue removal. Spleens were
removed following perfusion and immediately immersed in corresponding fixative
for 24 hours at 4°C.
Spleens were also immediately removed from mice following death by cervical
dislocation. Within 5 minutes, these tissues were sectioned into 2-3 mm slices, and
immersed in one of four fixatives for 24 hours at 4°C (see Table 2.5).
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Fixation Procedure Fixative
Perfusion 0.5% paraformaldehyde / 0.5% gluteraldehyde
Perfusion 4% paraformaldehyde / 0.1% gluteraldehyde
Immersion 4% paraformaldehyde / 0.5% gluteraldehyde
Immersion 4% paraformaldehyde /1 % gluteraldehyde
Immersion 0.5% paraformaldehyde / 0.5% gluteraldehyde
Table 2.5. Table showing details of initial tissue fixation study
Previous ultrastructural tissue processing carried out at VLA Lasswade, have
produced a standard technique for the processing of brain tissue, using 4%
paraformaldehyde / 0.1% gluteraldehyde as a perfusate. In order to identify whether
this fixative was equally useful for splenic fixation, various other fixative mixtures
were also compared. Phosphate buffer is relatively safe for handling, and exerts the
appropriate osmolality when combined with aldehyde-based fixatives (Hayat 1989).
Gluteraldehyde is the most commonly used fixative. It was demonstrated that
gluteraldehyde is the most effective fixative for the preservation of fine structure.
Using paraformaldehyde in conjunction with gluteraldehyde, has the added
advantage of rapid penetration of the tissue (Sabatini & Bensch 1962; Sabatini &
Bensch 1963).
Following standard techniques detailed in sections 2.2.2 - 2.2.4. and 2.2.6, these
tissues were processed, embedded in resin, sectioned and counterstained in order to
identify the optimal fixative and fixation procedure.
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Multiple blocks from each fixation group were studied, and quality of fixation judged
on the basis of overall tissue structure and the degree of organelle and membrane
preservation.
Spleens obtained from animals perfused with either 0.5% paraformaldehyde / 0.5%
gluteraldehyde, or 4% paraformaldehyde / 0.1% gluteraldehyde,
showed equally poor cell / cell apposition, mitochondrial turgidity and poor
membrane integrity. As a result of this, various adjustments were made to the
perfusion protocol (Appendix 6.1.a.). Chloral hydrate, which, in conjunction with
intracardiac perfusion is an accepted rodent anaesthetic, was used routinely for
murine perfusion. This is not barbiturate based and is unlikely to cause adverse
affects on the spleen such as splenic congestion.
Cannulation pressure was also decreased to 110-120 mm Hg (Hayat 1989) to ensure
no capillary damage of the highly vascularised tissue. However, tissue ultrastructure
did not appear to be improved by these modifications.
All immersion fixed spleens showed considerably greater membrane definition and
an improvement in tissue structure. Based on these findings, immersion fixation was
chosen as the standard fixation technique for murine spleen tissue. As no discernable
difference was apparent between different paraformaldehyde / gluteraldehyde
concentrations, that with the lowest gluteraldehyde content was chosen, as this
aldehyde is known to reduce the ability of antibody to recognise antigen (Totterdell
et al. 1992). Both 4% and 0.5% paraformaldehyde gave equally good results,
therefore the lower fixative content was chosen in order to reduce the possibility of
the fixative interfering with antigen recognition due to protein cross linking.
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2.2.1.2. Ovine
As with murine tissues, samples were immersed in various fixatives. 4%
paraformaldehyde / 0.1% gulteraldehyde was found to be the optimal fixative for
ovine lymphatic tissue. Paraformaldehyde is a slow penetrating fixative, while
gluteraldehyde fixes tissues in a short space of time and provides excellent
maintenance of tissue structure. However, gluteraldehyde is also known to impair
antigen localisation by altering cellular components (Glauert & Lewis. 1998). It was
therefore decided that the lowest possible concentration of gluteraldehyde should be
used. Where no gluteraldehyde was used, tissue structure was noticeably impaired.
2.2.2. Tissue processing
Following fixation, spleens were trimmed into 1 mm2 blocks and embedded in
araldite resin according to the protocol detailed in Appendix 6.1.d. Blocks were
cured at both 37°C and 60°C in order to determine whether curing temperature
affected tissue structure. Subject to the tissue block size, embedding capsules with a
conical or flat base were used. Following tissue sectioning and staining methods
detailed in sections 2.2.3, 2.2.4 and 2.2.6, structure of ovine MLN was analysed and
was found to be comparable to murine spleen in terms of tissue morphology and
preservation. Based on these previous criteria (see section 2.2.2.1), araldite-
embedded tissue cured at 60°C was used routinely for all ovine studies.
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2.2.3. Tissue sectioning
Flat-based resin blocks were trimmed into a conical shape using a Leica EM trim.
This method can be found in the instruction manual.
A Leica Ultracut E microtome was used to further remove excess resin from conical
resin blocks. Using a freshly cut glass knife, remaining resin is cut to form a sloping
rectangular shape, known as a mesa (see Figure 2.1). Mesa formation allows




Figure 2.1. A trimmed resin embedded tissue block.
2.2.3.I. LM sectioning
Prior to sectioning, plastic troughs (TAAB Laboratories Equipment LTD, Berkshire,
England; Agar Scientific LTD Essex, England) were attached to cut glass knives
using molten wax. Dental wax (TAAB) heated on a wax hot plate (Multiplate LKB,
Agar Scientific) was most commonly used. Freshly cut glass knives were used, and
formed a sealed water bath with the trough onto which cut sections were floated.
1 pm sections were cut from tissue blocks and floated into the water bath. They were
then stretched using a TAAB heat pen and removed using a fine hair. For
immunolabelling, sections were placed onto a water drop on BDH charged glass
slides, (VWR International Ltd., Leics) allowed to dry naturally then placed in a
60°C oven for 24 hours.
The protocol for staining 1pm sections is detailed in Appendix 6.I.e., and
protocols for immunolabelling 1pm sections are detailed in Appendix 6.1.g.
2.2.3.2. EM sectioning
Excess tissue was trimmed from blocks containing areas of interest. Orientation of
blocks was possible due to the formation of a mesa that could be directly correlated
with the 1pm immunolabelled sections.
55 nm sections were cut from blocks chosen for ultrastructural analysis using a 2.4
mm Diatome ultra diamond knife. Sections were straightened in the water bath using
the heat pen, and were lifted from the water bath by gold grids held by Dumont fine
forceps (TAAB). Excess water was removed from grids by touching fine filter paper
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to the periphery of the grid. Grids were allowed to air dry completely before being
placed in a dial-a-grid box (TAAB, Agar Scientific).
2.2.3.2A. Grid suitability for immunolabelling
Following initial investigations, standard nickel grids were found to be unsuitable for
use with formic acid pre-treatment, as grids disintegrated due to the intensity of the
acid reaction. Formic acid had a similar effect on copper and rhodium grids. The
inert nature of gold resulted in these grids being stable when incubated with formic
acid.
Due to the intense etching procedure required to expose ovine PrP, a smaller support
mesh was also required. 400 mesh gold grids were therefore used routinely when
immunolabelling murine tissue, while 600 mesh gold grids were used when
immunolabelling ovine tissues.
As nickel grids are considerably less expensive that gold grids, and no formic acid
treatment was required, sections were placed on 400 mesh nickel grids for all
counterstaining.
2.2.4, Light microscopical staining method
1 pm sections were stained using 1% Toluidine Blue dye. See Appendix 6.1. e.
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2.2.5. Light microscopical immunolabelling methods
1 pm sections were immunolabelled using one of the following techniques. Selected
blocks with appropriate immunolabelled areas were then taken for ultrastructural
studies. Although PrPc can be detected in cells of lightly fixed spleen by light
microscopy (McBride et al. 1992), the combination of fixatives and pre-treatments
employed destroys PrPc immunoreativity and reveals only PrPd accumulations.
Whether these deposits are protease-resistant, or protease-sensitive, cannot be
determined by the immunocytochemical methods described.
2.2.5.1. Peroxidase anti-peroxidase technique (PAP)
Initial murine studies were carried out using the peroxidase anti-peroxidase
technique (Appendix 6.1.f)
The peroxidase anti-peroxidase method is an indirect method; that is the antibody is
not directly labelled, but the secondary antibody binds to the primary antibody and it
is this reagent that is bound to the label. As more than one secondary molecule can
bind to the primary antibody, this step amplifies the reaction. A peroxidase anti-
peroxidase pre-formed conjugate then binds to the secondary antibody. The
peroxidase in this complex is involved in the visualisation reaction involving 3'3-
Diamiobenzidine Tetra-hydrochloride (DAB) and hydrogen peroxide. During this
reaction, peroxidase reacts initially with hydrogen peroxide, and then oxidises the
chromagen (DAB) to give a coloured product. See Figure 2.2a.
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2.2.5.2. Avidin Biotin amplification method (ABC)
This technique was used for all later immunolabelling of murine tissue, and all ovine
work (see Appendix 6.1.g). ABC kits are obtained from Vector Laboratories Inc.
Peterborough, UK. In both species, abundant FDC and intralysosomal TBM labelling
was present.
This is also an indirect labelling method, however, due to the affinity of avidin for
biotin the technique is considerably more sensitive. The avidin / biotin / HRP
molecule is bound to a biotinylated secondary antibody, which is attached to the
primary antibody. Again, peroxidase is the enzyme involved in the colour reaction.
See Figure 2.2b.
2.2.5.3. Envision system
The Dako Envision system (Appendix 6.1.h.) (DakoCytomation, Cambridgeshire,
UK), was used to immunolabel both murine and ovine tissue. Investigations showed
this system to be slightly less sensitive than the ABC technique, thus its use was
discontinued.
The technique is a direct method, whereby a polymer chain consisting of many
secondary antibodies bound to the primary antibody can bind a large number of
horseradish peroxidase molecules, which are then visualised using DAB as described




Peroxidase ^ Secondary antibody
Biotinylated secondary antibody Primary antibody
Anti peroxide antibody Antigen
Avidin molecule a Biotin molecule♦
Polymer chain
PaP-a ABC - b ENVISION - c
Figure 2.2. Diagrammatical representation of LM immunohistochemical
techniques used.
Figure2.2a. Peroxidase anti-peroxidase labelling. A secondary antibody is
attached directly to the specific primary antibody, followed by a peroxidase
anti-peroxidase molecule.
Figure 2.2b. Avidin-biotin complex immunolabelling. A biotinylated secondary
antibody is attached to the specific primary antibody. Avidin / biotin / HRP
complexes are then attached, amplifying the signal.
Figure2.2c. Envision system amplification. A polymer chain consisting of
many secondary antibodies bind to the specific primary antibody. This
complex also binds to a large number of horseradish peroxidase molecules.
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2,2.5.4 Antibodies - murine tissues
Polyclonal primary antibodies against PrP, previously shown to give excellent
labelling in murine tissues, include 1A8 and 1B3 obtained from the IAH - NPU in
Edinburgh (Farquhar et al. 1993). 1A8 was used routinely for all LM and
ultrastructural murine studies.
2.2.6. Ultrastructural staining method
Tissue sections mostly contain molecules of a low atomic weight, thus, they are
predominantly electron transparent (Hayat 1989). Ultrathin sections must therefore
firstly be stained with heavy metals to improve contrast.
The simplest method for staining 55 nm sections for EM analysis employs the heavy
metals lead citrate and uranyl acetate. The protocols for making these stains can be
found in Appendices 6.1 .i and 6.1 ,j. respectively.
These heavy metal stains are used in conjunction to label ultrathin sections
(Appendix 6.1 .k).
2.2.7. Ultrastructural immunolabelling method - murine
2.2.7.1. Use of Auroprobe 1 nm Immunogold silver stain technique (IGSS) for murine
studies - 1A8.
Ultrastructural immunological studies of murine splenic tissues were carried out
using the Auroprobe 1 nm gold probe (Amersham Biosciences, NJ, USA) as
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described in Appendix 6.1.1. See figure 3.5.7a. This probe consists of a gold
molecule attached directly to a secondary antibody.
2.2,7.2. Use of Nanoprobe lnm gold probe (Nanoprobes, NY. USA) with gold
enhancement for murine studies - 1A82
Nanoprobe 1 nm gold probe was substituted for Auroprobe 1 nm probe. Again, this
probe is a gold molecule directly conjugated to a secondary antibody. Using
Amersham silver enhancement, poor results were obtained on murine spleen tissue.
Using Nanoprobe gold enhancement with Nanoprobe gold probe (Figure 2.3a),
results were more positive, however, they were not comparable to those using
Auroprobe lnm with silver enhancement. Results from using Auroprobe 1 nm with
gold enhancement were considerably better than those from the original IGSS
technique (Figure 2.3b).
2 Ovine
Details of all methods specific to the ultrastructural visualisation of PrPd in ovine tissues are discussed
in chapter 3.5.
Figure 2.3a. x15K magnification. Terminally scrapie affected murine spleen.
Limited Immunolabelling is observed following immunolabelling with 1A8 anti
PrP serum, 1nm Nanoprobe immunogold and enhanced using Nanoprobe
goldenhance technique.
Figure 2.3b. x15K magnification. Terminally scrapie affected murine spleen.
Immunolabelled with 1A8 anti PrP serum, 1nm Auroprobe immunogold and
enhanced using Nanoprobe goldenhance technique. Considerably more
immunolabelling is present than the serial section above.
63
3. RESULTS
3.1. Sub-cellular sites of prion protein accumulation in scrapie-infected
mouse spleen
Introduction
In most experimental models, PrPdis a reliable indicator of the presence of TSE
infectivity (Diringer et al. 1983). Light microscopical studies have suggested that
both PrPc and PrPd are associated with follicular dendritic cells (FDCs) (Kitamoto et
al. 1991; McBride et al. 1992; Brown et al. 1999). Using immunogold electron
microscopy, the aim of this project was to demonstrate sub-cellular accumulation of
PrPd in the spleens of C57B1 70 days after i.e. infection with the ME7 strain of
scrapie and at the terminal stage of disease (170 days). Following i.p inoculation,
scrapie infectivity in the spleen is known to plateau at 70 dpi, however, no direct
con-elation can be made with the i.e. inoculated 70 day timepoint in this study. This
timepoint was therefore extrapolated from i.p. inoculation data.
This study was undertaken to try and better understand the cellular origin and sub¬
cellular distribution of PrPd in the spleen.
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Light microscopical and Ultrastructural staining and immunolabelling procedures.
Mice were obtained from IAH - NPU in Edinburgh (see section 2.1.1). C57B1 mice
were infected with an ME7 scrapie strain homogenate. An average of 40 spleen
tissue blocks were taken from each of two scrapie-infected mice at day 70, and an
average of 33 spleen tissue blocks were taken from each of three scrapie-infected
mice at terminal stages of the disease (mean incubation period approximately 170
days following i.e. injection). From two age-matched (70 dpi) normal brain (NB)
inoculated control mice, 70 blocks of spleen tissue were available for examination,
while 90 tissue blocks were available from the NB inoculated control group at 170
dpi. At least 5 tissue blocks were studied from each animal. An average of three
white pulp areas were present within each of the blocks studied.





At terminal stages of disease, PrPd was detected in the white pulp in of the majority
of macrophage-like cells with open nuclei containing little nuclear chromatin (Figure
3.1.1), and showing multiple intense puncta of labelling adjacent to the nucleus.
These cells were located throughout the white pulp and occasionally in red pulp
immediately surrounding white pulp, in the mantle zones, and in both the dark and
light zones of germinal centres. They were provisionally interpreted as TBMs. All
germinal centres were affected.
Another cell type, also with marginated nuclear chromatin and presumptively
identified as the FDC, showed a diffuse pattern of labelling adjacent to the nucleus,
and in a pattern suggestive of cytoplasmic processes (Figure 3.1.1). These processes
extended from the cell body.
Although more subtle, the patterns of PrPd labelling at 70 dpi were essentially the
same as terminally diseased spleens described above. No immunolabelling was seen
in the red or white pulp of age-matched, normal brain inoculated controls.
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Figure 3.1.1. Resin embedded spleen (1 |_im thick) from a terminally affected
mouse. The germinal centre shows two types of PrPd labelling. There is an




Uninfected tissues: morphology and immunolabelling
Control tissues did not show any immunolabelling when examined by electron
microscopy. In areas of white pulp directly adjacent to red pulp, small lymphocytes
between which were small FDC filiform dendritic processes could be seen. At the
centre of some areas of white pulp, secondary lymph follicles could be identified.
These follicles contained FDCs that had highly irregular nuclei and were often bi-
nucleate and occasionally multi-nucleate. The nuclei were clear with abundant
euchromatin and a distinctive band of heterochromatin adjacent to the nuclear
membrane. The perikaryonal cytoplasm was limited when compared with
lymphocytes, and contained moderate amounts of cell organelles. Dendritic
processes of mature FDC ran between germinal centre lymphoid cells. These
processes were often extensive and sometimes formed small knots; occasionally,
more complex arrangements of dendrites (labyrinthine glomerular complexes) were
present. Where several processes ran between cells they were usually uncomplicated
and ran in parallel straight or curved lines. No visible structural features were present
between the plasmalemmae of adjacent dendrites. Only rare desmosomes were found
joining two processes. In part of these follicles, lymphocytes were larger (the
germinal centre light zone), and between them, arranged in small knots, were more
complex branching processes (labyrinthine glomerular complexes) of FDCs (Figure
3.1.2). The processes were uncomplicated and associated with limited electron-
dense deposits, held in a uniform curvi-linear manner between the plasmalemma of
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adjacent dendrites. This electron-dense deposit formed an intermediate lamina
between dendrites and was held at roughly 0.14 pm from each dendritic process.
Figure 3.1.2. x17K magnification. FDC dendritic processes from an
uninfected mouse spleen (arrow). Simple FDC processes run between
lymphocytes. The associated electron-dense deposit is uniform and linear.
Figure 3.1.3. x50K magnification. Detail of labyrinthine glomerular complex
from the spleen of an uninfected mouse. The extracellular space surrounding
dendritic process plasmalemmae consists of an intermediate dense lamina
(arrows), bound on either side by two less electron-dense zones. This
assembly is of a consistent width.
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The intermediate lamina itself was on average 0.18 pm in width. FDCs of a similar
size and complexity were present in all control spleens (Figure 3.1.3).
TBMs, identifiable by their frequent lysosomes, abundant rough endoplasmic
reticulum and open nuclei containing mainly euchromatin with a peripheral margin
of heterochromatin, were identified in white pulp and less frequently in red pulp.
Scrapie-infected tissues: morphology and immunolabelling
In tissues obtained from ME7 infected mice at 70 dpi and at terminal disease, TBMs
showed marked immunogold labelling for PrPd within lysosomes (Figure 3.1.4). In
some of these lysosomes, immunogold deposits were concentrated at one particular
pole associated with a more electron-dense floccular material. Very occasionally,
TBMs showed immunogold affinity for fibrillar structures within a lysosome. Only a
proportion of TBMs were so labelled.
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Figure 3.1.4. x54K magnification. Intralysosomal TBM immunolabelling within
the spleen of a terminally diseased mouse. Short linear filamentous
structures are present within one lysosome (arrows).
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Figure 3.1.5. x28K magnification. Hypertrophic FDC labyrinthine complex
from the spleen of a terminally diseased mouse. Dendrites are highly
convoluted and abundant associated electron-dense deposit is present
between dendritic profiles.
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In addition to TBM labelling of secondary follicles containing mature FDCs,
intralysosomal PrPd labelling of macrophages was seen less consistently in the red
pulp, mantle zone and PALS.
At both timepoints, immunogold / silver complex labelling was also associated with
a second population of cells. These were characterised by a nucleus containing
abundant euchromatin and marginal heterochromatin and complex hypertrophic
branching processes (dendrites) which identified them as FDCs.
In the light zone of follicles obtained from spleens of clinically affected mice, the
FDC dendrites invariably formed large and complex labyrinthine glomeruli,
indicating a highly reactive response to stimulation. These were considerably larger,
with more florid branching and interweaving of dendritic processes than in control
tissues. Around each dendritic process, a significant margin of amorphous electron-
dense material was present (Figure 3.1.5). This electron-dense deposit was abundant
and irregular generally with the loss of the electron-dense lamina present in normal
tissues.
At both the terminal stage of disease, and, to a lesser extent at 70 dpi, a proportion of
immunogold labelling of both immature extended linear processes and mature
labyrinthine glomerular complexes was not associated with areas where the
amorphous electron-dense material situated between reactive FDC dendritic
processes was abundant. At these points, PrPd was seen to co-localise with the
plasma membrane itself. Labelling intensity of dendritic plasmalemma and the
complexity of branching of dendritic processes, increased in proportion to the
amount of electron-dense material within the extracellular space (Figure 3.1.6a).
This electron micrograph has been artificially coloured for ease of identification
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(Figure 3.1.6b). These changes were more evident in terminally affected spleens
when compared with the earlier stage of disease.
Immunolabelling of immature FDCs was rare in 70 day spleens and few mature
hypertrophic FDCs expressing PrP accumulations were present at this timepoint.
Most FDCs in the follicular light zones had relatively inconspicuous dendrites that
formed small knots of labyrinthine complexes interspersed between lymphocytes,
and, thus, were similar to controls. Any such processes had no obvious amorphous
electron-dense deposit at the plasmalemma, although some electron-dense material
was present around a minority of FDC dendrites.
Immunolabelling was generally weaker at the pre-clinical stage of disease, although
PrPd immunoreactive fibrils were located at both timepoints in the extracellular space
around some large labyrinthine complexes (see figure 3.4.1.1). These fibrillar forms
were seen within the extracellular space and generally involved the loss of the
majority of membrane-associated electron-dense deposit. Fibrils were of
approximately 20 nm diameter and from 40 to 300 nm long.
Coated pits were present at the surface of reactive FDC dendrites and adjacent
lymphocytes (see Figure 3.2.7). They were observed in both control and scrapie-
infected spleens, but numbers in scrapie-infected tissues were considered to be at
least doubled. These pits did not co-localise with PrPd accumulations.
Terminally differentiated plasmablasts with distended rough endoplasmic reticulum
containing electron-dense material consistent with accumulation of globulins, were
also present in the light zones of secondary follicles of all scrapie-infected tissues.
These were often fully surrounded, or engulfed by PrPd-expressing FDC dendrites.
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This process will be referred to as "emperipolesis". At this terminal stage of
differentiation, these cells are known as plasma cells (see Figure 3.2.8).
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Figure 3.1.6a. x13K magnification. Hypertrophic FDC labyrinthine glomerular
complex from the spleen of a terminally diseased mouse. PrPd
immunolabelling is clearly associated to a greater extent with the more
convoluted dendritic extensions. Immunolabelling is sparse in areas where
an intermediate dense lamina remains and excess electron-dense deposit
has not accumulated.
Figure 3.1.6b. Figure 6a has been digitally colourised to emphasise the lack
of PrPd immunolabelling (red), associated with the less convoluted dendritic
profiles that lack electron-dense deposit accumulation (green). The area
highlighted by the yellow rectangle shows limited dendritic complexity, which
correlates with little PrPd immunolabelling. The area immediately below this




These results confirm previous light microscopy studies showing that accumulations
of PrPd occur in the white pulp of spleen. Ultrastructural analysis revealed that PrPd
is associated with the plasmalemma of FDCs, and is localised intralysosomally
within macrophages. FDCs in scrapie-infected tissues demonstrated an exaggerated
or hypertrophic response to infection. Cell processes were elongated and
considerably more complex, forming large glomerular structures within the
secondary follicle, while electron-dense deposit previously presumptively identified
as antigen / antibody complexes which associated with these processes, was more
abundant in these tissues.
Although the antibody used does not distinguish between the protease-sensitive and
protease-resistant isoforms of PrP, it may be anticipated that at least some of the PrPd
accumulations, particularly those in fibrillar forms, would be protease-resistant. In
agreement with previous transmission and light microscopy studies (Brown et al.
1999), my observations do not suggest that PrPd accumulation occurs within B-
lymphocytes in ME7 scrapie-affected spleens (Klein et al. 1997).
During the development of germinal centres, FDCs lose the capacity to synthesise
matrix elements, and begin to produce specific surface antigens. As increasing
quantities of immune complexes are retained, imported by lymphoid cells or by other
means, the surfaces of FDCs enlarge, form plicae, and dendrites develop. Immune
complexes are bound to the cytoplasmic extensions (dendrites) of FDCs, where they
may remain for weeks or months. The mechanism of antigen / antibody complex
attachment was found to be the fixation of the antigen in the extracellular space to
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adjacent FDC membranes via the complexed antibody attachment to FDC expressed
C3b and Fc receptors (Bosseloir et al. 1995). These complexes are not endocytosed,
but are held at the surface of the dendrite by receptors. Free antigens are not bound
to the surface of FDCs. Antigen / antibody complexes serve to periodically re-
stimulate B cells although many of the complexes are deep within the cytoplasmic
invaginations of FDCs and not readily revealed to other cells.
In uninfected tissues, these antigen / antibody complexes form an ordered line or
lamina equidistant from FDC dendritic process plasmalemma. The ordered binding
of antibody / ferritin complex as an electron-dense line, within the dense material
between adjacent FDC membranes has been previously described (Radoux et al.
1985a). This would suggest the lamina seen in the extracellular space surrounding
normal uninfected FDC dendritic processes is a feature of the normal antigen /
antibody complex binding mechanism. However, no normal lamina was associated
with dendritic processes of FDCs in scrapie-infected tissues. Hypertrophic ME7-
infected FDCs did not show the tri-laminar assembly indicative of normal antigen /
antibody complex binding, but demonstrated an excess binding affinity for these
complexes. These complexes are visualised in the form of dendrite-associated
electron-dense deposit. Complex binding is greatly increased in these tissues
suggesting that the normal immune complex trapping mechanism associated with
normal FDC function has been disrupted in scrapie-infected animals, resulting in the
loss of lamina and subsequent FDC hypertrophy. Thus, as previously described, the
greater concentration of antigen / antibody complex in the extracellular space
surrounding FDC dendrites and subsequent increased attachment of immune
complexes to FDC plasmalemma, triggers FDC hypertrophy (Terashima et al. 1992;
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Heinen et al. 1995a; Heinen et al. 1995b). Insofar as it is possible to determine the
localisation of FDCs within the follicles of mice, immature FDCs similar in maturity
to those found in the dark zone of the follicle of other species, were similar in
controls and in infected mice. However, in presumed light zones all FDCs at
terminal stages of disease and a proportion of FDCs at 70 dpi had large and highly
complex labyrinthine glomeruli. This appears to represent an abnormal reactive or
hypertrophic change of FDCs compared to controls.
Unlike the FDCs described by Rademakers et al. (1992) in which classification was
based on both nuclear and dendrite morphology, unless otherwise specified, FDC in
this thesis will be defined on dendritic appearance alone. FDCs will be deemed
"mature" if inter-dendritic electron-dense deposits are observed, and dendritic
profiles are considered to be extended. Immature FDCs have no accumulated
electron-dense deposit and possess simple, unbranched dendritic profiles of limited
length. Dendrites of mature FDCs extend for considerable distances from the cell
body, interweaving between lymphocytes of the germinal centre. It is therefore often
impossible to determine which dendrites extend from a specific cell body. For this
reason, the above definitions will be used throughout this thesis. The term
"immature" is used frequently to describe FDCs associated with some
immunologically-altered models, for example SCID or TNF-null mice (Brown et
al.1997; Mabbott et al.2002). These authors employ molecular tools for FDC
classification, which do not directly correlate with those in this thesis.
Transmission studies using chimaeric mice in which some immune system cells carry
the PrP gene and some do not, and light microscopy immunocytochemical studies of
spleen and lymph nodes, suggest that mature FDCs accumulate PrPd. Our sub-
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cellular immunolabelling confirms that FDCs are associated with PrPd accumulation.
It could be observed that immunogold-labelled PrP is associated with the
plasmalemma of dendritic processes and not electron-dense deposits which suggests
that PrPd remains membrane-bound and is not released into the extracellular space
until stimulated to aggregate into a fibrillar form, as is also found in the brain
(Jeffrey et al. 1994b). However, the mechanism for this change remains unclear.
Where present, amyloid fibrils that are known to form from full-length PrPd correlate
with a marked reduction in excess antigen / antibody trapping. It is therefore
possible that some PrPd associated with the plasmalemma in scrapie-infected FDCs,
is directly responsible for excess complex trapping.
The observations presented in this study indicate that there is an excess accumulation
of electron-dense deposit at the FDC dendrite plasmalemma, increased complexity of
FDC dendritic branching and accumulation of excess or abnormal PrP associated
with scrapie infection. As attachment of immune complexes is the trigger for a
marked increase in the complexity of dendritic processes, the pattern of dendritic
branching and distribution of immunogold deposit in terminally diseased mice
indicates that the FDCs were highly stimulated by either (or both) of the abundant or
abnormal PrP, or by excess trapping of immune complexes. These findings suggest
that PrPd is involved in dendritic process elongation or in the process of trapping
immune complexes.
In support of this hypothesis, accumulation of PrPd associated with one cell type in
scrapie-infected sheep lymph nodes and spleen, is co-localised with the cell surface
marker CD 21 and is confined to the light zone of germinal centres (M. Jeffrey,
personal observations). Only fully mature, process-bearing FDCs express CD21 in
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the light zone. In the present study, at the terminal stage and to a lesser extent at 70
dpi, immunolabelling of FDCs with limited plasmalemma-associated electron-dense
deposits suggest that early PrPd accumulation may occur initially in the absence of
antigen / antibody complex trapping. In the terminal stages of disease, more linear
dendritic processes were associated with PrPd, indicating infection of immature
FDCs in the later stages of disease. This would suggest PrPd accumulation precedes
the follicular changes described.
TBMs ingest apoptotic cells, mostly B cells that are not selected to form clones of
immunoglobulin-producing cells. However, they also scavenge the ends of FDC
processes, and perhaps effete FDCs themselves (Smith et al. 1991). Intralysosomal
PrPd accumulation has also been seen within phagocytic cells of the CNS, including
microglia, astroglia and Kolmer or epiplexus cells. TBMs may be ingesting excess or
abnormal PrP. It is unclear whether this is the result of phagocytosis of entire
degenerate FDCs or their processes or merely by scavenging the extracellular space.
TBMs containing intralysosomal PrPd were found adjacent to PrPd accumulation
associated with FDCs and as individual labelled cells distant from other foci of PrPd
immunoreactivity. In terminally diseased animals, the presence of intralysosomal
PrPd labelling of macrophages outwith the germinal centre suggest that these cells
play an important role in the transportation of infectivity away from the secondary
follicle.
All known amyloids are formed within the extracellular space from precursor
proteins and therefore, as some macrophages possess intralysosomal filaments
consistent with amyloid, these at least would presumably have been internalised to
the macrophage from the extracellular space around FDCs.
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In the present study it has also been observed that scrapie-infected FDCs are
associated with the abnormal retention and maturation of B cells within the
secondary follicle (refer to plasmablast discussion, results page 73). If scrapie
infection of FDCs induces abnormal antigen / antibody trapping, the presentation of
these immune complexes to B cells may also occur abnormally or in excess, thus
inducing the prolonged retention of B cells within the secondary follicle. It is
generally accepted that FDCs shed part of their cell membrane and associated
immune complex (ICCOSOME), which then binds to B cell surface
immunoglobulins before being internalised (Szakal et al. 1988). During this process,
the FDC creates an enclosed environment that allows B cells to be selected based on
the affinity of their receptors for the antigen retained by the FDC. Perhaps the
release of immune complexes from the plasmalemma of FDCs exhibiting PrPd
accumulations is somehow impaired. Thus the emperipolesed B cell is not
stimulated adequately, no immune complex is internalised, and the cell is unable to
be released from the stimulating FDC. This might be due either to the alteration of
the mechanical FDC binding to the B cell itself via the immune complex, or the lack
of internal signal by the B cell to leave the secondary follicle. In support of this
hypothesis, plasma cell PrPd accumulation has not been observed.
At this stage, coated pit activity associated with FDC hypertrophy is also
upregulated. The reason for this increased pit activity remains unclear, however, it
can be hypothesised that although coated pits do not directly associate with the PrPd,
they may still relate indirectly to disease pathology. It has been noted that in purified
preparations of coated pits from the brain, PrPc co-localises with these structures
(Harris 1999). In diseased animals, normal PrP might be upregulated resulting in
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increased endocytic trafficking, however, this has to date, not been tested.
Alternatively, coated pits might be attempting to remove abnormal PrP from the cell
surface or plasmalemma. Abnormal increased frequency of coated pits also occurs in
scrapie-infected brain tissue (Ersdal et al. 2003).
Disruption of the normal immune complex binding mechanism and cellular PrPc-
trafficking, increased plasma cell retention within the secondary follicle and infection
of immature FDCs in the later stages of disease, all suggest a basic pathology and
possibly an alteration to immune system output, occur within scrapie-infected
tissues. It has previously been demonstrated that some scrapie infections upset the
control of IgG production, as increased amounts of IgG have been detected in
cerebrospinal fluid (CSF) of sheep, and serum of scrapie affected mice (Collis et al.
1979; Collis & Kimberlin 1983; Collis & Kimberlin 1989). However, what remains
unclear is whether the pathological effects and possible alteration to normal immune
function observed here are all scrapie-specific, or whether immune challenge from
any antigen could cause these sub-cellular reactions. In order to test the hypothesis
that scrapie alone causes these abnormal changes, normal mice must be antigenically
challenged and the splenic ultrastructure analysed for the presence of morphologic
and immunologic changes.
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3.2. An ultrastructural study of the morphological changes associated
with immune challenge in scrapie-infected mouse spleen.
Introduction
In the previous chapter, the experimental design rendered it impossible to determine
whether pathological responses described were specific to scrapie infection, or were
simply a part of the normal or exaggerated or otherwise altered immunological
response to antigenic stimulation in a scrapie-affected mouse. To help discriminate
between these possibilities, we immunologically stimulated scrapie-infected and
scrapie-uninfected mice, and examined the tissue response. As before, immunogold
labelling was used to determine the sub-cellular localisation of PrPd in scrapie-
infected and uninfected tissues, with and without immune stimulation.
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Light microscopical and Ultrastructural staining and immunolabelling procedures.
Mice were obtained from IAH - NPU in Edinburgh (see section 2.1.2). ME7 scrapie
was administered i.p, and is known to give a mean incubation period of 270 days.
One group ofME7 infected, and one group of NB mice were given one
immunization of SRBC or saline followed by a boost 21 days later (approximately 63
days post infection (dpi)). A duplicate set of mice were challenged with SRBC or
saline at 240 dpi, and were given one immunization of SRBC or saline followed by a
boost 21 days later (approximately 261 dpi) (see table 2.1). These mice were allowed
to become terminally diseased. Spleens were immersion fixed, processed and
labelled as described in sections 2.2.1. - 2.2.7. From each experimental group, at




At both 70 dpi and terminal stages of disease, morphological examination indicated
that reactive germinal centres were more abundant in scrapie and scrapie / sheep red
blood cell (SRBC) challenged spleens than in the corresponding NB and NB / SRBC
inoculated controls at these timepoints. The germinal centres from scrapie-infected
tissues showed PrPd labelling mainly within the secondary follicles, though some
TBM labelling was seen at the periphery of follicles. The intensity of
immunolabelling in the terminally diseased spleens was considerably greater than in
the 70 dpi spleens, with most follicles showing extensive PrPd accumulation of a
magnitude similar to that seen in Figure 3.1.1. PrPd immunolabelling provisionally
identified as TBM labelling, was also detected in the red pulp, mantle zone and
PALS of ME7 infected tissues. No immunolabelling was seen in spleens of age-
matched normal brain inoculated control mice, with or without immune stimulation.
Electron Microscopy
Uninfected tissues: morphology and immunolabelling
Tissues from normal brain homogenate inoculated mice and normal brain
homogenate inoculated mice treated with SRBC demonstrated very similar
ultrastructural morphology. When examined by electron microscopy, follicles of
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uninfected tissues contained FDCs at various stages of maturation. Mature FDCs
were confined to the secondary follicle. The ultrastructural morphology of uninfected
murine splenic tissue is described in detail in section 3.1. FDCs of a similar size and
complexity were observed in all control and immune stimulated uninfected spleens.
Within the secondary follicles, some FDCs appeared less mature as they had more
rounded, mono-nuclei and poorly developed processes. In contrast to other species
such as sheep and humans, lymphocytes within the germinal centre of rodents are
only slightly larger and paler than those outwith this area. This effectively means that
distinguishing between the light and dark zones in rodents is difficult using
morphological parameters alone (Steiniger & Barth 2000). The location of the
immature FDCs relative to the dark and light zones was therefore not determined.
Numerous TBMs, with phagocytosed nuclear remnants in their cytoplasm and
containing abundant lysosomes, were present within secondary follicles.
Occasionally whole degenerate (presumed apoptotic lymphocytes) cells were found
within the cytoplasm of these macrophages. Most lymphocytes showed little or no
evidence of differentiation within the light zone of the secondary follicle. Only rarely
did lymphocytes show signs of early B cell differentiation. These cells had distended,
oval or rough endoplastic reticulum (RER) containing floccular material. In the
mantle and PALS, occasional lymphocytes showed even more recognisable
differentiation towards plasma cells. Such cells had numerous cisternae of widely
distended RER containing an amorphous electron-dense material (presumed
immunoglobulins). No PrPd immunolabelling was detected in these tissues.
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Infected tissues: morphology
In tissues obtained from all terminally affected ME7 groups, the majority of dendritic
processes of FDCs within secondary follicles formed large labyrinthine glomerular
structures. These were estimated to be in the order of 10 to 20 times larger in
diameter than those of control tissues, with more florid branching and interweaving
of dendritic processes. The space between dendrites was markedly increased, and
contained an electron-dense material that apparently obliterated the intermediate
electron-dense lamina described in normal tissues. In some parts of hypertrophic
labyrinthine glomerular complexes the membrane associated electron-dense deposit
was not abundant, or was absent. Where the electron-dense material was limited, the
space between dendritic processes remained relatively constant. In these areas, the
intermediate electron-dense line could clearly be seen (see Figure 3.1.3). In yet other
FDC dendritic complexes, there was no abnormal electron-dense deposit and the size
and frequency of branching of dendrites was similar to that of controls. This was
more frequently the case in 70 dpi-infected mice that showed a similar yet more
restricted FDC response. The complexity of branching of dendritic processes, and the
abundance of extracellular electron-dense material were directly proportionate: less
complex branching of dendrites correlated with less electron-dense material. In
some of the highly hypertrophic labyrinthine glomerular complexes there was a
reduction in electron density of the material in the extracellular space around the
dendrites. Within these areas were short, usually single fibrillar structures though
occasionally small groups of randomly oriented fibrils were also seen (Figure 3.2.1).
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Figure 3.2.1. x35K magnification. Fibrillar structures associated with the
spleen from a terminally affected mouse treated with SRBC. Fibrillar
structures (arrows) are present in the expanded extracellular space
surrounding mature FDC dendritic profiles.
Figure 3.2.2. x8K magnification. Hypertrophic FDC complex from the spleen
of a terminally affected mouse treated with SRBC. A markedly hypertrophic
FDC labyrinthine complex with highly convoluted dendrites and abundant
associated electron-dense deposit is shown. Embedded within the
hypertrophic dendrites is a differentiating plasmablast (asterisk), which is
dwarfed by the hypertrophic FDC complex.
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When compared with terminally diseased ME7 infected tissues, both the overall size
of the hypertrophic labyrinthine glomerular complexes, and the amount of
extracellular material between labyrinthine glomerular complexes were increased in
SRBC challenged ME7 infected mice (Figure 3.2.2).
In both terminally diseased and SRBC boosted terminally diseased tissues, TBMs of
secondary follicles contained abundant lysosomal compartments. Apoptotic cells
were occasionally seen within these compartments, including B-lymphocytes with
distended RER. Similarly sized TBMs were observed in 70 dpi-infected spleens.
Well-differentiated plasmablasts with distended RER containing moderate electron-
dense material, presumed to be globulins, were present in the secondary follicles of
both ME7 and ME7 SRBC boosted tissues. They were frequently surrounded or
emperipolesed by FDC dendritic processes. Less mature B cells still with distended
RER were found in the secondary follicles of scrapie-infected animals. The
differentiated B cells were generally more abundant in all scrapie-infected tissues
than in either of the control groups.
Coated pits and vesicles were observed in all experimental groups, but these
structures were considerably more numerous in ME7 infected tissues. Up-regulation
was primarily confined to the plasmalemma of reactive FDC dendrites, although pits
were also observed less frequently at the cell surface of lymphocytes, adjacent to
infected FDCs. Infected FDCs at 70 dpi showed similar coated pit up-regulation.
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Infected tissues: immunogold labelling
Immunogold labelling of both immune stimulated and unstimulated ME7 mice was
associated with FDC dendritic plasmalemma of both immature extended linear
processes (Figure 3.2.3), and mature labyrinthine glomerular complexes. Where the
immunogold / silver reaction product was of a sufficiently small dimension, labelling
was generally associated with the plasma membrane itself. Only a minority of the
reaction product was found within the electron-dense material of the extracellular
space. This was conspicuous in the SRBC challenged animals where the extra¬
cellular electron-dense material was particularly abundant between separated
adjacent FDC dendrites making the distinctions between plasmalemma-associated
PrPd and PrPd accumulation in electron-dense material more readily apparent (Figure
3.2.4). Within the extracellular space surrounding some FDC labyrinthine glomerular
complexes, immunolabelled short fibrillar forms were observed.
Although immunolabelling of hypertrophic labyrinthine glomerular complexes was
identical in both 70 dpi and terminal spleens, subtle differences in the distribution of
immunogold labelling occurred in respect of immature FDCs and smaller groups of
dendrites. At 70 dpi, all PrPd accumulations were restricted to mature hypertrophic




immature FDC profiles from
the spleen from a terminally
affected mouse treated with
SRBC. A lymphocyte
emperipolesed by FDC
dendrites is shown at A.
Immunolabelling is associated
with the plasmalemma of




Figure 3.2.4. x17K magnification. Immunolabelled spleen from a terminally
affected mouse treated with SRBC. Detail of a hypertrophic FDC complex.
Immunogold PrPd labelling is primarily associated with the plasmalemma of
dendrites and not the adjacent electron-dense deposit. The abundant
amorphous electron-dense material is unstructured and lacks an intermediate
dense lamina.
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Figure 3.2.5. Schematic diagram showing relationship between immune
complexes and FDC in normal and scrapie-infected mice.
Figure 3.2.5a. Antigen / antibody complexes (blue circles) are held in the
extracellular space at a regular interval between FDC dendrites.
Figure 3.2.5b. Following scrapie infection, abnormal PrP (PrPd) accumulates
at the surface of FDC dendritic plasmalemma. This is associated with
increased extracellular electron-dense material (presumptively immune
complexes) and FDC hypertrophy.
Figure 3.2.5c. At early stages of infection, few FDCs within a germinal centre
/ secondary follicle show evidence of PrPd accumulation. However, where
PrPd accumulation is found, evidence of hypertrophy is present. In contrast,
at late stages of disease, almost all FDCs show PrPd accumulation. Most of
these are hypertrophic but occasionally PrPd can be found at the
plasmalemma of unreactive FDCs.
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Where labelling occurred it was invariably associated with more abundant amounts
of electron-dense material. At the terminal stage of disease, very few FDCs did not
form hypertrophic complexes. However, immunolabelling was found at the
plasmalemma of dendrites of rare immature FDC dendrites, where no intermediate
lamina was present and no extracellular electron-dense material was formed. These
observations suggest a progression of events illustrated schematically in Figure 3.2.5.
Large TBMs containing many apoptotic bodies within their lysosomes, were more
frequently observed within the secondary follicle of scrapie-infected groups than in
both the NB and NB / SRBC immunized control groups. In addition to TBM
labelling of secondary follicles, intralysosomal PrPd labelling of TBMs was seen in
the red pulp, mantle zone and PALS of both immune-stimulated and unstimulated
terminally infected ME7 mice (Figure 3.2.6). In some cases, PrPd accumulations
appeared to associate with dense floccular material within lysosomes.
Intralysosomal PrPd labelling of TBMs was not seen outwith the secondary follicle in
pre-terminal tissues.
As described above, coated vesicles and pits were more abundant in scrapie-infected
tissue groups. However, immunolabelling did not associate with these structures
(Figure 3.2.7).
Transformation of B lymphoblasts into plasmablasts and differentiated plasma cells
was associated with immunolabelled emperipolesing PrPd expressing FDC dendrites.
An association between lymphocyte emperipolesis and PrPd immunolabelling could
also be seen within areas of the follicle where labyrinthine glomerular complexes
were not observed. A full range of differentiating B cells could be visualised within
the follicle of all scrapie-infected groups, from undifferentiated lymphocytes to fully
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mature plasma cells (Figure 3.2.8). Less mature B cells, still with distended
endoplasmic reticulum similar to the maturity seen at the bottom of figure 3.2.8,
were found in the secondary follicles of both control and scrapie-infected animals;
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Table 3.2.1. Nature and frequency of the morphological changes in each of
the four groups.
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Figure 3.2.6. x8K magnification. Immunolabelled spleen from a terminally
affected mouse treated with SRBC. Lysosomal TBM labelling is seen in the
red pulp adjacent to a capillary containing erythrocytes.
Figure 3.2.7. x22K magnification. Immunolabelled spleen from a terminally
affected mouse treated with SRBC. Numerous coated pits are associated
with FDC dendritic profiles (arrows), but are not associated with immunogold
labelling. Immunogold plasmalemmal PrPd labelling is present both in areas
with and without excess electron-dense deposit.
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Figure 3.2.8. x9K magnification. Immunolabelled spleen from a terminally
affected mouse treated with SRBC. Two differentiated B cells emperipolesed
by PrPd accumulating FDC dendrites are shown. The B cell indicated by an
asterisk is terminally differentiated and shows endoplasmic reticulum
organised into globulin-producing compartments (red arrow). The B cell




Following on from initial investigations described in section 3.1, this study confirms
that the pathological changes observed within the spleen, previously hypothesised as
a specific response to scrapie infection, are not present following SRBC antigenic
challenge and are therefore likely to be scrapie-specific.
All scrapie-infected tissues studied, whether or not challenged with SRBCs,
demonstrated an exaggerated or hypertrophic response of FDC dendrites within
germinal centres. Cell processes were elongated and considerably more convoluted,
forming large glomerular structures within the secondary follicle, while an electron-
dense deposit accumulated around and between these processes. Both the
accumulated electron-dense material and the hypertrophic FDC glomerular responses
were more conspicuous in the scrapie / SRBC challenged animals than those infected
with ME7 scrapie alone.
In uninfected tissues, an ordered electron-dense line or lamina, equidistant from FDC
dendritic process plasmalemma, could be seen within extracellular electron-dense
deposit. This line was visualised as a tri-laminar assembly in conjunction with two
FDC plasmalemmal membranes. As discussed in the previous section, antibody /
ferritin complex binds to adjacent FD plasmalemmae in the form of a line,
equidistant between adjacent FDC membranes (Radoux et al. 1985a). The
mechanism of antigen / antibody complex attachment was later shown to be the
fixation of the antigen in the extracellular space to adjacent FDC membranes via the
complexed antibody attachment to FDC receptor molecules C3b and Fc (Bosseloir et
al. 1995). This would suggest the electron-dense lamina seen in detailed electron
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micrographs of the extracellular space surrounding normal uninfected FDC dendritic
processes is the site of normal antigen / antibody complex binding.
The extracellular space around hypertrophic ME7 infected FDCs did not show the
tri-laminar assembly indicative of normal antigen / antibody complex binding, but
demonstrated an abundant electron-dense material within the extracellular space.
Because of its location and similarities in the electron density of the intermediate
dense line, I suggest that this is representative of accumulated antigen / antibody
complexes, although the exact nature of these complexes is yet to be determined. An
abnormal or excessive antigen / antibody complex trapping by FDC dendrites with a
subsequent breakdown of the normal binding and structural relationships between
antigen-antibody complex receptors is therefore implied by the presence of abnormal
amounts of this extracellular electron-dense material. The amount of FDC
hypertrophy, and extracellular electron-dense material was greater in SRBC
challenged ME7 infected animals when compared with mice infected with ME7
alone. It has previously been shown that the triggers for FDC process extension are
an increased concentration of antigen / antibody complexes in the extracellular space
surrounding FDC dendrites, and the subsequent attachment of these complexes to
FDC plasmalemma (Terashima et al. 1992; Heinen et al. 1995). Thus, the increase in
FDC hypertrophy and assumed immune complex attachment in SRBC boosted
scrapie-infected tissues may simply be due to an increase in available antigens and
complexes.
In the present study, I have noted changes that suggest scrapie infection
perturbs the processes of B cell maturation and development. In the normal situation,
antigen / antibody complexes retained at the surface of FDCs, and the presence of
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CD4+T-lymphocytes are initial requirements for the formation of a germinal centre
follicle. Where primed circulating B cells recognise their cognate antibody held at
the surface of FDCs they cease their cycle of recirculation, proliferate and
hypermutate. Many hypermutated B cells (centrocytes) are immediately destroyed by
apoptosis, but B cells with improved antigen binding affinity of their surface
immunoglobulins survive. Interaction with CD4+cells results in affinity maturation
of the immunoglobulin produced by centrocytes. Some centrocytes become memory
B cells; others join the pool or recirculating lymphocytes, while others migrate into
body tissues where they further differentiate into long-lived antibody-secreting
plasma cells.
Increased numbers of plasmablasts, and morphologically mature plasma cells were
observed to be present within the germinal centre of scrapie-infected spleens when
compared with controls. In addition there is an increase in the number of TBMs
containing large amounts of apoptotic debris (presumed apoptotic B cells).
I therefore suggest that scrapie infection leads to an increase in the number of B cells
that are selected for hypermutation. Although many of these will undergo apoptosis,
many continue to survive and are retained beyond the normal states at which they
would migrate from the germinal centre. If scrapie infection induces FDC
hypertrophy and subsequent abnormal antigen / antibody trapping by facilitation of
the C3b or Fc receptor binding or by impairing the release of transiently attached
immune complexes, the presentation of these immune complexes to B cells may also
occur abnormally or in excess, thus inducing the prolonged retention of B cells
within the secondary follicle. During this process, the FDC creates an enclosed
environment that allows B cells to be selected based on the affinity of their
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immunoglobulins for the antigen retained by the FDC. It can be hypothesised that the
release of immune complexes from the plasmalemma of FDCs from scrapie-infected
spleens is somehow impaired. Thus the emperipolesed B cell is unable to be released
from the stimulating FDC. Whether these morphologically mature B cells are in fact
secreting antibody was not tested in the present study.
At all stages of ME7 infection in mice, with and without SRBC stimulation,
increased numbers of coated pits and vesicles are found in association with FDC
hypertrophy. The reason for this increased coated pit activity remains unclear,
however, it can be hypothesised that although coated pits do not directly associate
with the disease-specific form of PrP, they may still relate indirectly to disease
pathology (Harris 1999). Immunogold labelling was found at the plasmalemma of
FDC dendrites and in adjacent associated extracellular space, on extracellular fibrils
and in lysosomes of TBMs. As in the previous study, the intensity of
immunolabelling is increased in proportion to the tortuosity of process convolutions,
complexity of branching of dendrites and the amount of extracellular electron-dense
material. In the present study a smaller size of immunogold reaction product allows
for the localisation of the majority of FDC associated PrPd to the plasmalemma of
dendrites within labyrinthine glomerular complexes. That most immunogold labelled
PrP d associates with the plasmalemma of dendritic processes and not electron-dense
deposit suggests PrPd remains membrane-bound and is not released into the
extracellular space. A minority of extracellular PrPdis located within the extracellular
space around FDC dendrites, mostly visualised on fibrils. These FDCs are
conspicuous not only by the increased amount of fibrils within the extracellular
space, but also by the lack of membrane associated electron-dense deposit and highly
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convoluted dendritic profiles. The mechanism or sequence of events leading to PrPd
aggregation, complex release and increase in dendrite complexity remains unclear.
These findings suggest that PrPdis initially attached to the FDC membrane until
released or otherwise stimulated to aggregate and form fibrils.
The amounts of extracellular electron-dense material, dendritic hypertrophy and
tortuosity and plasmalemmal PrPd are directly proportional to each other. However,
in terminally diseased mice, some immature FDCs that lack any intermediate dense
lamina between FDC dendrites, or in some cases lack any extracellular electron-
dense material, show PrPd accumulation at the plasmalemma. The accumulation or
presence of PrPd at the plasma membrane would appear to precede pathological
change. As both the accumulation of electron-dense material (presumed immune
complexes) and hypertrophy of FDCs are considered to be the sequel to increased
immune complex trapping, I suggest that excess PrPd retained at the FDC dendritic
plasmalemma may enhance capacity to trap complexes via C3b or Fc receptors. PrPd
accumulation at the plasmalemma of immature FDCs may be interpreted to suggest
that PrPd accumulation at the cell surface initiates this chain of events.
In this and previous studies of both sheep and mice infected with scrapie, I have
found that all or virtually all follicles at the stage of terminal disease are scrapie-
infected, as shown by the accumulation of PrPd. This further suggests that follicles do
not regress but are stimulated to continue to produce antibody. That excess numbers
of mature plasma cells are present is also consistent with delayed or impeded B cell
migration from the follicle. PrPd immunolabelling was observed at the plasmalemma
of all emperipolesing FDC dendritic profiles.
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Again, within the spleens of terminally diseased animals, intralysosomal PrPd
labelling of macrophage was apparent outwith the germinal centre, suggesting these
cells play an important role in the transportation of infectivity away from the
secondary follicle.
In summary, several scrapie-specific changes have been identified in the spleens of
scrapie-infected mice. Taken together, the loss of the membrane associated electron-
dense lamina, FDC hypertrophy and increased plasma cell retention within the
secondary follicle all suggest that germinal centre functionality is pathologically
affected as a result of scrapie infection. The nature of these changes suggests that
there is a change in immune complex binding mechanisms, normal plasma cell
maturation and perhaps cellular PrPc trafficking. I can speculate that these changes
are due to the presence of abnormal PrP at the surface of FDCs and that this PrPd
retains a functional role in facilitation of immune complex trapping. In order to
challenge disease at the cellular level, the sub-cellular progression of the disease
must also be clearly understood; we have shown PrPd accumulation precedes
immunopathology while PrPdmay be transported from the germinal centre in
macrophage lysosomal compartments. PrPd accumulation associated with the
plasmalemma of FDCs has a function: it is directly related to excess immune
complex trapping which in turn induces FDC hypertrophy. While the exact
mechanism for the delayed release of B cells from the secondary follicle and increase
in coated pit expression are unknown, it is clear that scrapie infection induces these
pathological effects. It can therefore be concluded that scrapie infection causes both
morphological and functional pathology of the LRS, and seems to alter the way in
which the host responds to immunological challenge.
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3.3. Ultrastructural strain specific localisation of disease-specific PrP in
murine spleen.
Introduction
The importance of FDCs in the neuroinvasion of the ME7 strain of scrapie has been
extensively discussed in previous sections. However, the involvement of FDCs in
disease progression has to date, only been tested in the ME7 scrapie strain and Rocky
Mountain Laboratory (RML) isolate(Klein et al. 1998; Weissmann et al. 2001).
Different murine scrapie strains have different incubation periods when inoculated
by i.e., oral or peritoneal injections (Kimberlin & Walker 1979b). Neuroinvasion
takes place at approximately 50% of the incubation period after i.p. challenge.
This investigation aims to ascertain whether different TSE strains target different cell
types in murine spleen. In the event that FDCs are invariably targeted by different
scrapie strains, the structure of the secondary follicles will be studied to determine
whether the nature and progression of morphological changes are the same in models
with differing incubation periods.
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Materials and methods
Mice were obtained from IAH - NPU in Edinburgh (see section 2.1.3). Scrapie-
infected tissues taken are detailed in table 2.2. Spleens were immersion fixed,
processed and labelled as described in sections 2.2.1. - 2.2.7. Phenotypic properties
of different scrapie strains were analysed ultastructurally within the spleen. Initial
PrPd detection, incubation periods and cellular targeting differences between TSE
strains were compared. All mice were challenged i.e. with the TSE agent.
Tissues from each of the inoculated groups were collected 5 weeks after scrapie
infection, 10 weeks after scrapie infection and finally at terminal disease (see table





5 weeks after scrapie infection: within the spleens of all scrapie-infected groups,
white pulp areas were easily distinguished. These areas varied greatly in size,
although no consistent pattern was seen when the different strains were compared.
FDC like cells were identified within the white pulp areas of all scrapie strains
studied, while cells presumptively identified as TBMs were present both within the
follicle and adjacent sites.
10 weeks after scrapie infection: the morphology of the spleens of mice at the
lOweek after scrapie infection timepoint was not subjectively different from those at
the 5 week timepoint. White pulp areas were easily identified, and contained both
FDCs and TBM like cells.
Terminal stages ofdisease: again, distinct white pulp areas were identified within the
spleens of all experimental groups.
Light microscopy: PrPd immunolabelling
5 weeks after scrapie infection: PrPd immunolabelling was observed only in the
spleens of mice infected with the 139A strain of scrapie. This labelling present in
very few follicles, and, where present was not abundant. It was consistent with an
FDC-type pattern of labelling as described in the previous sections 3.1 and 3.2. No
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immunolabelling was seen in any of the tissue blocks studied from the 87V, 79A or
ME7 scrapie-infected groups at the 5 week timepoint.
10 weeks after scrapie infection: spleens from 79A, ME7 and 139A scrapie-infected
groups showed PrPd accumulation within the secondary follicles. Within the spleens
of mice infected with the 87V strain of scrapie, no immunolabelling was observed.
Within spleens from mice infected with the 139A, 79A and ME7 strains of scrapie,
PrPd immunolabelling was widespread, with the majority of follicles affected.
Patterns of labelling within the follicles from these infected animals are consistent
with both FDCs and TBMs. No labelling was observed outwith the follicle in any of
these spleens.
Terminal stages ofdisease: within the white pulp of spleens from the 139A, 79A
and ME7 scrapie-infected animals at the terminal stage of disease, extensive PrPd
immunolabelling was observed. Patterns of labelling indicate PrPd is associated with
both macrophage and FDC-like cells. Immunolabelling was present within the dark
and light zones of most follicles in the spleens of mice infected with the 139A, 79A
and ME7 strains of scrapie. Occasional intense puncta of immunolabelling were
observed adjacent to red blood cells outwith the follicle, and in areas provisionally
identified as the marginal zones. At the terminal stages of disease, immunolabelling
of spleens infected with the 87V strain of scrapie was absent.
Ultrastructural morphology and immunolabelling.
Tissue blocks with previously identified white pulp areas were examined
ultrastructurally. The morphology of the spleens of the i.e. inoculated 139A, 79A
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and ME7 strains of scrapie correspond to the previously seen i.e. inoculated ME7
spleens, at both 10 weeks after inoculation and the terminal stage of infection (see
section 3.1). FDCs at various stage of hypertrophy were observed at these timepoints,
while TBMs with many intracytoplasmic lysosomal bodies were prolific. Other
scrapie-specific pathological effects such as prolonged follicular B cell retention,
were observed intermittently in all three scrapie strains studied, with increased
frequency at the terminal stages of infection. These morphological observations are
described in detail in sections 3.1 and 3.2. Spleens at the 5 week timepoint were not
studied ultrastructurally. As no immunolabelling was observed in the 87V
experimental group, these spleens were also not examined at the sub-cellular level.
Patterns of immunolabelling in the 3 groups studied were similar to the results
discussed in previous chapters. At the 10 week timepoint, a proportion of mature and
rarely, immature FDCs accumulate PrPd on the plasma membrane of dendrites, while
labelling was also seen within TBM lysosomes. At the terminal stage of disease,
FDCs that were not associated with PrPd immunolabelling were not observed in any
of the tissue blocks from the mice inoculated with 79A, 139A and ME7 strains of
scrapie. Patterns of immunolabelling correspond to those described in sections
3.l.and 3.2. (and Figure 3.2.1).
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Figure 3.3.1. x13K magnification. Spleen from a terminally affected mouse
infected with 139A scrapie. FDC and TBM immunolabelling patterns do not
differ from those described in previous sections FDC labelling is associated
with dendritic plasmalemmae, while TBM labelling is limited to lysosomal




Much discussion of murine scrapie strain variation has reflected upon the
mechanisms of incubation period differences, and the severity and distribution of
pathological changes seen in the brains of mice of defined genotypes. Based on these
criteria, about 20 phenotypically distinct murine scrapie strains have been identified
(Dickinson & Fraser 1977). This study demonstrates that pathological variation and
disease-specific localisation of PrP within the spleen is not scrapie strain specific, at
least for the ME7, 139A, and 79A scrapie strains.
Incubation period, i.e. the time between initial infection and clinical endpoint, is
generally very similar where a single cloned scrapie strain is used to infect
genetically uniform mice. Incubation periods with standard errors of <2% of the
mean are measured following i.e. inoculation of mice with a high dose of a single
scrapie strain (Bruce 1996). The host gene which influences incubation period and
pathology is known as the Sine or Scrapie incubation gene, and can exist in one of
two forms: s7, indicative of a short incubation period with the ME7 strain of scrapie,
and p7 which gives a more prolonged incubation period with this strain.
Of the four strains studied, only the 87V strain of scrapie was injected into a Sine p7
mouse strain (the VM mouse strain). I.e. inoculation was used in this experiment as a
time limiting factor; peripheral routes of infection have considerably longer
incubation periods. Incubation period following i.e. inoculation determined from this
and previous studies, is in the order of 285 days, which is in stark contrast to the
remaining strains which were injected into mice of the Sine s7 strain (the C57B1
strain). The incubation periods for the 139A, 79A and ME7 strains of scrapie are 170
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days, 175 days and 185 days respectively (Bruce 1996). Initial PrPd accumulations
within the spleen correlate with previous studies of PrPd accumulations in the brain
in so far as the earliest disease-specific PrP accumulations are to be found in the
spleens of mice infected with the 139A strain of scrapie. This could be anticipated
due to the short incubation period of this strain in C57B1 mice. At the 10 week
timepoint, all C57B1 mice strains demonstrate moderate PrPd accumulations within
secondary follicles, while PrPd could not be located within germinal centres of VM
mice inoculated with the 87V strain of scrapie.
The results of this study suggest that, unlike the brain, splenic PrPd accumulations
within the spleen are associated with the same cell types. Although there were
differences in the onset of PrPd detection in FDCs with different strains, no
significant magnitude differences in PrPd accumulation or pathology of FDCs were
noted at terminal stages. Although this study examined only a few mice infected by
i.e., rather than i.p. inoculation, the changes seen did not suggest variability of FDC
susceptibility to infection, which could explain the limited variation in times of
neuroinvasion for the three scrapie strains which show splenic PrP accumulation.
However, the early detection of FDC-associated PrP in the 139A strain suggests that
this strain may replicate faster that the other strains in FDCs. Faster replication of
139A in FDCs offers a potential explanation for the more rapid neuroinvasion in this
strain by i.p. or oral inoculation, when compared with other strains. Such a
suggestion would need to be further studied in oral or i.p. challenged mice.
The combination of murine strain or genotype, and scrapie strain may explain the
absence of peripheral PrPd immunolabelling in the VM mouse strain following 87V
scrapie inoculation. For example, in sheep, peripheral PrPd accumulation does not
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occur in certain sheep genotypes following natural infection (Jeffrey et al. 2002),
while in cattle, there is no peripheral involvement following natural BSE infection
(Wells et al. 1996). Where i.e. scrapie inoculations of susceptible sheep genotypes
are carried out, magnitude and frequency of peripheral involvement is dependent
upon infective dose, i.e. low dose inoculation results in no peripheral accumulation
(Martin et. al., submitted). It therefore seems likely that 87V scrapie does not have an
effective LRS phase.
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3.4. Inhibition of Follicular Dendritic Cell maturation and subsequent
effect on scrapie pathogenesis.
The role of some lymphoreticular cell types in the peripheral pathogenesis of TSEs
has been extensively studied using mouse models deficient in particular cell
populations of the immune system, or in specific signalling molecules. The
involvement of T cells, B cells and FDCs has been explored using mice lacking
specific cellular components. Signalling between lymphocytes and FDCs by
cytokines is essential in the formation of the germinal centre. Many studies have
demonstrated the importance of LT and TNF in the formation of B cell follicles,
FDC networks and germinal centres (Matsumoto et al. 1997; Pasperakis et al. 1996).
The studies discussed in this section were carried out in collaboration with
colleagues at the IAH -NPU in Edinburgh, and investigated FDC involvement in
scrapie pathogenesis. Sections 3.4.1. and 3.4.2., investigate the effect of the
inhibition of specific cytokine signals from B-lymphocytes on the sub-cellular
localisation of PrPd, and transmission of scrapie infectivity to the CNS.
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3.4.1. Ultrastructural analysis of the effect of the blockade of the
Tumour Necrosis Factor signalling pathway on scrapie neuroinvasion.
Introduction
Studies of immunodeficient mice infected with scrapie have shown that mature FDCs
which express host derived PrP, are necessary for PrPd accumulation in the lymphoid
tissues. Immunodeficient mouse models have demonstrated that the absence of
mature FDCs significantly impairs the spread of infection to the CNS (Brown et al.
1999).
It has been demonstrated that B-lymphocyte derived tumour necrosis factor (TNF-a)
signalling is critical for FDC development as mice deficient in this cytokine lack
mature FDCs in lymphoid tissues (Pasparakis et al. 1996). TNF-a influences FDC
development via the cell surface receptor TNF receptor 1 (TNFR-1), expressed on
FDCs and /or their precursors (Tkachuk et al. 1998). Lack of signal via this pathway
leads to the temporary inactivation of FDCs, suggesting they require constant
stimulation from TNF-a to maintain their differentiated state (Mackay & Browning
1998). Temporary blockade of this cell signalling pathway was achieved using a
single i.p injection of human TNFR fusion protein (huTNFR:Fc), which binds TNF-
a, thus inactivating the cell signalling process (Mohler et al. 1993).
This study was undertaken to investigate the effect of TNF-a signal blockade on the
morphology of FDCs, and the sub-cellular localisation of PrPdin scrapie-infected
mice treated with TNF-a at early stages of infection.
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Materials and Methods
Mice were obtained from IAH - NPU in Edinburgh (see section 2.1.4.1). Details of
tissues from these experimental groups are shown in table 2.3. Animals were
sacrificed 7 days after human immunoglobulin (hu-Ig) or huTNFR:Fc boost. Spleens




At 14 dpi, few spleen tissue blocks from each experimental group showed defined
germinal centre development. Those tissue blocks in which a mature follicle could be
identified, were immunolabelled using the technique described in section 2.2.5. No
PrPdimmunolabelling was observed in tissue sections taken from animals in any of
the experimental groups.
Mature secondary follicles were easily identified in mice treated with hu-Ig 38 days
after scrapie infection and sacrificed at day 45. Follicles showed moderate PrPd
immunolabelling within germinal centres. Patterns of labelling were those associated
with FDCs, and punctate intracytoplasmic labelling typical of intralysosomal TBM
PrPd deposits.
Although secondary follicles were again relatively abundant, mice treated with
huTNFR:Fc showed less follicular PrPd immunolabelling. Where present,
immunolabelling was not of a typical linear FDC type pattern. TBMs contained
many ingested apoptotic ceils, although little immunolabelling.
Electron Microscopy
As observed at light microscopy, ultrastructural morphological analysis of spleens at
14 days after scrapie infection revealed few follicles in all experimental groups.
FDCs were occasionally identified due to their large irregular nuclei containing a
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peripheral margin of chromatin, but did not exhibit extended or hypertrophic
dendritic profiles associated with scrapie infection. Of the limited morphologically
identifiable FDCs present in huTNFR:Fc treated spleens, no FDC apoptosis was
observed, however, a small number of ingested apoptotic B cells were seen within
TBMs in these spleens. No morphological evidence of B cell apoptosis was observed
in hu-Ig treated spleens.
At the later timepoint (38 days + 7), hu-Ig inoculated scrapie spleens showed some
FDC hypertrophy, with extended dendritic profiles forming both large labyrinthine
glomerular complexes and small knots of dendritic processes between lymphocytes
of the secondary follicle. FDC glomeruli were occasionally observed to loose
extracellular electron-dense deposit in favour of the formation of fibrillar structures
(Figure 3.4.1.1) As discussed in previous chapters, there fibrillar structures were seen
to co-localise with immunogold labelling. A proportion of FDCs identified by their
typical nuclear morphology, were in an immature state with poorly developed
dendritic profiles. TBMs, with phagocytosed nuclear remnants in their cytoplasm and
containing abundant lysosomes, were also present within the secondary follicle.
Occasionally, whole degenerate (presumed apoptotic lymphocytes) cells were found
within the cytoplasm of these macrophages.
Mice treated with huTNFR:Fc 38 days after scrapie infection showed extensive
cellular degeneration. Apoptotic lymphocytes with dark fragmented nuclei were
present within the secondary follicle when mice were killed one week after the
treatment (Figure 3.4.1.2). Many TBMs with abundant cytoplasm containing
intralysosomally digested lymphocytes, and occasionally whole B cells, were also
present.
118
Some limited FDC networks were observed, however, most dendritic processes were
relatively uncomplicated when compared to hu-Ig treated control mice.
119
Figure 3.4.1.1. x16K magnification. Labyrinthine glomerular complex from a
hu-lg inoculated mouse spleen 42 days after scrapie infection. Many fibrillar
structures are present within the extracellular space (arrows) and are
associated with PrPd immunolabelling.
Figure 3.4.1.1a. x63K magnification. Detail of fibrillar structures (Arrows)
within the extracellular space surrounding FDC dendrites.
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Figure 3.4.1.2. x5K magnification. Immunolabelled spleen from a scrapie-
infected mouse inoculated with huTNFR:Fc 38 days after scrapie infection
(killpoint = 45 days). Extensive cellular degeneration can be seen, in addition
to many TBMs containing intralysosomal PrPd.
Figure 3.4.1.3. x23K magnification. Immunolabelled FDC complex from the
spleen of a scrapie-infected mouse inoculated with huTNFR:Fc 38 days after
scrapie infection (killpoint = 45 days). Limited dendritic profiles are sparsely
labelled.
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As no PrPd was observed in any spleen blocks at the 14 day timepoint using light
microscopical techniques, no ultrastructural immunolabelling was carried out on
these tissues.
Immunoelectron microscopical analysis of hu-Ig treated spleens killed at the 45 day
timepoint revealed as anticipated from earlier studies, that PrPd accumulations were
associated with mature FDCs. Labelling was observed primarily at the FDC
plasmalemma of both convoluted labyrinthine complexes, and to a lesser extent more
linear immature processes. In some follicles, occasional fibrillar structures could be
seen within the extracellular space between FDC dendrites. Immunolabelling was
associated with these structures. Intralysosomal TBM PrPd labelling was also
observed.
PrPd immunolabelling of huTNFR:Fc treated mice, revealed light PrPd labelling in
association with only the more developed FDC dendritic profiles (Figure 3.4.1.3).
Although TBMs were morphologically identified in the tissue sections more
frequently than the h-Ig controls, immunolabelling was light and limited to a small
portion of the lysosomes present.
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Discussion
Work undertaken at the IAH - NPU by Neil Mabbott and his colleagues,
demonstrated that a single treatment of mice with huTNFR:Fc before peripheral
inoculation with the scrapie agent, significantly reduced PrPd accumulation in the
spleen, which, in turn, delayed the onset of CNS disease (Mabbott et al. 2002). It
was further demonstrated that the mean incubation period of control mice inoculated
with hu-Ig 14 days after i.p. scrapie infection was 262+ 8 days (SE), while those
mice treated with huTNFR:Fc at this timepoint developed disease at 281± 7 days.
Inoculation with huTNFR:Fc at the later timepoint of 38 days after scrapie infection
did not significantly alter incubation periods. Treatment with huTNFR:Fc before or
after peripheral scrapie inoculation did not have an effect infectivity at 70dpi when
compared to controls. These results are consistent with previous findings that suggest
that the absence of mature FDCs in lymphoid tissues leads to impaired neuroinvasion
following peripheral scrapie inoculation (Brown et al. 1999).
Ultrastructural analysis of the secondary follicles from mice treated at 14 days after
scrapie infection revealed a TNF influence upon maintenance of B cell
differentiation, although differences in FDC development between hu-TNFR:Fc and
hu-Ig treated were insignificant, with no extended dendritic processes present in
either experimental group. As FDCs are known to provide necessary co-stimulatory
factors which prevent B cells from undergoing apoptosis (Tew et al. 1997), the
detection of an increased level of B cell apoptosis in hu-TNFR:Fc treated spleens
suggests a lack of antigen, co-stimulatory or cytokine signalling due to the loss of
FDCs. It might be anticipated that developing immature FDCs may gradually express
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more cell surface molecules. A parallel light microscopical study by Neil Mabbott at
the IAH - NPU demonstrated that in mice treated with hu-TNFR:Fc or hu-Ig 14 days
after scrapie infection and allowed to reach a terminal stage of disease, survival time
of those animals inoculated with hu-TNFR:Fc was seen to increase. This suggests
hu-TNFR:Fc inoculation in the early stages of infection causes a significant delay in
neuroinvasion. This delay may be due to the absence of mature FDCs as a result of
hu-TNFR:Fc inoculation, suggesting FDCs are not able to sustain or multiply
infection until fully mature. Alternatively, de-differentiated FDCs may be partly
susceptible to scrapie infection with low levels of inoculum able to infect FDCs
followed by limited PrP amplification. The absence of morphologically identifiable
mature FDCs and related ultrastructural PrPdimmunolabelling in both hu-Ig and hu-
TNFR:Fc inoculated spleens at this stage would suggest a level of FDC associated
PrPd accumulation, which is not detectable using ultrastructural
immunohistochemical methods.
An alternative hypothesis may be that the de-differentiated FDCs are as susceptible
as mature FDCs to initial scrapie infection. However, the PrPd is unable to amplify
due perhaps to a physical or chemical alteration to the cell. Both of these last two
hypotheses imply that following hu-TNFR:Fc exposure, the capacity of FDCs to
produce a sufficient quantity of PrPd to allow neuroinvasion is impaired.
At 38 days after scrapie infection, colleagues at NPU demonstrated that hu-TNFR:Fc
inoculation did not significantly alter survival time when compared to that of hu-Ig
inoculated controls. Temporary de-differentiation of FDCs as a result of hu-TNFR:Fc
inoculation was demonstrated to last for between 7 and 14 days, while at 38 days
after scrapie infection high levels of scrapie infectivity are present in the spleen. This
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observation suggests that either infection of peripheral nerves has already occurred
by this timepoint, or the period of FDC de-differentiation is inadequate to alter
incubation periods significantly once infectivity is established. Again, at this later
timepoint, extensive B-lymphocyte apoptosis suggests the loss of mature FDCs
causes major degenerative changes in the follicle. When compared with hu-Ig treated
murine spleens, hu-TNFR:Fc treatment results in extensive FDC de-differentiation
and associated pathological effects, with many whole apoptotic B-lymphocytes
phagocytosed by TBMs. FDC networks, where present were very limited in extent,
and only occasionally formed small knots. Whether these processes were consistent
with regenerating FDCs, or mature FDCs unaffected by the cell signalling blockade
remains unclear. It has been suggested that FDCs participating in a strong antigenic
response may be unaffected by treatments which inhibit the TNFR signalling
pathway (Mackay & Browning 1998).
PrPdimmunolabelling within the spleen of hu-TNFR:Fc inoculated mice, was
considerably more limited than the hu-Ig treated controls at the 38 day timepoint,
with light FDC labelling and low PrPd accumulation within TBM lysosomes.
Following de-differentiation of FDCs, it might be expected that FDC-related PrPd
would be released into the extracellular space to be internalised by macrophage. As
PrPd levels within lysosomal compartments of TBMs were lower in hu-TNFR:Fc
treated murine spleens, it may be hypothesised that the rate of lysosomal digestion of
PrPd is sufficient to allow the digestion of the majority of PrPd prior to the
regeneration, re-infection and subsequent disease amplification by FDCs, and re-
internalisation of FDC related PrPd by TBMs.
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If cytokines are inhibited at an early timepoint of scrapie infection, subsequent FDC
dedifferentiation causes an increased scrapie incubation period. However, the
connection between this and neuroinvasion remains provocative. Although
peripheral nerves have been detected in the light zone of sheep Peyer's patches
(Heggebo et al. 2003), no peripheral nerves were seen in the secondary follicles of
mice in the present studies. There is therefore no clear structural relationship between
sub-cellular sites of PrPd accumulation and peripheral nerves. The possibility that the
infectious agent is delivered to the CNS via mechanisms independent of PrPd
accumulation of FDCs or any cell type, cannot be eliminated.
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3.4.2. Ultrastructural analysis of the germinal centres of scrapie-
infected murine spleen, following treatment with an inhibitor of the
lymphotoxin pathway.
Generation and maintenance of FDCs within germinal centres is dependent on
signals from cytokines, including lymphotoxins, members of the tumour necrosis
factor family (De Togni et al. 1994). Lymphotoxin a and P (LTa and LTp,
respectively) are known to be produced by activated B cells, activated T cells and
Natural Killer cells (Paul & Ruddle 1988; Ware et al. 1995), and their absence
results in an almost complete loss of germinal centres and FDC networks (Koni et
al. 1997). However, previous studies have shown that residual FDC-like cells are
present within B cell follicles in spleens of LTp and LTp receptor (LTpR) deficient
mice (Alimzhanov et al. 1997).
In normal mice, the LTa molecule lacks a transmembrane domain, and can only be
retained on the cell surface in complex with LTp, which is a transmembrane protein
(Browning et al. 1993). This complex signals though the LTPR, expressed on
stromal cells such as the FDC and / or its precursor. In mice born with the absence
of either LTa / P or its corresponding receptor, no splenic B or T cell zones, or
germinal centres are formed, and FDCs do not differentiate. Likewise, if a specific
inhibitor blocks the LTpR signalling pathway, FDCs quickly de-differentiate
(Mackay & Browning 1998).
Recent studies have shown that in the absence of FDCs caused by blockage of the
LTpR pathway, early accumulation of PrPdin the spleen is impaired and
neuroinvasion is delayed (Mabbott et al. 2000b).
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In order to further understand the effects of the blockade of the LT0R pathway on
scrapie pathogenesis, we studied the spleens of scrapie-infected mice
ultrastructurally, following treatment with both LT|3R immunoglobulin fusion
protein (LT|3R:Ig) and human immunoglobulin IgG (hu-Ig) as a control.
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Materials and Methods
Mice were obtained from IAH - NPU (see section 2.1.4.2.). Details of tissues from
these experimental groups are shown in Table 2.4. ME7 scrapie was administered i.p,
and animals were sacrificed 3 or 35 days after hu-Ig or LT(3R:Ig treatment. Spleens
were immersion fixed, processed and labelled as described in sections 2.2.1. - 2.2.7.
Mice were then sacrificed at a later scrapie incubation period, again, either 3 or 35
days after LTPR:Ig or hu-Ig treatment.




Control hu-Ig treated mice
Within the spleens of mice treated with hu-Ig 42 days after scrapie infection and
harvested 3 days later, follicles were relatively abundant in all tissue sections studied.
Slight PrPd immunolabelling, with a linear pattern consistent with an FDC
association, and a more punctuate, intracytoplasmic PrPd labelling, were observed.
Immunolabelling was extremely limited and was restricted to the more mature
follicular germinal centres. Immunolabelling was not consistent in all mice studied,
with 2 of the 4 mice studied showing no PrPd accumulation within splenic tissue
blocks studied.
In spleens of control mice treated at 42 days and killed at day 77, mature germinal
centres were more abundant, with more florid FDC and TBM type immunolabelling.
At the 73 and 105 day killpoints (see Table 3.4.2), germinal centres were more
developed with well defined FDC and TBM labelling. At these timepoints, all mice
studied showed PrPd accumulation within the spleen.
At the 45 and 73 / 77 day kill points, the morphology and immunolabelling of hu-Ig
treated ME7 infected mice within the spleen were similar to those ofME7 infected
mice at 45 dpi ( section 3.4.1), and 70 dpi described in section 3.2.
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LTpR-Ig treated spleens
In tissues inoculated with LTpR-Ig at the 42 day timepoint and killed 3 days later,
areas of white pulp appeared relatively abundant. Germinal centres however, were
not readily apparent, and, subsequently, very little PrPd immunolabelling was
observed. Due to the sparseness of labelling, it was impossible to determine whether
this immunolabelling was associated with cells of a FDC or TBM type morphology.
In spleens from mice inoculated with LTPR-Ig at day 42 after scrapie infection, and
killed at day 70, mature follicles were again present. Extensive PrPdimmunolabelling
was observed within a portion of these follicles and was consistent with both an FDC
and TBM type pattern.
Follicles from the spleens of mice inoculated with LTpR-Ig at day 70 after scrapie
infection, and killed 3 days later were again present, however they generally
appeared less organised than corresponding hu-Ig controls, with less well defined
white pulp areas. Immunolabelling for PrPd was profuse and was associated with
FDC and TBM type cells. Within spleens of mice inoculated with LTpR-Ig at day 70
and killed 35 days later, again white pulp appeared generally disorganised, with few
identifiable germinal centres. Within these white pulp areas, low - moderate levels
of PrPd immunolabelling was observed. It was not possible to determine the exact
location of these labelling patterns, or indeed which cells they were associated with.
Labelling patterns did not appear as intense as hu-Ig controls.
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Electron microscopy
Controls hu-Ig inoculated tissues: morphology
Ultrastructural study of scrapie-infected spleens inoculated with hu-Ig, showed a
marked increase in FDC hypertrophy as incubation period increased, as previously
described in section 3.4.1. At all timepoints, FDCs with extended dendritic profiles
forming small knots of dendritic processes between lymphocytes of the secondary
follicle were observed; however, at the 70 day killpoint and beyond, an increasing
proportion of FDCs also formed large extended labyrinthine glomerular complexes.
At the 45 day killpoint, although smaller labyrinthine glomerular complexes were
present, the majority of FDCs, with a typical nuclear morphology, were in an
immature state with poorly developed dendritic profiles.
Within all hu-Ig inoculated experimental groups, TBMs, identified by their abundant
lysosomes and cytoplasmic phagocytosed nuclear remnants, were present within the
secondary follicle. Occasionally, whole degenerate (presumed apoptotic
lymphocytes) cells were found within the cytoplasm of these macrophages. Within
the PALS region of a spleen from a mouse inoculated with hu-Ig at the 70 day
timepoint and killed 35 days later, a macrophage containing two B-lymphocytes at
different stages of maturity was observed.
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Control hu-Ig inoculated tissues: Immunolabelling
Ultrastructural immunolabelling of scrapie-infected spleens at the 45 day killpoint
produced low levels of immunogold labelling in some tissue blocks from two of the
four mice studied. There were no differences in patterns of immunolabelling of these
control tissues at this stage of infection, when compared to those described in section
3.4.1. Other tissue blocks that showed a more restricted pattern of immunolabelling
at the light microscopical level showed no specific labelling by electron microscopy.
It therefore seems likely, that the lesser sensitivity of ultrastructural immunolabelling
when compared with light microscopic methods of PrPd detection, is responsible for
this effect.
At both the 73 day (hu-Ig inoculation at day 70), the 75 day (hu-Ig inoculation at day
42) and the 105 day (hu-Ig inoculation at day 70) killpoints, PrPd immunolabelling
was associated with the plasmalemma of a proportion of FDCs which formed
labyrinthine glomerular complexes, while other FDC dendritic profiles, which
interweaved between lymphocytes, were only immunolabelled in a small proportion
of tissues from the 105 day killpoint. TBMs, present in close association with FDCs,
demonstrated low levels of PrPd immunolabelling both at the periphery of lysosomes
and in association with denser intralysosomal areas.
These latter observations are in line with those anticipated from the 70 and terminal
disease labelling patterns described for ME7 scrapie described in section 3.2.
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LT(3R-Ig inoculated spleens: morphology
At all timepoints, FDCs identified by their large, irregular nucleus containing a
peripheral margin of chromatin, were present within germinal centres
At the 45 day killpoint (3 days after lymphotoxin inoculation), no FDCs observed
formed labyrinthine structures, although FDC nuclei and dendritic profiles were
easily identified, the profiles running between lymphocytes forming small knots.
This contrasts to the corresponding control tissues at this timepoint that did exhibit
labyrinthine-like structures. However, limited conclusions may be drawn from this as
the LT(3R-Ig inoculated group consists of only two animals, while the four animals
were studied in the control group. TBMs containing multiple lysosomes were also
identified in areas adjacent to FDCs.
Within the spleens of mice inoculated with LTpR-Ig 42 days after scrapie infection,
and killed 35 days later, a proportion of FDC dendrites present formed small to
moderately sized glomerular complexes between lymphocytes within the germinal
centre. Again, TBMs were easily identified in areas populated by FDCs, and these
contained lysosomal compartments.
At the 73 day kill point (3 days after lymphotoxin inoculation), both FDC nuclei and
dendritic networks were observed within germinal centres (Figure 3.4.2.1). Easily
recognisable knots of FDC dendritic profiles were interspersed between germinal
centre lymphocytes, as well as limited linear profiles. FDCs demonstrated
characteristics previously seen in hu-Ig inoculated control tissues at this timepoint.
TBMs containing many lysosomes were observed in close proximity to FDCs.
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Similar morphological observations were made of spleens obtained from mice
inoculated with LT(3R-Ig 70 days after scrapie infection and killed 35 days later.
Within tissue blocks studied at this timepoint, neither FDCs nor TBMs varied in size
and complexity from those observed at the 73 day killpoint. Apoptotic cells,
presumed to be B cells due to the dense concentric circles surrounding the nuclear
remnants, were observed within the follicle.
LT(3R-Ig inoculated spleens: immunolabelling
Ultrastructural immunoelectron analysis of spleens inoculated with LT(3R-Ig
following scrapie infection, revealed PrPd immunolabelling associated with FDC
dendritic processes in all experimental groups, with the exception of the earliest
killpoint of 45 days. At this point, all FDC processes observed were limited in
development, with no formation of labyrinthine complexes. The immature linear
processes that run between lymphocytes of the germinal centre did not show any
immunolabelling. As immature FDC processes do not accumulate PrPd during the
early stages of infection, this result could be expected. TBMs were also unlabelled at
this timepoint.
Within spleens from mice inoculated both at 42 days and 70 days after scrapie
infection and killed 35 and 3 days later respectively, immunolabelling of the
plasmalemma of mature FDCs complexes could be seen within germinal centres.
FDC were readily identified in both experimental groups with mature processes
forming both small knots and, to a lesser extent labyrinthine glomeruli (Figure
3.4.2.2). PrPd immunolabelling of these structures was similar in magnitude to
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corresponding control tissue blocks. A proportion of lysosomes within TBMs
adjacent to mature FDCs were also immunolabelled.
Spleens from mice inoculated with LT(3R-Ig 70 days after inoculation and killed at
day 105, showed similar patterns of immunolabelling to those discussed in the
previous paragraph. These levels of immunolabelling were conspicuously lower than
those observed in the corresponding control tissues at 105 days. Labelling of
immature FDC dendrites, where present was extremely limited. FDC nuclei,
surrounded by small knots of relatively uncomplicated dendritic profiles with
electron-dense deposit held uniformly between adjacent dendrites, were occasionally
seen at this timepoint. No PrPd immunolabelling was associated with these
cytoplasmic extensions. As discussed in Section 3.2, at 70 days after i.p. scrapie
infection, all stimulated FDCs would be expected to show pathological effects of
scrapie infection, with only immature dendritic profiles that have not accumulated
any excess electron-dense deposit, remaining unaffected. At this timepoint FDC
dendrites that accumulate any electron-dense deposit, no longer do so uniformly,
while immunolabelling is associated with the plasmalemmae of all stimulated FDC
dendrites. Spleens from mice inoculated with LT(3R-Ig 70 days after inoculation and
killed at day 105, did not show this magnitude of PrPd immunolabelling.
Immunolabelling of TBMs did not appear to vary from the matching controls.




Figure 3.4.2.1. x6K magnification. Immunolabelled spleen from a scrapie-
infected mouse inoculated with LT(3R-lg 70 days after scrapie infection
(killpoint = 73 days). An FDC nuclei (asterisk) and limited dendritic profiles
are present.
Figure 3.4.2.2. x4K magnification. Immunolabelled spleen from a scrapie-
infected mouse inoculated with LT(3R-lg 70 days after scrapie infection
(killpoint = 73 days). Interspersed between lymphocytes of the follicle FDC
dendritic complexes can be seen. PrPd immunolabelling is present in addition
to excess accumulation of electron-dense deposit.
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Discussion
Due to both the small experimental group size and investigated timepoints, it is
difficult to draw many conclusions from this study. With hindsight, it may have been
better to study the morphological effect and putative altered distribution of PrPd at
several time intervals after LT(3R-Ig treatment in mice sacrificed at a single (e.g. 75
dpi) stage of scrapie infection. Nevertheless, it can be clearly seen that LT(3R-Ig
inoculation of scrapie-infected mice does not result in complete de-differentiation of
FDCs, either 3 days or 35 days after LTpR-Ig inoculation. Whether complete de-
differentiation of FDCs is achieved between these two points cannot be determined
within this study.
In contrast to the present findings, previous studies have demonstrated that, after
LTpR-Ig inoculation, FDC networks temporarily de-differentiate within 72 hours
and return approximately 28 days later. FDC markers such as FDC-M1, FDC-M2
and CR1 disappear within 1 day (Mackay & Browning 1998; Mabbott et al. 2003).
However, following the discovery that within spleens of mice already infected with
scrapie, PrPd immunolabelling remains apparent 72 hours after LTPR-Ig inoculation,
it was suggested that this PrPd immunolabelling may be associated with macrophages
or unknown extracellular sites (Mabbott et al. 2000b). Our study indicates not only
the presence of FDCs in 70 dpi scrapie-infected murine spleens 72 hours after LT|3R-
Ig inoculation, but that these FDCs have not lost their previous PrPd accumulation,
and exhibit other scrapie-specific pathological effects such as abnormal antigen /
antibody complex retention and labyrinthine glomerular complex formation.
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Although no mature FDCs were observed in 42 dpi scrapie inoculated spleens 3 days
after LT(3R-Ig inoculation, it is difficult to state conclusively the significance of this
finding due to the small group size. The presence of mature FDCs 35 days after
LT(3R-Ig inoculation is perhaps expected, as previous evidence suggests that the
period of de-differentiation following a single inoculation of LTpR-Ig is in the
region of 4 weeks (Mabbott et al. 2003). There is some indication that the FDCs
present at this timepoint are regenerating, with FDCs present that have a uniform
electron-dense deposit held between dendrites. These mature FDCs, which do not
exhibit scrapie-specific pathology or immunolabelling, are present in the follicles of
spleens inoculated with LT(3R-Ig 70 days after scrapie infection, then killed 35 days
later. Following extensive ultrastructural studies of murine spleens 70 days after
scrapie infection (see section 3.2), where all mature FDCs show evidence of scrapie-
specific pathology, the presence of these apparently normal cells may indicate FDCs
are regenerating, having lost scrapie infection. In addition, where PrPd
immunolabelling was present and associated with mature FDCs in these tissues, it
appeared considerably less abundant than that of the corresponding hu-Ig controls.
Again, this suggests that dendritic extensions have regressed due to LT(3R-Ig
inoculation, with PrPd released in to the extracellular space or phagocytosed by
adjacent macrophages.
The absence of FDC cell markers 72 hours after LT(3R-Ig inoculation, may indicate
an alteration in FDC cell marker expression as opposed to complete de-
differentiation of these cells. This may explain the light microscopic pattern of FDC
cell marker immunolabelling observed 72 hours after LT(3R-Ig inoculation as
described in earlier studies of these mice (Mabbott et al. 2003). Investigations
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regarding the absence of cell markers following cytokine inoculation have, however,
not been undertaken following scrapie infection. If scrapie infection was established
within the spleen prior to cytokine inoculation, perhaps FDCs would be unable to de¬
differentiate to the same extent as uninfected cells, and persist in the spleen due to
this abnormal scrapie-infected state, Alternatively, FDCs observed ultrastructurally
may still be in the process of degenerating. Ultrastructural morphological
observations do not allow quantification of FDCs or associated dendritic networks,
therefore conclusions cannot be drawn concerning the possible degree of de-
differentiation.
Light microscopical analysis of scrapie-infected mice, inoculated with LT(3R-Ig prior
to i.p. scrapie infection, revealed a significantly reduced susceptibility to scrapie
infection, increased survival time (Mabbott et al. 2003), with scarcely detectable
levels of infectivity in the spleen 70 days after scrapie challenge (Mabbott et al.
2000b). At this point, scrapie infection within the spleen should reach plateau levels
(Farquhar et al. 1994; Brown et al. 1999). In comparison to this single dose
treatment, consecutive prolonged treatments were given at 21 day intervals. Despite
this extended cytokine inhibition, both survival time and susceptibility were similar
to those of animals given only a single treatment. This suggests LT(3R-Ig induces de-
differentiation of FDCs that prevents initial uptake of scrapie infection, but has little
or no effect on replication of the agent. In mice inoculated with LT(3R-Ig 14 and 42
days after i.p. scrapie infection, levels of infectivity in the spleen at 70 days after
scrapie infection were similar to those of controls even though incubation periods
were extended. Following FDC de-differentiation the inhibitory effects of the
LT(3R-Ig would be absent allowing for further amplification of the scrapie agent.
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Following oral scrapie infection, LT(3R-Ig inoculation 14 days later does not increase
survival time or affect disease susceptibility when compared to control mice. In
contrast to this, inoculation with LT(3R-Ig prior to infection remained asymptomatic
of scrapie infection for at least 518 days, while post mortem findings suggested no
scrapie-specific pathology or PrPd accumulation (Mabbott et al. 2003). This would
suggest LT(3R-Ig blocked PrPd accumulation in gut associated LRS and prevented
CNS infection. Administration of LT(3R-Ig after scrapie inoculation did not achieve
this effect. These results suggest oral scrapie inoculation has a quicker or easier route
to peripheral nerves than following i.p infection. This has recently been clarified: a
close contact has been established between FDCs and TBMs of Peyer's patches with
the peripheral nerves that innervate the gut (Heggebo et al. 2003).
The study detailed in this section suggests LT|3R-Ig involvement in scrapie
intervention is only possible before neuroinvasion occurs. In addition, levels of PrPd
accumulation within the spleen do not directly correlate with disease progression if
LT(3R-Ig inoculation occurs after scrapie infection.
Further study of the effects and subsequent possible intervention potential of LT(3R-
Ig must depend on confirmation of FDC de-differentiation. In addition, further study
should be undertaken to investigate the fate of FDC-associated PrPd following
LT(3R-Ig inoculation.
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3.5. Visualisation of disease-specific PrP in the LRS of sheep.
Introduction
The sub-cellular pathology of scrapie-infected murine spleens has been characterised
in detail in the previous sections. Much research has also been undertaken regarding
gross and cellular pathology of scrapie infection in its natural host: the sheep.
However, the sub-cellular localisation of PrPd has not been studied in this species. In
this section, I will discuss the development of ultrastructural immunocytochemical




MLNs were obtained from clinically affected Suffolk sheep of the most susceptible
genotype: prpARQ/ARQ; as described in section 2.1.5. This tissue was chosen for all
ovine studies as, with the exception of the spleen, it is the largest lymph node in the
sheep, and therefore available in abundance for this and related studies. Infection of
follicular areas is also consistent in this tissue (M. Jeffrey, personal observation).
Spleen was not chosen for study, as the method of anaesthesia used was barbiturate
based, and is known to cause splenic distension. Immersion fixation would not allow
for adequate removal of all red blood cells from the tissue, which would prove
detrimental to immunolabelling and morphological study of the tissue.
Many tissue blocks were studied from at least 10 sheep.
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Methods and Results
Studies of ovine tissue were carried out using a variety of PrP specific antibodies.
PrP antibodies, initially found to give good immunolabelling in paraffin embedded
ovine tissues (Jeffrey et al. 2001a), were tested on resin embedded tissues. At the
light microscopical level, the rabbit polyclonal antibody R486 was found to give
excellent results, and was therefore used routinely for all light microscopic work on
ovine tissues.
As a result of difficulties arising from ultrastructural immunolabelling studies (see
below), a wide variety of PrP antibodies were used to label PrPd-positive ovine
tissues using the standard ABC technique.
The PrP antibodies tested and their specific amino acid target sites are detailed in
Figure 3.5.1. Those highlighted in red gave specific PrPd labelling of both FDCs and




1A8 IAH, NPU, Edinburgh, UK
6H4 Prionics, Schlieren, Switzerland
BG4 IAH, Compton, UK
F89 K O'Rourke, Washington State University, Washington, USA
L42 M Groschup, Insel Riems, Germany
R145 R Jackman, CVL, Weybridge, UK
8G8 CEA, Gif sur Yvette cedex, France
P4 R-Biopharm, Darmstadt, Germany
R505.5 J Langeveld, ID -Lelystad The Netherlands
R521.7 J Langeveld, ID -Lelystad The Netherlands
R523.7 J Langeveld, ID -Lelystad The Netherlands
SAF 32 CEA, Gif sur Yvette cedex, France
R486 R Jackman, CVL, Weybridge, UK
Table 3.5.1. Table identifying the source of all antibodies tested. Those in
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Figure 3.5.1. PrP antibody epitopes. Antibodies in red immunolabel ovine
PrPd to varying extents, those in blue do not. The amino acid sequence
recognised by antibody is indicated on the bottom axis.
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Light microscopical staining method (see section 2.2.4 and Appendix 6.1.e)
Using this technique, MLN tissue blocks containing developed germinal centres were
identified. No discernable difference in the amount of secondary follicles present in
the uninfected and scrapie-infected animals was observed in tissue blocks studied.
Light microscopical immunolabelling: Avidin Biotin amplification method (see
section 2.2.5.2 and Appendix 6.1.g)
This method was used routinely for all light microscopical immunolabelling. PrP
antibody R486 was found to give the most intense labelling patterns, although as can
be seen from Figure 3.5.1, R145, L42, 523.7, 6H4, F89 and 1A8 all immunolabel
both FDCs and TBMs to some degree. The intensity and relative abundance of
immunolabelling was deemed to be greater following immunolabelling using R486
antibody. Patterns of PrPd immunolabelling of samples of scrapie-infected MLN
impregnated with resin were consistent with those from previous studies of paraffin
wax embedded tissues (Van Keulen et al. 1996; Jeffrey et al. 2001b; Heggebo et al.
2002). Uninfected ovine MLNs were also immunolabelled using this technique; no
PrPd immunolabelling was observed. Within the MLN of a clinically affected
scrapie-infected sheep, PrPd was associated with cells of the light zone of the
secondary follicle that resembled FDCs. Another pattern of labelling consistent with
TBMs was observed within the light zone, dark zone and mantle zone of the follicle
(Figure 3.5.2).
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Figure 3.5.2. Light microscopically immunolabelled follicle from a scrapie-
infected ovine MLN. Two distinct patterns of immunolabelling are present. A
linear pattern, consistent with FDC labelling predominates the lower part of
the follicle, while more intense foci of granular immunolabelling is present in
the upper part of the follicle. This pattern of labelling is consistent with TBM
labelling.
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Light microscopical immunolabelling: Envision system (see section 2.2.5.3. and
Appendix 6.1.p)
Although this method gave good immunolabelling, when serial sections were
labelled by different techniques, results were inferior to those of tissues labelled with
the ABC method.
Ultrastructural staining method (see section 2.2.6, and Appendices 6.1.i, 6.1.j, 6.1.k)
55 nm thick sections from tissue blocks previously shown to contain secondary
follicles, were stained using the method described.
FDCs within the light zone of the secondary follicles of normal uninfected ovine
MLNs had greater numbers and more complexly folded dendrites than those of
normal FDCs within murine spleens. Processes formed small knots between
lymphocytes, and although electron-dense deposit was uniform between adjacent
processes, many spherical profiles were observed within this space (Figure 3.5.3).
These were similar in both size and frequency to those previously described
(Fandsverk 1987; Landsverk et al. 1990). The MEN often has more numerous and
larger secondary follicles than other lymph nodes of the sheep. This finding has been
noticed for several species and it has been suggested that this is because of the
constant exposure of the MEN to dietary associated antigens (M. Jeffrey, personal
communication). It is possible that the increased complexity of sheep MEN FDC
profiles relative to those found in the white pulp of murine spleens (Figure 3.1.2)
may be because of diet-related antigenic challenge.
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Figure 3.5.3. x10K magnification. Detail from a secondary follicle of a normal
uninfected ovine MLN. FDC processes form small knots between
lymphocytes, while electron-dense deposit is held uniformly between
adjacent processes.
Figure 3.5.4. x8K magnification. Detail from a secondary follicle from a
scrapie-infected ovine MLN. FDC profiles form hypertrophic labyrinthine
glomerular complexes interspersed between lymphocytes. Abundant
electron-dense deposit is held between adjacent dendrites.
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To further explore this possibility, sub-mandibular lymph nodes were studied.
Similar profiles were observed in comparable quantities.
TBMs containing lysosomes were also present in the light zone and dark zone of the
follicle. Occasionally, TBMs contained whole apoptotic lymphocytes.
Ultrastructural analysis of MLN from a clinically scrapie-infected sheep revealed
extensive FDC networks within easily definable germinal centres. In comparison to
FDC networks from scrapie-infected murine spleens, dendritic profiles were more
widespread and stretched to sites distant from the FDC nucleus. Hypertrophic FDC
networks were more abundant, although they rarely formed labyrinthine complexes
of a similar magnitude to those observed in murine spleen. Instead, FDCs formed
smaller yet more numerous glomerular complexes that were interspersed between
many light zone lymphocytes (Figure 3.5.4). At some points, FDC dendrites were not
associated with an excess electron-dense deposit. Rather, simple, yet extended linear
profiles stretched between cells to form small knots again, joined by other more
linear processes.
Extracellular electron-dense deposit was associated with all mature FDC dendritic
profiles and was highly irregular. Within the extracellular space, many small
spherical bodies could be seen (Figure 3.5.5). Mature B-lymphocytes were present
within the light zone of the follicle, surrounded by extended FDC dendritic profiles
(Figure 3.5.6). FDC processes which formed labyrinthine complexes were seen
adjacent to blood vessels. TBMs were again numerous and were present in both the
light and dark zones of the secondary follicle, and at sites distant from the germinal
centre. These TBMs contained abundant lysosomes and remnants of apoptotic cells.
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Figure 3.5.5. x45K magnification. Detail from a hypertrophic labyrinthine
glomerular complex from a scrapie-infected ovine MLN. Many small spherical
bodies are present within the extracellular electron-dense deposit.
Figure 3.5.6. x8K magnification. Scrapie-infected ovine MLN. FDC dendritic
profiles surround a mature B-lymphocyte (asterisk).
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Ultrastructural immunolabelling method: use of Auroprobe 1 nm or Nanoprobe 1 nm
Immunogold probe, and either silver stain or gold enhancement (See Appendix 6.1.1.
and Figure 3.5.7a).
The standard technique used in all ultrastructural immunolabelling of murine tissue
was applied to ovine MLN i.e. the Auroprobe 1 nm gold probe as described in
section 2.2.7. This technique was also adapted for the use of 1 nm Nanoprobe gold
probe. All primary anti-PrP antisera, found to give immunolabelling using the ABC
method at the light microscopical level, yielded poor results using this technique.
Following a series of titrations of the primary and gold conjugated antibodies, 1A8
and R486 antibodies were not found to immunolabel known positive ovine tissue
adequately using the Auroprobe or Nanoprobe 1 nm immunogold techniques with
either silver stain or gold enhanced methods. PrPd labelling, where present, was very
light and confined to TBM lysosomes, and, occasionally, small areas of larger FDC
labyrinthine glomerular complexes.
Ultrastructural immunolabelling: tyramide amplification with anti-biotin gold (See
Appendix 6.1.n. and Figure 3.5.7b).
The Dako Catalysed signal amplification technique was adapted for use at the
ultrastructural level. This technique is a recently devised amplification system used
to enhance light microscopical immunohistochemical techniques, where antigen is
present in small quantities, or where primary antibody has a low affinity for the
studied antigen. This technique is based on the principle that peroxidase already
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present in the form of attached immune complex can catalyse the deposition of
biotinylated tyramide molecules at the antigen / antibody complex site (Mayer &
Bendayan 2001). Neither a 1 nm nor 5 nm anti-biotin gold probe (British Biocell
International, Cardiff, UK) enhanced with silver (Amersham Pic, Buckinghamshire,
UK) improved PrPd immunolabelling in ovine tissues when compared to the
Auroprobe and Nanoprobe methods detailed above.
Ultrastructural immunolabelling: NEN tyramide amplification with anti-biotin gold
The working principles of the NEN tyramide amplification system are similar to
those of the Dako system detailed above, however, the NEN system has previously
been used in conjunction with gold probes to visualise ultrastructural antigens (NEN
life sciences, Boston, USA). Again, silver-enhanced 1 and 5 nm anti biotin gold
probes were used. This technique did not improve the 1 nm Nanoprobe technique.
Ultrastructural immunolabelling: ABC with anti biotin gold probe (see Appendix
6.I.O. and Figure 3.5.7c)
The ABC technique described in section 2.2.5.2. was adapted for use at the
ultrastructural level using both anti-biotin gold probes described above. This method
resulted in no PrPd immunolabelling of ovine tissue.
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Ultrastructural immunolabelling: Envision with anti HRP gold probe (see Appendix
6.1.p. and Figure 3.5.7d)
The Envision system described in section 2.2.5.3. was adapted and applied to ovine
and murine control tissue. A silver enhanced 1 or 5 nm anti E®P conjugated gold
probe was used as a visualisation product. No immunolabelling was seen in ovine or
murine tissue.
As none of the amplification systems tested enhanced immunolabelling, this would
suggest the antigen itself or the attached primary antibody are unavailable for further
amplification steps.
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Silver / gold amplification
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Figure 3.5.7a. Direct immunogold labelling. A gold probe is attached directly
to the specific primary antibody and is enhanced using a silver or gold
enhancement technique.
Figure 3.5.7b. Tyramide amplification. Peroxidase immune complex
catalyses biotinylated tyramide deposition of gold molecules at the antigen /
antibody complex site. Gold is enhanced using silver or gold enhancement.
Figure 3.5.7c. Avidin / biotin amplification. This is an indirect labelling
method. An avidin / biotin complex is attached to the biotinylated secondary
antibody. A gold probe is attached to the complex that is then enhanced.
Figure 3.5.7d. Envision system amplification. This is a direct method whereby
a polymer chain consisting of many secondary antibodies bound to the
primary antibody can bind a large number of horseradish peroxidase
molecules. A gold probe is attached to the HRP molecules followed by
enhancement.
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Light microscopical immunolabelling: application of ultrastructural Immunogold
silver stain (IGSS) technique
In order to ascertain whether immunogold labelling of ovine MLN was possible, i.e.
if the gold probes couple with primary antibodies, the Nanoprobe gold probe
technique was adapted for use at the light microscopical level. Using the etch and
pre-treatments applied to 1 pm sections using the ABC technique, followed by
application of R486 PrP anitsera, Nanoprobe 1 nm and finally Nanoprobe LM silver
enhancement, good follicular PrPd immunolabelling was obtained. Using sodium
meta-periodate etch technique, no immunolabelling was obtained.
Fixative / embedding medium comparison
As described above, poor immunolabelling of ovine tissue at the ultrastructural level
following application of immunohistochemical methods was observed. To ensure
antigenicity was not compromised as a result of fixation or processing, formalin-
fixed lymph node was processed into resin, and paraformaldehyde-fixed lymph node
was embedded in paraffin wax. Levels of immunolabelling in paraformaldehyde
fixed tissue were found to be similar to that of formalin-fixed paraffin-embedded
tissue. Formalin-fixed resin-embedded tissue also gave poor immunolabelling at the
ultrastructural level.
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Effect of section thickness at LM
The effect of section thickness on antigenicity was tested in order to identify whether
the lack of immunolabelling at the ultrastructural level was as a result of the
reduction in section thickness and subsequent decrease of detectable antigen. 100
nm, 250 nm, 400 nm, 600 nm and 1 pm sections were immunolabelled using the
avidin biotin technique and R486 PrP antisera. At all antibody concentrations, all
tested sections showed immunolabelling, however, decreased section thickness
resulted in very pale DAB reaction product. Retention of counterstain also became
increasingly poor as section thickness decreased, suggesting visualisation of a
labelled molecule or molecules is dependent on molecular density.
Section thickness study at EM
Ovine lymph nodes were sectioned at various thicknesses ranging from 55 nm to 1
pm. These grids were then counterstained (see Appendix 6.1.k). At thicknesses
greater than 100 nm, it became impossible to determine tissue ultrastructure due to
the decreasing penetration of electrons through the tissue. Thick sections were
therefore not immunolabelled for ultrastructural study.
Etching techniques for ultrastructural study
Araldite is an epoxide resin that is tightly bonded allowing very little penetration of
aqueous reagents and antibodies into the hydrophobic matrix. Permeation of this
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plastic matrix is only possible if a surface gel layer is created which can be swollen
with water and subsequently allows reagents and antibodies to reach the tissue.
A gel layer may be created in 2 ways:
1. Treatment with an oxidising agent e.g. hydrogen peroxide, sodium meta-
periodate. Hydrophobic alkane side chains are oxidised, which increases the
hydrophillicity of the resin.
2. Treatment with an alkoxide, e.g. sodium ethoxide. The curing system for
epoxy resin involves ester cross-linking. The addition of sodium ethoxide
causes the ester cross links to be broken, resulting in a net increase in
hydrophilic groups (Causton 1984).
In order to investigate which "etching" techniques would be suitable for ovine
ultrastructural PrPd immunolabelling, 1 pm sections on glass slides were studied.
Light microscopical resin labelling is a considerably easier technique, therefore a
more appropriate initial method for this study.
• Sodium meta-periodate
The immunogold technique previously identified for use with murine tissues (see
section 2.2.7. and Appendix 6.1.1) involves the application of saturated sodium meta-
periodate to tissue sections as an oxidising reagent, allowing penetration of reagents
into the resin matrix. Although murine tissues could be etched appropriately to reveal
immunolabelling, when this reagent was applied as an etching technique to ovine
tissues for ultrastructural study, no PrPd immunolabelling was observed. This was
confirmed at the light microscopical level, where no immunolabelling was observed
using a sodium meta-periodate etch and the standard ABC technique.
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It was therefore considered possible that the sodium meta-periodate etching
technique resulted in the loss of antibody (R486) epitopes. Therefore, a wide cross
section of PrPd antibodies, each targeting different amino acid sequences within the
PrP molecule were used to immunolabel PrPd at the light level using the ABC
technique. Neither R145, 1A8, 505.5 nor 521.7, immunolabelled PrPd positive ovine
MLN at the ultrastructural level, using the Auroprobe technique with a sodium-meta
periodate etch. Murine brain and spleen were also treated with a sodium-meta
periodate etch. Moderate immunolabelling was observed in all murine tissues
studied.
• Hydrogen peroxide.
10% hydrogen peroxide is commonly used to oxidise the resin matrix (Newman &
Jasani 1984). Chemically, this has a similar effect to sodium meta-periodate. When
hydrogen peroxide was applied to 1 gm murine tissues, PrPd immunolabelling was
observed. However, PrPd was not immunolabelled in 1 gim ovine tissues when
similarly treated. Therefore no ultrastructural studies were undertaken utilising this
etching technique.
• Periodic acid
10% aqueous periodic acid was used in conjunction with sodium meta-periodate to
etch 1 jam sections; however, again, no immunolabelling was observed at light
microscopy in ovine tissues using this technique.
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• Iodine solution (acetone)
Iodine in absolute acetone is known to soften epoxy resin, and can be employed in
conjunction with absolute acetone washes to remove resin prior to immunolabelling.
Slides were placed in a 10% iodine solution in acetone for 16 hours, followed by
consecutive washes in 100% acetone for between 4 and 24 hours. Limited
immunolabelling was observed in all murine tissues, regardless of the length of
acetone wash. No immunolabelling was seen in any ovine tissue sections.
• Sodium ethoxide
Unlike the previous etching techniques, this technique involves the breaking of ester
cross links within the resin matrix. It is routinely used for light level resin
immunohistochemistry, and is therefore known to remove resin sufficiently from
tissue sections to allow immunolabelling.
In order to ascertain an appropriate etching time for 55 nm sections for ultrastructural
study, sections on grids were etched at various dilutions of neat sodium ethoxide in
ethanol for various times (see Table 3.5.2). Sections were counterstained and
analysed ultrastructurally. Good tissue integrity and reasonably good structure were
obtained using 1:4 dilution of sodium ethoxide for 10 seconds, followed by graded
alcohol / water washes. Shorter times, or more dilute etching solution, maintained
good structure while longer etching times or more concentrated etching solution,
resulted in loss of tissue.
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Etch Time Etch Cone.
Tissue structure
/ integrity Immunolabelling
3 sec 1:1 Damaged N/A
3 sec 1:2 Damaged N/A




10 sec 1:1 Damaged N/A
10 sec 1:2 Damaged N/A
10 sec 1:4 Good Moderate
I
10 sec 1:10 Very good None
30 sec 1:1 Damaged N/A
i
30 sec 1:2 Damaged N/A
30 sec 1:4 Damaged N/A
30 sec 1:10 Good Light
Table 3.5.2. Table showing sodium ethoxide concentrations and times, and
results obtained.
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Figure 3.5.8. x16K magnification. Immunolabelled secondary follicle from the
MLN of a scrapie-infected sheep. FDC dendritic profiles are sparsely
labelled, while PrPd immunolabelling is abundant within an adjacent TBM
lysosome.
Figure 3.5.9. x20K magnification. Immunolabelled secondary follicle from the
MLN of a scrapie-infected sheep. Moderate PrPd immunolabelling is
associated with the plasmalemma of FDC dendritic profiles.
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When this etching solution was applied to 55 nm sections of ovine MLN, followed
by the standard Nanoprobe / gold enhance immunogold technique, light to significant
immunolabelling was observed within TBM lysosomal compartments (Figure 3.5.8),
and in association with FDC labyrinthine complexes (Figure 3.5.9). Replication of
this technique was extremely difficult to achieve on consecutive tissue sections.
Where tissue was retained following the immunolabelling procedure, only very slight
labelling was observed, a large portion of sections treated demonstrated no
immunolabelling. Although etching times and concentrations were considered to be
very accurate, some tissue sections were lost during immunolabelling, presumably
due to over-etching of the tissue. This was considered the likely explanation, as some
tissues, although present, were virtually destroyed, membranes were unrecognisable,
while intracellular organelles were absent or appeared distorted. As the chemical
process involved in alkoxide etching is considerably more aggressive than the
oxidation reaction, it appears tissue destruction is more likely using this technique.
Even tissues that were briefly etched appeared more damaged than those that were
etched using an oxidation reaction. Although four different antibodies were applied
using this technique, the TBM and FDC labelling described was only seen using
R486 antibody.
Routinely, ultrastructural studies involved immunolabelling sections from ovine
brain in conjunction with the MLN tissues. Surprisingly, where tissue sections were
not over-etched, some immunolabelling was consistently seen. In scrapie-infected
brain tissue sampled at the dorsal motor nucleus of the vagal nerve both intracellular
and extracellular labelling patterns were detected. Intracellular labelling consisted of
intralysosomal labelling in neurons and astrocytes. Additionally, labelling was found
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within the extracellular space, where it was occasionally seen in association with
short rods or amyloid-like filaments. It was also detected in association with
abnormal coated pits. As mentioned previously, tissues did appear less well-
preserved than following oxidation etching. Light and electron microscopical
















- + n/t - - - n/t -
Hydrogen
peroxide
n/t n/t n/t n/t - n/t n/t n/t
Periodic
acid n/t n/t n/t n/t
- n/t n/t n/t
Iodine n/t n/t n/t n/t - n/t n/t n/t
Sodium
ethoxide
++ ++ n/t n/t +++ - ++ -
n/t: not tested
- : negative
+ : light immunolabelling
++: Moderate immunolabelling
+++: good immunolabelling
Table 3.5.3. Table showing the degree of positive immunolabelling of ovine
MLN using a variety of etching and immunolabelling techniques.
165
Discussion
Despite the satisfactory immunolabelling of scrapie-infected murine spleen, it has
proved extremely problematic to achieve adequate sub-cellular visualisation of PrPd
within the LRS of sheep. Immunolabelling of resin-embedded, scrapie-infected ovine
MLNs at the light microscopical level demonstrated abundant labelling of
comparable magnitude to that of routine paraffin wax light microscopy. However,
when the technique is adapted for use at the sub-cellular level, limited
immunolabelling of the LRS, and to a lesser extent the CNS, is achieved. Sub¬
cellular murine PrPd is easily obtained using this method.
The results discussed in this chapter suggest perhaps that inter-species and inter-
tissue conformational differences of the PrPd molecule may be paramount in
understanding differences in immunolabelling between both ovine and murine
tissues, and CNS and LRS tissues of sheep.
Using antibodies specific to ovine PrP in conjunction with the technique developed
for light microscopical immunolabelling of murine splenic tissue, two distinct
patterns of immunolabelling were observed within easily defined secondary follicles
of the MLN from scrapie-infected sheep. Unlike murine spleen, these follicles were
clearly outlined by a distinct margin of cells known as the mantle zone, while PrPd
within germinal centres of scrapie-infected sheep was considerably more easily
defined and abundant using immunolabelling techniques. These results correlate with
previous light microscopical studies of paraffin embedded ovine lymph nodes
obtained from clinically sick sheep (Van Keulen et al. 1996; Schreuder et al.1998;
Jeffrey et al. 2001b).
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Ultrastructural study of scrapie-infected MLNs, revealed a much more widespread
network of hypertrophic FDCs within the light zone of the germinal centre, than was
previously observed within scrapie-infected murine spleen. Again, this correlates
with light microscopical findings insofar as FDC networks have been observed to
occupy most of the space between lymphocytes of the light zone of the follicle. This
may simply be due to the inherent size difference between murine and ovine lymph
nodes, but what is clear is that the abnormal FDC hypertrophy, and subsequent
increase in electron-dense deposit as a result of scrapie infection, is not restricted to
murine spleen. Small vesicular bodies observed within the extracellular space
surrounding FDC cytoplasmic extensions from ovine MLN, were not present within
the spleens of mice. Spherical bodies of unknown cause and function within the ileal
Peyer's patches similar to the particles seen in this study, have been previously
described. These authors suggest that the particles may initially be membrane-bound
to the follicle associated epithelium then shed into the intercellular space. Later,
these particles are found within the follicles of the Peyer's patches in association
with both FDCs and lymphocytes (Landsverk 1987; Landsverk et al. 1990;
Landsverk et al. 1991).
All murine immunolabelling is undertaken using the 1A8 PrP antisera. This antibody
recognises epitopes of the PrP molecule at 3 different amino acid sequences from the
N' terminus, through the globular domain to the C' terminus (Farquhar et al. 1993)
(see also Figure 3.5.1 in this chapter). 1A8 gives excellent immunolabelling of all
murine tissues tested, both at the light and ultrastructural levels. Using the same light
microscopical and ultrastructural immunolabelling techniques, ovine CNS and LRS
tissues immunolabelled poorly at the LM level, and not at all the sub-cellular level
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using 1A8 antisera. This suggests the configuration of the PrPd molecule differs
between species, and that the antigenic sites, recognised by the 1A8 antisera, remain
hidden in ovine tissues. Not only do interspecies differences in the protein
conformation of PrP lead to antibody specificity differences, but inter-tissue
conformation changes probably also occur. The conversion of the normal PrP
molecule to that of the disease-specific form has been well documented (Caughey et
al. 1991; Pan et al. 1993). This conversion results in structural change, and the PrPd
may be present in many truncated and non-truncated forms (Hope et al. 1986; Jeffrey
et al. 2001a). It may therefore be possible that PrPdcan be released or accumulated in
many different conformational forms, depending on cell type or location, for
example, an N' terminally truncated form is known to be present within macrophages
(Jeffrey et al. 2001a).
Resin removal techniques, such as oxidation and transesterification, also influence
levels of immunolabelling. Resin removal at the light microscopical level is
sufficient to allow good immunolabelling of ovine tissues, however, using many
different ultrastructural etching techniques, immunolabelling is inconsistent and at a
considerably lower level than murine labelling patterns. PrPd immunolabelling can be
achieved at the light microscopical level using transesterification etch, and
ultrastructural level following both oxidation and transesterification in murine brain
(Jeffrey & Goodsir 1996) and spleen (chapter 3.1 and 3.2). Although light
microscopical labelling can be obtained in sheep tissue using the same etch
techniques as defined for murine tissue, none of the ultrastructural etching techniques
employed allow for comparable levels of labelling as seen in murine tissue. This
would infer that the nature of the chemical etch is important for antigen exposure. In
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ovine tissue, resin removal may be inadequate to expose the specific antigenic site, or
alternatively, the site may be damaged by the etching techniques. As PrP
immunolabelling was easier to obtain in the CNS of sheep, it may be more resilient
within the CNS than the LRS. This may suggest the specific PrP epitope recognised
by the antibody has been damaged in the LRS. However, PrP within the CNS may
also be more abundant, suggesting the lack of LRS immunolabelling may relate to
sensitivity of the immunolabelling technique. To further address the problem of
sensitivity, more must be understood regarding cross linkage and bonding between
tissue molecules and the resin matrix. This may in turn result in more study of the
nature of the PrP protein itself.
Although formalin fixed, resin embedded tissue did not yield an increase in
immunolabelling over gluteraldehyde-fixed resin-embedded tissues, the fixative may
nevertheless have some influence upon antigenicity. The detrimental effects of
fixation have been well documented (Sabatini & Bensch 1963; Hayat 1989), and the
cumulative negative effect of fixation and resin embedding may be significant. In
this case, pre-embedding techniques may need to be deployed in order to achieve any
significant immunolabelling of ovine lymphoreticular tissues.
Future study must involve experimentation with different forms of embedding; for
example, water-based resins require no etching, although fine structure is
compromised. At the very least, this would allow further analysis of the
conformation of the PrP protein and its interactions with fixatives and resin
polymers. If, as seems likely, chemical etching is the key to PrPd exposure, further
investigation of post-embedding immunohistochemistry of ovine tissue should be
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based on this premise. Trans-esterification etching techniques must be modified to
allow better tissue preservation while exposing the PrPdmolecule more thoroughly.
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4. SUMMARY
In these studies I have determined methods for the ultrastructural detection of
abnormal disease-associated PrP (PrPd), characterised previously unreported sub¬
cellular scrapie-associated lesions and determined the sub-cellular localisation of
PrPd in the spleen of mice, and, to a lesser extent, the lymphoreticular system of
sheep.
Ultrastructural immunohistochemistry is a technically demanding procedure. In order
to determine methods of fixation which retain good ultrastructural morphology but
allow the de-plasticization of tissues without loss of relevant antigenic epitopes,
meticulous and carefully performed chequer-board investigations were needed to
compare the effect of many different parameters. My studies of murine spleens have
shown that satisfactory tissue morphology, combined with a significant level of
antigenic recovery, may be obtained using a 0.5 % paraformaldehyde / 0.5%
gluteraldehyde fixation procedure, followed by oxidative de-plasticization and an
indirect immunogold visualisation method. Nevertheless, when all the different
forms of PrPd labelling seen at the light microscopical level are taken into account,
the optimal ultrastructural immunogold technique developed still appears to have a
reduced level of sensitivity, when compared to light level immunohistochemistry. It
is not clear what parameters affect these differences in labelling sensitivity. It is
possible that only the more robust and more highly aggregated forms of PrPd are
labelled by immunogold, with some accumulations of PrPd observed by LM
apparently remaining undetected at the sub-cellular level. Harsh fixation and
processing techniques required for the ultrastructural analysis of tissues may degrade
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or mask some forms of the PrPd protein, and impair the ability of PrP antibodies to
recognise the relevant epitopes present. Whether these epitopes have been
irreversibly damaged, or whether they remain masked by resin polymer remains to be
determined. This, coupled with the lack of signal amplification using the relatively
basic indirect immunogold technique, may explain the probable lowered sensitivity
of sub-cellular immunohistochemistry, when compared with light microscopical
immunohistochemistry.
Loss of sensitivity was more conspicuous following immunolabelling of ovine
lymphoid tissues, where only weak labelling was observed with different
immunogold techniques, fixation and unmasking procedures. In addition to this,
ovine sub-cellular studies have been restricted by the apparent difficulty of adequate
resin removal. In conjunction with the indirect immunolabelling method used for
murine ultrastructural studies, limited sub-cellular immunolabelling was achieved
using a trans-esterification de-plasticization technique, normally reserved for light
microscopical immunohistochemical techniques. With tissue de-plasticization
proving to be a vital constituent of the immunolabelling procedure, both at the light
and ultrastructural levels, the resin / tissue interaction that renders ovine lymphoid
tissue completely impregnable to oxidative etching techniques, must be further
examined.
Observations of the sub-cellular localisation of PrPd in murine spleen tissue correlate
with light microscopical immunohistochemistry studies (McBride et al. 1992, Brown
et al. 1999). Patterns of immunolabelling observed at the light microscopical level,
tentatively described as both follicular dendritic cell (FDC)-associated and tingible
body macrophage (TBM) labelling patterns, were confirmed using the ultrastructural
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immunocytochemical techniques described above. PrPd immunolabelling was
associated with the plasmalemma of both mature, and to a lesser extent, immature
FDC dendritic profiles. Lysosomal TBM labelling is a feature common to all scrapie-
infected spleens studied, but perhaps the most striking ultrastructural
immunolabelling is related to convoluted FDC dendrites, which form labyrinthine
glomerular complexes, a feature specific to all strains of scrapie which exhibit a
peripheral accumulation phase, and in some cases occurring as early as 6 weeks post
infection (at 15 % of the incubation period following i.p. inoculation). FDCs have
been reported to be involved in various disorders affecting lymphoid tissues and in
inflammation, and may be the target cell type following some viral infections. FDC
proliferation is observed in several types of non-Hodgkin's lymphoma, for example
follicle centre lymphoma and T cell lymphoma (Petrasch et al. 1992; Suchi et
al. 1987) . Lymphoid tissues also demonstrate an inflammatory reaction by becoming
enlarged, and can exhibit hyperplasia. Viral particles have been observed in
association with FDCs, and viral replication has been demonstrated in lymphoid
follicles. This suggests that the immune complex trapping mechanism of FDCs may
play an important role in the pathogenesis of such diseases (Armstrong & Home
1984; Smith et al. 2001). FDCs are considered to play a vital role in HIV infection of
germinal centres by infecting CD4+T cells. They are thought to process the virus as
antigen, whereby infecting CD4+T cells as they pass through the germinal centre
(Tenner-Racz et al. 1988). Ultrastructural analysis has revealed that the viral particles
are located within the extracellular electron-dense deposit between adjacent dendritic
profiles (Racz &.Tenner-Racz 1995). In patients with persistent generalised
lymphadenopathy, FDCs reveal an increased number of organelles, and can become
173
hypertrophic forming small labyrinthine glomerular complexes (Armstrong & Home
1984). These complexes appear smaller than those observed following scrapie
infection, and have less abnormal accumulation of electron-dense deposit. As the
HIV disease progresses and the follicle becomes increasingly distorted, in areas with
abundant viral particles FDC networks degenerate and in the later stages of disease
are completely lost (Tenner-Racz et al. 1985; Armstrong 1991).
The strain inoculation involving the Sine p7 mouse strain did not result in peripheral
accumulation, and only minor variations of the immunolabelling patterns were
observed when different strains of murine scrapie were examined in Sine s7 mouse
strains. Variability was confined to differences in the temporal progression of
changes, albeit these changes were consistent with the clinical disease onset and
incubation times specific to the different scrapie strains examined (Bruce et al. 1994;
Bruce 2003). Sub-cellular pathology of disease is indistinguishable in these strains.
Excess extracellular electron-dense deposits accumulate, and occasional fibrils were
found between individual FDC dendritic processes. This results in the loss of the
normal tri-laminar arrangement consisting of a central electron-dense line
corresponding to the site of accumulation of antigen / antibody complexes (Radoux
et al. 1985) between the plasmalemmae of two adjacent FDC dendrites. Coated pits
are upregulated within the follicles of scrapie-infected murine spleens, while B-
lymphocytes mature to become plasmablasts within the follicle, probably due to an
abnormal prolonged retention of clonally selected B cells by PrPd expressing FDC
dendrites. Contrary to previous dogma, these results provide morphological
evidence to suggest that immune surveillance mechanisms are altered in scrapie.
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Studies of scrapie - infected murine spleens following inhibition of cytokine
signalling and subsequent FDC development have provided little conclusive data.
Although light microscopical results suggest FDCs play a role in neuroinvasion
during the early stages of scrapie infection (Mabbott et al. 2000b), the studies
undertaken in section 3.4. do not conclusively reveal the relationship between these
manipulated murine models and neuroinvasion. Larger experimental groups with
both longer scrapie incubation periods and varying time intervals between cytokine
inhibition and tissue collection may enable more definitive conclusions to be drawn.
I have also confirmed that scrapie infection of sheep causes similar disease-specific
pathological effects within the lymphoreticular system to those identified in the
spleen of mice. As previously seen in murine spleens, FDCs within the follicle of
mesenteric lymph nodes of sheep form highly convoluted dendritic complexes with
excess associated electron-dense deposit and the loss of intermediate dense line.
Unlike that seen within murine spleens, this electron-dense deposit contains many as
yet unidentified spherical structures. Other pathological changes associated with
scrapie infection, such as up-regulation of clathrin-coated pits, fibril formation and
abnormal retention of B-lymphocytes are also present within ovine lymph nodes.
Although sensitive methods of immunolabelling of ovine MLN remain to be
developed, it may be hypothesised from the limited results obtained that PrPd within
ovine MLN has a similar pattern of expression to that previously recognized within
murine spleen. In order to confirm these preliminary observations, further
investigation of the nature of resin / tissue interaction with antigen recovery must be
obtained.
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A more complete understanding of the pathological features of scrapie infection
already discussed within this thesis must also be acquired. The exact nature of the
disease-specific excess extracellular electron-dense deposit surrounding FDC
plasmalemmae, and the cause and mechanisms of coated pit upregulation must be
further investigated.
In conclusion, the work undertaken in this thesis has both advanced the
understanding of immunohistochemical techniques for the sub-cellular study of
scrapie infection in the lymphoreticular system of mice and sheep and distinguished
abnormal sub-cellular features associated with scrapie infection. I have also analysed
the importance of FDCs in the pathogenesis of the disease. Collectively, these results
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6.1 .a. Murine perfusion protocol.
Under deep anaesthesia with 0.3 ml of chloral hydrate (320-350 mg/kg i.p) animals
are first injected with 1ml heparin (1000 units /ml buffer), slowly administered.
Animals are perfused at a rate of 5 ml / min with 100 ml of fixative over a period of
20 min at room temperature via a cannula inserted through the left ventricle into the
base of the aorta. Recommended perfusion pressure for murine brain is 150mmHg.
Tissues are removed and allowed to fix for 24 hours in a fresh solution of the
perfusate at 4°C.
6. l.b. Preparation of Phosphate buffer (PB) stock solution.
Reagents and equipment required:
11 flask




di-sodium hydrogen orthophosphate (Na2HP04.2H20)




Prepare the following stock solutions in distilled water:
A: 0.2M Na2HP04.2H20 = 35.6g/l
B: 0.2M NaH2P04. 2H20 = 31.2g/l
• For stock solution 0.2 M phosphate buffer at pH 7.4, mix solutions A and B
in a ratio of 4:1 and pH as necessary.
• To prepare a 0.1 M phosphate buffer solution, mix equal volumes of 0.2 M
Phosphate buffer and distilled water.
Note: Stock solutions A and B may be stored for long periods at 4°C but should be
warmed prior to use and stirred to dissolve crystals.
0.2 M PB can be stored for up to 1 week at 4°C.
Different pH values can be gained or adjusted by adding either solution A to increase
the pH or solution B to decrease the pH.
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6.I.e. Paraformaldehyde / Gluteraldehyde fixative protocol.
Reagents and equipment required:
Paraformaldehyde
Gluteraldehyde (supplied as 25% aqueous solution from all EM suppliers, stored at
4°C)
0.5 M NaOH







• Weigh out required volume of paraformaldehyde. Paraformaldehyde is a
know respiratory allergen:all procedures must be carried out according to
Health and Safety regulations - a particle facemask must be worn for this
step.
• Using a Bunsen burner, heat distilled water (just under half the final required
volume of fixative) to 70°C. Paraformaldehyde should be added while
distilled water is between 65 and 70°C. Stir continuously with a magnetic
stirrer in a fume hood.
• Allow paraformaldehyde solution to stir for 10 min.
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• Slowly add 0.5 M NaOH drop wise until solution clears.
• Paraformaldehyde solution should be covered and allowed to cool.
• Filter paraformaldehyde solution.
• Add half the final volume of 0.2 M phosphate buffer (see appendix 6.1.b).
• Add the appropriate volume of 25% gluteraldehyde solution to give the
desired final concentration. See Table 6.1.c.i. If this is less than the final




Volume of fixative (ml) required
100 200 300 400 500 750
1000
0.01% 0.04 0.08 0.12 0.16 0.2
0.3 0.4
0.05% 0.2 0.4 0.6 0.8 1.0
1.5 2.0
0.1% 0.4 0.8 1.2 1.6 2.0
3.0 4.0
0.2% 0.8 1.6 2.4 3.2 4.0
6.0 8.0
0.5% 2.0 4.0 6.0 8.0 10.0
15.0 20.0
1.0% 4.0 8.0 12.0 16.0 20.0
30.0 40.0
2.0% 8.0 16.0 24.0 32.0 40.0
60.0 80.0
2.5% 10.0 20.0 30.0 40.0 50.0
75.0 100.
5.0% 20.0 40.0 60.0 80.0 100.0
150.0 200.
Table 6.1.c.i. Volume of 25% gluteraldehyde solution required for the
preparation of fixatives.Protocol and Table adapted from: Experimental
Neuroanatomy - (Ed. J.P.Bolam) (Bolam 1992)
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6.1.d. Araldite processing
Three days should be allowed for this process.
• Cut tissue into 1 mm blocks and place in vial containing 0.1 M PB. This is
placed on shaker - 15 min.
• Replace PB with 2% Osmium tetroxide (4% stock diluted in 0.1 M PB) - 2
hours (Osmium concentrate protocol: 6.1.d.i.). This step must be carried out
in a fume hood.
• Wash in 0.1 M PB -2x5 min.
• Wash in dist. water -2x5 min.
• Replace water with 40% acetone - 15 min.
60% acetone - 15 min.
80% acetone - 15 min.
100% acetone - 15 min. x 2
• Replace acetone with 50 / 50 dilution of acetone/ araldite - overnight.
• Replace with 25/75 dilution of acetone/ araldite - daytime.
• Change to 100% araldite - overnight.
• Replace with fresh araldite - 2 hours fresh.
• Embed.
• Polymerize at 37°C or 60°C - 48 hours.
Stages 1-9 should be carried out on a shaker or mixer.
During this procedure temperature must remain relatively constant.
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Reagent Quantity required
CY212 49g 24.5g 12.25g
DDSA 49g 24.5g 12.25g
Dib. Phthalate 0.75g 0.37g 0.185g
BDMA 1.5g 0.75g 0.37g
Table 6.1 .d.i - Quantities of chemicals required for araldite production.
CY212, DDSA (Dodecenyl Succinic Anhydride) and Dibutyl Phthalate should be
mixed thoroughly prior to the addition of BDMA (Benzyldimethylamine). This
should take approximately 45 min.
After the addition of BDMA the araldite should be mixed for a further 30 min.
6.1.d.i. Stock osmium tetroxide preparation (4%).
Reagents / equipment required:
1 g ampule of solid osmium tetroxide (TAAB)
25 ml distilled H2O
Dark glass bottle
parafilm
• The ampule of osmium tetroxide is opened by conventional glass scoring
methods or using an ampule breaker.
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• The contents of the ampule and 25 ml distilled water are placed into the glass
bottle, a stirrer added and the lid tightly fixed.
• This should be stirred inside the fume hood until the crystals are seen to
dissolve, i.e. for 2-3 hours.
• The lid is then covered in parafilm and the bottle placed in a sealed container.
This may be stored at 4°C for several months.
6.I.e. Staining 1pm sections with Toluidine blue dye.
Toluidine Blue dye:
1 g Toluidine blue
1 g Borax
100 ml distilled H20






Beaker with distilled water
Method:
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• Place a large droplet of toluidine blue dye onto a clean glass slide.
• Lift one stretched 1 pm section out of the water bath using hair stick and float
onto the dye.
• Place the slide onto the hotplate (50°C) for 15 sec. or until the edges of the
dye begin to evaporate.
• Remove slide and lift section from the dye into the water filled beaker. Water
should be moved until excess dye is rinsed away.
• Place a drop of distilled water on a clean glass slide.
• Transfer section from the beaker to the water drop.
• Allow section to dry naturally.
Sections should not be coverslipped to allow for ease of mesa orientation.
6.1.f. Peroxidase anti-Peroxidase technique (PAP).
1 pm araldite embedded sections of tissue on glass slides. Dry sections in oven at
60°C overnight before immunolabelling.
Never allow sections to dry throughout the entire staining procedure.
Pre treatment:
• Plastic removal: Sections placed in a solution of saturated sodium ethoxide
(See appendix 6.1.f.i.). A slide should be studied under the microscope at
regular intervals to determine the degree of etching. As soon as visible resin
is seen to begin disintegrating, the sodium ethoxide should be removed.
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• Slides transferred to four consecutive washes in absolute ethanol (slides
totally submerged) 4x5 min each.
• Inhibit endogenous peroxidase by treating with freshly prepared 6% hydrogen
peroxide (H202) in methanol 10 min.
• Rinse in running water for 10 min.
• Enhance antigenicity with neat ( 98%) Formic Acid for 5 min.
• Rinse in running water for 10 min.
• Rinse sections in wash buffer (Appendix 6.1.f.ii.) before immunolabelling.
Peroxidase anti-peroxidase labelling method.
• Block non-specific binding: Incubate sections with normal swine serum
diluted 1:10 in incubation buffer (Appendix 6.1.f.iv.) for 1 hour.
• Primary antibody incubation: Incubate sections with a 1:2000 dilution of 1A8
anti PrP serum. Antibody is diluted in incubation buffer. This should be
carried out overnight at 4°C.
• Rinse the slides in washing buffer for 2 hours with regular buffer changes.
• Apply second layer antibody swine anti rabbit IgG at a 1:40 dilution in
incubation buffer for 1 hour at room temperature.
• Rinse the slides in washing buffer for 4x10 min.
• Apply rabbit peroxidase anti-peroxidase complex at a 1:100 dilution in
incubation buffer for 30 min at room temperature.
• Rinse the slides in washing buffer for 3x10 min.
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• Reaction product is developed by the application of 3-3' Diaminobenzidine
(DAB) (Appendix 6.1.f.v.) substrate for 10 min. This is diluted to a 1:100
with wash buffer. 50 pi H2O2 is added.
• Wash slides in running tap water for 5 min.
• Enhance DAB with copper sulphate (4g Cu S04 and 7.2g NaCl in 1 litre
distilled water) solution for 10 min.
• Wash in water.
• Counterstain with Harris' haematoxylin for 30 min - check staining under a
microscope.
• Blue the sections using Lithium Carbonate (0.5g CLiCCL in 1 litre distilled
water). The term "Blue" refers to washing slides in a solution of pH>5.0. In
most cases ordinary tap water will suffice, but may take a few minutes.
Virtually instantaneous conversion can be obtained with a dilute solution of
lithium carbonate.
• Dehydrate, clear and mount.
6.1.f.i. Saturated Sodium Ethoxide.
• 15 g NaOH pellets are added to 100ml absolute ethanol in a 250 ml flask,
covered with parafilm and placed on a magnetic stirrer for 1 hour.
• The solution is left for 5 days at room temperature.
• The resultant transparent supernatant is decanted into a plastic 100 ml bottle,
labelled and placed in a sealed container. Sodium ethoxide is ready for use.
• Sodium ethoxide should be freshly made on a weekly basis.
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6.1.f.ii. Wash buffer.
Wash buffer consists of 10% Phosphate Buffer Saline concentrate in distilled water
with 0.2% Tween 20 added.
6.f.iii. Phosphate buffer saline (PBS) protocol - concentrate.
Reagents required:
Sodium Chloride 80 g (mw 58.44)
Potassium Chloride 2 g (mw 74.55)
Di-Sodium Hydrogen Orthophosphate 11.5 g (mw 141.96)
Potassium Di-Hydrogen Orthophosphate 2 g (mw 136.09)
11 distilled H2O




Wash buffer as detailed above with the addition of 20% normal serum (this is
dependent on the tracer system used) e.g. PAP technique will use normal swine
serum.
6.1.f.v. Diaminobenzidine (DAB) protocol.
DAB concentrate
Reagents required: 3-3 Diaminobenzidine - 1 g
40 ml Distilled H2O
• Mix ingredients thoroughly on a magnetic stirrer.
• Filter.
• Aliquot 0.5 ml into vials.
• Freeze at -20°C.
Working strength protocol:
• Defrost a vial ofDAB concentrate.
• Dilute immediately in 50 ml wash buffer (see Appendix 6.1.f.ii.).
• Add 50 pi neat Hydrogen peroxide.
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6.1.g. Avidin Biotin technique.
lpm araldite embedded sections of tissue are placed on charged glass slides
(BDH,VWR International Ltd., Leics). Sections are dried in oven at 60°C for 48
hours before immunolabelling.
Never allow sections to dry throughout the entire staining procedure.
Pre-treatment:
• Plastic removal: A solution of saturated sodium ethoxide is placed on
sections. (See Appendix 6.1.f.i) A slide should be studied under the
microscope at regular intervals to determine the degree of etching. As soon
as visible resin is seen to begin disintegrating, the sodium ethoxide should be
removed.
• Slides transferred to consecutive washes in absolute ethanol (slides totally
submerged). Agitate slides gently in the ethanol and repeat process until no
more ethoxide can be removed from slides (approx. 4 times).
• Inhibit endogenous peroxidase by treating with freshly prepared 6% hydrogen
peroxide (H2O2) in distilled water for 10 min. Rinse in running water for 10
min.
• Enhance antigenicity with Formic Acid for 5 min. Rinse in running water for
10 min.
• Remove slides individually from water and place onto plastic coverslip
ensuring there is a layer of water trapped between the slide and coverslip and
there are no air bubbles present. Do this by adding a few droplets of water to
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the coverslip and slowly pressing the slide tissue side down towards the
coverslip.
• Place slide and coverslip on the Sequenza rack and add 100 pi of PBST to
prevent tissue from drying out. Allow sections to sit in PBST for 20 min
before adding normal serum. Change PBST two times during this time.
ABC immunolabelling procedure:
• Block non-specific binding: - Incubate sections with normal serum diluted
1:10 in PBST (blocking buffer) for 60 min. Note the normal serum used
depends on the ABC kit selected. Current EM R&D spec, is:- murine tissue
with Rabbit Kit and normal goat serum, ovine tissue with Universal Kit and
normal horse serum.
• Primary antibody incubation: - Incubate sections with appropriate dilution of
specific primary antiserum in blocking buffer overnight at 27°C in Sequenza
rack.
• Wash slides in two changes of PBST for 10 min each.
• Apply biotinylated second layer antibody IgG from the kit diluted in blocking
buffer for 1 hour at room temperature.
• Make appropriate dilution of avidin biotin complex in PBST. This must be
made at least 30 min before use.
• Wash slides in two changes of PBST for 10 min. each.
• Apply avidin biotin complex for 30 min. at room temperature.
• Wash slides in two changes of PBST for 10 min. each.
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• Prepare DAB in black plastic troughs by adding 2 x 1ml DAB to 200 ml
PBST and 200 pi Hydrogen Peroxide. Slides placed in DAB for 10 min.
• Rinse slides in four quick changes of PBST.
• Immerse in 0.5% aqueous copper sulphate for lOmin to enhance DAB
reaction.
• Rinse in tap water.
Counterstain by hand as follows: -
• Mayer's Haematoxylin at 37°C for 30 min (use Haematoxylin preheated to
37°C).
• Rinse in tap water until it runs clear.
• Differentiate in 1% acid alcohol (1% HC1 in ethanol) 2-3 sec.
• Rinse in tap water.
• Blue in 0.05% lithium carbonate.
• Rinse in tap water.
• Dehydrate in two changes of absolute ethanol, clear in xylene and mount in
DPX.
6.1.h. Envision technique.
lpm araldite embedded sections of tissue on glass slides. Dry sections in oven at
60°C overnight before immunolabelling.
Never allow sections to dry throughout the entire staining procedure.
Pre treatment:
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• Plastic removal: Sections placed in a solution of saturated sodium ethoxide.
(See Appendix 6.1.f.i.) A slide should be studied under the microscope at
regular intervals to determine the degree of etching. As soon as visible resin
is seen to begin disintegrating, the sodium ethoxide should be removed.
• Slides transferred to four consecutive washes in absolute ethanol (slides
totally submerged) 4x5 min each.
• Inhibit endogenous peroxidase by treating with freshly prepared 6%
hydrogen peroxide (H2O2) in methanol 10 min.
• Rinse in running water for 10 min.
• Enhance antigenicity with Formic Acid for 5 min.
• Rinse in running water for 10 min.
• Remove slides individually from water and place onto plastic coverslip
ensuring there is a layer of water trapped between the slide and coverslip and
there are no air bubbles present. Do this by adding a few droplets of water to
the coverslip and slowly pressing the slide tissue side down towards the
coverslip.
• Place slide and coverslip on the Sequenza rack and add 100 pi ofPBST to
prevent tissue from drying out. Allow sections to sit in PBST for 20 min
before adding normal serum. Change PBST two times during this time.
Note: no blocking serum is required as the envision kit is a polymer raised
against a primary antibody. Therefore there will be no non-specific globulin
binding.
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• Primary antibody incubation: - Incubate sections with appropriate dilution of
specific primary antiserum in incubation buffer overnight at 37°C in humidity
chamber.
• Carefully drain slides onto absorbent paper and return to holder. Rinse in
wash buffer with regular changes for 90 min.
• Apply labelled envision polymer diluted in wash buffer for 30 min. at room
temperature.
• Carefully drain slides onto absorbent paper and return to holder. Rinse in
wash buffer with regular changes for 30 min.
• Apply DAB (50 ml PBST + 500 pi DAB + 50 pi hydrogen peroxide)
substrate for 10 min.
• Rinse slides in four quick changes of wash buffer.
• Immerse in 0.5% aqueous copper sulphate for lOmin. to enhance DAB
reaction.
• Rinse in tap water.
Counterstain by hand as follows: -
• Mayer's Haematoxylin at 37°C for 30 min (use haematoxylin preheated to
37°C).
• Rinse in tap water until it runs clear.
• Differentiate in 1% acid alcohol (1% HC1 in ethanol) 2-3 sec.
• Rinse in tap water.
• Blue in 0.05% lithium carbonate.
• Rinse in tap water.
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6.1A. Reynolds Lead citrate.
Lead nitrate Pb(NC>3)2 1.33 g
Tri Sodium Citrate NasCCeHsOy^O 1.76 g
Boiled autoclaved Distilled H2O 30 ml
NaOH 6 ml
• Lead nitrate, sodium citrate and H2O are shaken vigorously for lmin.
• The resultant suspension is allowed to stand with intermittent shaking in
order to ensure the complete conversion of lead nitrate to lead citrate.
• After 30 min, 6 ml NaOH is added and the suspension is diluted to 50 ml with
Boiled autoclaved distilled water and mixed by inversion.
• Lead citrate should dissolve and the solution will be ready for use.
• pH the solution - if the pH is below pH 11.9 or above pH 12.1, discard.
Store in a labelled plastic bottle at 4°C.
The solution can be stored for up to 3 months although this depends on use, as the
solution is unstable when exposed to air.
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6.1.i. Uranyl acetate.
• Make 100 ml of 50% Ethanol.
• Filter 50 ml neat ethanol and add 50 ml Boiled Autoclaved Distilled water
• Add to brown glass bottle.
• To this add 2 g uranyl acetate.
• Stir for at least 1 hour.
pH the solution - if the solution is below pH 3.7 or above pH 4.5, discard.
Label and place in fridge.
This stain should be stored for a maximum of 3 weeks.
6.1 ,k. Lead citrate / uranvl acetate EM Counterstain.
Lead stains provide a general increase in contrast. Lead is a cumulative poison and
all necessary precautions should be taken when handling.
Uranyl stains also increase contrast, but may also be used as semi specific stains for
DNA containing structures. Membranous organelles are not stained well.
Safety
Gloves should be worn at all times when handling Uranyl acetate and Lead citrate.




5% hydrogen peroxide in boiled and filtered distilled water
2% uranyl acetate in ethanol
Reynolds lead citrate
50% ethanol (nylon membrane filtered)
Sodium hydroxide pellets
Distilled water




3 dental wax sheets
Disposable pipettes
Square filter paper
2 disposable 1ml syringe
0.2 pm nylon membrane filters
2 Eppendorf vials
Procedure
• Fill a beaker with 50% nylon filtered ethanol; fill the other with boiled
autolcaved distilled water. This should be covered at all times.
• Place filter paper into the labelled staining dishes.
213
For uranyl acetate, soak filter paper in 50% ethanol.
For lead citrate, place pellets in dish
For hydrogen peroxide soak in with boiled autolcaved distilled water
Cover filter paper with dental wax and replace the lid on the dishes.
Using a 1 ml disposable syringe, withdraw required amount of uranyl acetate
from the bottle and filter using the 0.2 pm nylon filter into an Eppendorf vial.
Clear filer by removing plunger to push air through.
Repeat for Lead citrate.
Place balanced eppendorf vials in the microcentrifuge at 13000 rpm for 5
min.
Place Hydrogen peroxide on the wax (1 drop per grid).
Float grid tissue side down on the drop for 5 min.
Meanwhile, place appropriate amount of drops of uranyl acetate into the
staining dish.
After removing the grids from hydrogen peroxide, rinse in with boiled
autolcaved distilled water for 15 sec.
Float grids tissue side down on the drops of Uranyl acetate for the appropriate
length of time.
5 min prior to completion of this step, place drops of lead citrate into staining
dish.
Remove grid and rinse in 50% ethanol for 15 sec followed by 15 sec in with
boiled autolcaved distilled water.
Place tissue side down onto the drops of lead citrate. Care should be taken
keep the lid on this staining dish whenever possible.
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• Leave for the appropriate length of time.
• Rinse grids in 0.02 M NaOH followed by with boiled autolcaved distilled
water.
• Touch dry on filter paper and hold in forceps until visibly dry.
• Place the stained grid tissue side up onto a grid plate in a Petri dish.
6.1.1. Immunogold technique
AUROPROBE ONE (lnm gold probe) and INTENSE M (silver enhancement) and
NANOPROBE (lnm gold probe) and NANOPROBE GOLDENHANCE (gold
enhancement): staining on ultrathin araldite sections.
On grid staining.
All steps are performed at room temperature on reagent droplets on a sheet of dental
wax. Never allow grids to dry throughout the procedure.
Pre-treatment:
• Etching step. Float grids section side down on a droplet of saturated filtered
Sodium meta-periodate for 60 min.
• Rinse grids in boiled and filtered, distilled water for 3 x 5 min.
• Block endogenous peroxidase and de-osmicate with filtered (use nylon filter)
3% hydrogen peroxide in boiled filtered distilled water for 10 min.
• Rinse grids in boiled, filtered distilled water for 3 x 5 min.
• Enhance antigenicity with filtered Formic acid for 10 min.
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• Rinse grids in boiled, filtered distilled water for 3 x 5 min.
• Rinse grids in filtered wash buffer (British Biocell Protocol - Appendix
6.1.1.i.), before immunolabelling for 2 x 10 min.
Immunogold staining procedure:
• Quench residual aldehyde groups with filtered 0.2 M glycine (Appendix
6.1.1.ii.) in PBS buffer pH 7.4 for 3 min.
• Rinse the grids on filtered washing buffer for 5 min.
• Blocking step. Incubate the grids on filtered washing buffer for 1 hour.
• Primary antibody incubation: Incubate grids with appropriate dilution of
specific primary antiserum in filtered washing buffer overnight at 27°C.
• Rinse grids on filtered washing buffer for 6x10 min.
• Immunogold incubation. Incubate with Auroprobe One diluted 1:50 in
filtered washing buffer for 2 hours, or Nanoprobe 1 nm gold probe diluted
1:50 in washing buffer for 2 hours.
• Rinse grids in washing buffer for 3 x 30 min and in PBS (see Appendix
6.1 .f.iii.) for 3x5 min.
• Post fixation step. Post-fix the grids with filtered 2.5 % gluteraldehyde in
PBS for 10 min.
• Rinse in excess boiled and filtered distilled water for 2 x 5 min.
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Silver/gold amplification step:
• Prepare the silver solution by mixing equal parts of Enhancer and Initiator of
the Intense M kit just before use. This should be removed from the fridge at
least 1 hour prior to use. Perform_silver amplification for 4 min.
• Prepare the goldenhance solution by mixing equal parts of component A and
B. This should be allowed to develop for a minimum of 10 min. Equal parts
of components C and D are added and the goldenhance solution as applied to
grids for 10 min.
• Rinse grids in excess boiled and filtered distilled water for 3 x 10 min.
• Counterstain with uranyl acetate and lead citrate. See Appendix 6.1.k.
6.1.l.i. British Biocell buffer protocol.
• Make up fresh PBS (pH 7.6). Use boiled polished reverse osmosis pre-treated
water.
• Add 2% Normal serum (depending on the 2° antibody host animal e.g. Goat
anti Rabbit would be normal goat).
• Add 0.1% Tween 20.
• Add 1% BSA.
• Add 0.1% Sodium azide.
• Mix thoroughly.
• pH to 8.2 using 1 M NaOH.
• Pass buffer through a nylon filter and dispense into glass vials, label and
freeze.
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6.1.1.ii. Glycine - 0.2 M in PBS.
• Make up fresh PBS (pH 7.6). Use boiled polished reverse osmosis pre-treated
water.
• Add 1.5 g glycine to 100 ml PBS.
• Filter into 1 ml vials, label and freeze.
6.1.1.iii. Gluteraldehyde - 2.5% in PBS.
• Make up fresh PBS (pH 7.6). Use boiled polished reverse osmosis pre-treated
water.
• Add 10 ml neat EM grade gluteraldehyde (25%) to 90 ml PBS.
• Filter into 1 ml vials, label and freeze.
6.1.m. Immunogold for light microscopical analysis.
1 p,m araldite embedded sections of tissue are placed on charged glass slides.
Sections are dried in oven at 60°C for 48 hours before immunolabelling.
Never allow sections to dry throughout the entire staining procedure.
Pre-treatment:
• Plastic removal: A solution of saturated sodium ethoxide is placed on
sections. (See Appendix 6.1.f.i.) This procedure is carried out on a metal
slide tray. A slide should be studied under the microscope at regular intervals
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to determine the degree of etching. As soon as visible resin is seen to begin
disintegrating, the sodium ethoxide should be removed. For 5 day old
ethoxide this should be around 25-30 min.
• Slides transferred to consecutive washes in absolute ethanol (slides totally
submerged). Agitate slides gently in the ethanol and repeat process until no
more ethoxide comes off slides (approx. 4 times).
• Inhibit endogenous peroxidase by treating with freshly prepared 6.0%
hydrogen peroxide in distilled water for 10 min. Rinse in running water for
10 min.
• Remove slides individually from water and place onto plastic coverslip
ensuring there is a layer of water trapped between the slide and coverslip and
there are no air bubbles present. Do this by adding a few droplets of water to
the coverslip and slowly pressing the slide tissue side down towards the
coverslip.
• Place slide and coverslip on the Sequenza rack and add 100 pi ofPBST to
prevent tissue from drying out. Allow sections to sit in PBST for 20 min
before adding normal serum. Change PBST two times during this time.
ABC immunolabelling procedure:
• Block non-specific binding: - Incubate sections with normal serum diluted
1:10 in PBST (blocking buffer) for 60 min. Note the normal serum used
depends on the ABC kit selected. Current EM R&D spec, is: - murine tissue
with Rabbit Kit and normal goat serum, ovine tissue with Universal Kit and
normal horse serum.
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• Primary antibody incubation: - Incubate sections with appropriate dilution of
specific primary antiserum (e.g. R486 is applied at a 1:1500 dilution) in
blocking buffer overnight at 27°C in Sequenza rack.
• Wash slides in two changes of PBST for 10 min each.
• Apply Auroprobe lnm or Nanoprobe lnm gold probe at a dilution of 1:50 in
PBST for 2 hours at room temperature.
• Wash slides in four changes of PBST for 10 min each.
• Remove slides from Sequenza rack and place in metal slide tray. Working
strength silver stain (Intense M, Amersham, or LI silver enhance,
Nanoprobes) is applied for 20 min.
• Wash slides in running tap water for 10 min.
Counterstain by hand as follows: -
• Mayer's Haematoxylin at 37°C for 30 min (use haematoxylin preheated to
37°C).
• Rinse in tap water until it runs clear.
• Rinse in tap water.
• Blue in 0.05% lithium carbonate.
• Rinse in tap water.
• Dehydrate in two changes of absolute ethanol, clear in xylene and mount in
DPX.
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6.1.n. Tyramide amplification for Ultrastructural analysis.
Carry out pre-treatments as detailed in Appendix 6.1.1.
Immunolabelling and tyramide amplification procedure:
• Quench residual aldehyde groups with filtered 0.2 M glycine (Appendix
6.1 .l.ii) in PBS buffer pH 7.4 for 3 min.
• Rinse the grids on filtered washing buffer for 5 min.
• Blocking step. Incubate the grids on filtered washing buffer for 1 hour.
• Primary antibody incubation: Incubate grids with appropriate dilution of
specific primary antiserum (R486 at 1:250) in filtered washing buffer
overnight at 27°C.
• Rinse grids on filtered washing buffer for 6x10 min.
• Apply pre-prepared biotinylated secondary antibody for 15 min.
• Apply streptavidin-biotin complex for 15 min. This should be prepared at
least 30 min prior to use.
• Apply biotinylated tyramide for 15 min according to manufacturers
instructions.
• Incubate grids in 5nm goat anti biotin gold probe diluted to 1:50 in washing
buffer for 2 hours.
• Rinse grids in filtered washing buffer for 6x10 min.
• Apply Nanoprobe goldenhance for 10 min (see Appendix 6.1.1. for details).
• Rinse in excess boiled and filtered distilled water for 2 x 5 min.
• Counterstain - see Appendix 6.1.k.
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6.1.0. Avidin Biotin amplification for ultrastructural analysis.
Carry out pre-treatments as detailed in Appendix 6.1.1.
Immunolabelling and ABC amplification method:
• Quench residual aldehyde groups with filtered 0.2 M glycine (Appendix
6.l.l.ii.) in PBS buffer pH 7.4 for 3 min.
• Rinse the grids on filtered washing buffer for 5 min.
• Blocking step. Incubate the grids on filtered washing buffer for 1 hour.
• Primary antibody incubation: Incubate grids with appropriate dilution of
specific primary antiserum (R486 at 1:250) in filtered washing buffer
overnight at 27°C.
• Rinse grids in filtered washing buffer for 6x10 min.
• Apply biotinylated secondary antibody, diluted to 1:50 in washing buffer for
lhour. Rinse grids in filtered washing buffer for 3 x 10 min.
• Apply avidin biotin complex, diluted to 1:50 in filtered PBST for 30 min.
• Rinse grids in filtered washing buffer for 3x10 min.
• Incubate grids in 5 nm goat anti Biotin gold probe diluted to 1:50 in washing
buffer for 2 hours.
• Rinse grids in filtered washing buffer for 6x10 min.
• Apply Nanoprobe goldenhance for 10 min (see Appendix 6.1.1. for details).
• Rinse in excess boiled and filtered distilled water for 2 x 5 min.
• Counterstain - see Appendix 6.1 .k.
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6.1.p. Envision system for ultrastructural analysis.
Carry out pre-treatments as detailed in Appendix 6.1.1.
Immunolabelling and Envision method:
• Quench residual aldehyde groups with filtered 0.2 M glycine (Appendix
6.1 .l.ii.) in PBS buffer pH 7.4 for 3 min.
• Rinse the grids on filtered washing buffer for 5 min.
• Blocking step. Incubate the grids on filtered washing buffer for 1 hour.
• Primary antibody incubation: Incubate grids with appropriate dilution of
specific primary antiserum (R486 at 1:250) in filtered washing buffer
overnight at 27°C.
• Rinse grids in filtered washing buffer for 6x10 min.
• Dilute Envision reagent 1:1 in filtered PBST. Apply for 30 min.
• Rinse grids in filtered washing buffer for 3x10 min.
• Incubate grids in 5 nm goat anti-Horseradish peroxidase gold probe diluted to
1:50 in washing buffer for 2 hours.
• Rinse grids in filtered washing buffer for 6x10 min.
• Apply Nanoprobe goldenhance for 10 min (see Appendix 6.1.1 for details).
• Rinse in excess boiled and filtered distilled water for 2x5 mm.
Counterstain - see Appendix 6.1.k.
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Abstract
Prion protein (PrP) from the brains of animals with transmissible spongiform encephalopathies is
partially protease resistant (PrPrcs) compared with fully sensitive PrP (PrPstn) from uninfected
brains. In most experimental models, PrPres is a reliable indicator of infectivity. Light
microscopic studies have suggested that both PrPsen and disease-specific accumulations of PrP
are associated with follicular dendritic cells (FDCs). Using immunogold electron microscopy, this
study has demonstrated disease-specific accumulation of PrP in the spleens of C57 BL mice, 70
days after intracerebral infection with the ME7 strain of scrapie and at the terminal stage of
disease at 170 days. At both stages, tingible body macrophages contained PrP within lvsosomes
and PrP was also detected at the plasmalemma of FDCs. In the light zone of follicles of
terminally diseased mice, all FDC dendrites were arranged in the form of highly reactive or
hyperplastic labyrinthine glomerular complexes, within which PrP was consistently seen between
FDC processes in association with abundant electron dense material, interpreted as antigen-anti-
body complexes. Within some glomeruli, fibrillar forms of PrP consistent with amyloid were seen.
At 7(1 days after challenge, large or hyperplastic labyrinthine complexes were rare and invariably
labelled for PrP. However, sparse PrP labelling was also seen on simple FDC processes at this
stage. The ubiquitous accumulation of extracellular PrP in complex glomerular dendrites of
FDCs in spleens from terminally affected mice, contrasted with simple FDC profiles, sparse PrP
and limited electron dense deposits in all but a few FDCs of 70-day post-infected mice. This
suggests that FDCs continually release PrP from the cell surface, where it is associated with
trapped antigen-antibody complexes and dendritic extension. It is likely that tingible body
macrophages acquire PrP following phagocytosis of PrP within iccosomes or from the
extracellular space around FDC dendrites. These studies would not support an intracellular
phase of PrP accumulation in FDCs but show that PrP is produced in excess by scrapie-infected
cells from where it is released into the extracellular space. We suggest that PrPsc" is involved in
dendritic extension or in the process of antibody-antigen trapping, perhaps as part of the binding
mechanism for antigen-antibody complexes. © Crown copyright 2000. Reproduced with the
permission of Her Majesty's Stationery Office. Published by John Wiley & Sons, Ltd.
Keywords: prion protein; scrapie; spongiform encephalopathies; immunogold; amyloid; spleen;
follicular dendritic cells
Introduction
The transmissible spongiform encephalopathies
(TSEs), or prion diseases, are a group of slowly
progressive neurological disorders characterized by
the accumulation of an abnormal post-translationally
modified form of a host-encoded cell surface glycopro¬
tein called prion protein (PrP). The abnormal form of
the protein is partially protease resistant (PrPres) and
accumulates in brain and also in lymphoreticular
tissues and peripheral nervous system in most experi¬
mental models and some natural disease. This abnor¬
mal isoform of PrP copurifies with infectivity [1], The
normal form of the prion protein (PrPsen) is expressed
abundantly in the CNS and at a lower level in many
visceral tissues [2],
Many studies indicate that the lymphoreticular
system is important for scrapie pathogenesis [3].
Within a few weeks of scrapie infection, agent
replication can be detected in a variety of lymphoid
tissues [4], and, at least in murine scrapie models,
initial neuroinvasion is thought to occur following
retrograde transportation of infectivity to the spinal
cord via splanchnic nerves which innervate the spleen
[5],
Studies employing a variety of experimental
approaches, including the use of cell fractionation
techniques, severe combined immunodeficient (SCID)
mice and whole body gamma irradiation, suggest that
the follicular dendritic cell (FDC) is important for
scrapie pathogenesis [6-11], Procedures which deplete
mitotic cells, such as gamma irradiation, as well
as genetic athymia or surgical thymectomy, do not
significantly alter incubation periods [7,8], suggesting
that scrapie replication does not depend upon B or
T cells but requires radioresistant mitotically inactive
© Crown copyright 2000. Reproduced with permission of Her Majesty's Stationery Office.
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cells. Disease specific accumulations of PrP are also
seen in association with FDCs of TSE infected mice,
sheep and human beings [12-15], PrPsen can be
detected in association with FDCs of the murine
spleen [12].
SCID mice lack B and T cells and FDCs fail to
mature [16]. They are relatively resistant to scrapie
challenge by peripheral routes and fail to replicate
infectivity in their spleens [9,17], Following reconstitu-
tion by bone marrow grafting, these mice become fully
susceptible to peripheral challenge and capable of
supporting replication in their spleens. In further
studies, chimeric mice have been produced by bone
marrow grafting either SCTD or gamma-irradiated
mice which express PrP in FDCs but not lymphocytes,
and vice versa. This has been possible because, in adult
mice, FDCs probably derive from a stromal cell within
the lymphoreticular system and are not replaced
significantly from the bone marrow. Following ME7
scrapie infection, replication has been shown in the
spleens of mice with a functional PrP gene (PrP + / + )
reconstituted with PrP + /+ or PrP null (PrP"/_) bone
marrow, but not in the spleens of PrP_/" mice re¬
constituted with either PrP + /+ or PrP_/~ bone marrow
[9,18]. These observations indicate that mature PrP-
expressing FDCs are necessary for scrapie replication.
However, other studies using a different murine scrapie
strain have suggested that B cells may be involved,
although this now appears to be in some doubt [20].
Nevertheless, it has been clearly shown that some
lymphocytes express PrPscn on their cell surface [21,22].
This study was undertaken to try to understand
better the role of the spleen in the peripheral
pathogenesis of scrapie. We have used immunogold
electron microscopy to locate PrP at subcellular levels
of ME7 infected spleen.
Materials and methods
C57 BL mice infected with the ME7 scrapie strain by
intracerebral injection of 20 pi of a 1 per cent brain
homogenate were available for study. 47 spleen tissue
blocks were taken from 2 scrapie infected mice at 70
days after infection and 33 spleen tissue blocks were
taken from 3 mice at terminal stages of the disease
(mean incubation period approximately 170 days.)
From 5 age-matched normal brain inoculated control
mice, 70 blocks of spleen tissue were available for
examination.
Light microscopical immunohistochemical staining
procedure
Spleens were immersion fixed in 2 per cent PLP, 0.5 per
cent paraformaldehyde/0.5 per cent glutaraldehyde or
in a variety of concentrations of paraformaldehyde/
glutaraldehyde for 24 hours at 4°C. One millimetre
cubes of spleen were post fixed in osmium tetroxide,
dehydrated and embedded in araldite. Thick sections
were stained by toluidine blue or were etched (deplas-
ticized) with saturated sodium ethoxide diluted 1 : 1 in
absolute ethanol for up to 60 minutes. Endogenous
peroxidase was blocked and sections de-osmicated with
6 per cent hydrogen peroxide in methanol for 10
minutes, followed by pre-treatment with formic acid
for 30 minutes [23], Normal serum was then applied
for 1 hour to block non-specific staining. The peroxi¬
dase anti-peroxidase immunohistochemical staining
method using 1A8 anti PrP serum [24] at a dilution of
1 :2000, or pre-immune serum, was applied to the
etched and pre-treated sections. Reaction product was
developed using 3-3' diaminobenzidine. Selected blocks
with appropriate immunostained areas were then taken
for ultrastructural studies.
Ultrastructural immunohistochemical methods
Serial 65 nm sections were taken from blocks pre¬
viously identified as containing immunostained cells in
white pulp. These sections were placed on 300 mesh
nickel grids and etched in sodium periodate for
60 minutes. Endogenous peroxidase was blocked
and sections de-osmicated with 3 per cent hydrogen
peroxide in methanol for 10 minutes followed by
enhancement of antigen expression with formic acid
for 10 minutes. Residual aldehyde groups were
quenched with 0.2 M glycine in PBS, pH 7.4 for 3
minutes. Primary antibody (1A8) at a 1 : 500 dilution in
incubation buffer or pre-immune serum were then
applied for 15 hours. After rinsing extensively, sections
were incubated with Auroprobe 1 nm colloidal gold
diluted 1 :50 in incubation buffer for 2 hours. Sections
were then post fixed with 2.5 per cent gluteraldehyde in
PBS and staining was enhanced with IGSS for 4
minutes. Grids were counterstained with uranyl acetate
and lead citrate. Tissues fixed in PLP fixative generally
had better preservation of immunoreactivity but tissue
fixed in mixtures of glutaraldehyde/paraformaldehyde
had better tissue structure. In each case, observations
were made on tissues fixed by PLP and by mixed
aldehydes.
Although PrPsen can be detected in cells of lightly
fixed spleen by light microscopy [12], the combination
of fixatives and pre-treatments described above
destroys PrPsen immunoreativity and reveals only
disease-specific PrP accumulations. Whether these
deposits are protease resistant or protease sensitive




At terminal stages of disease, PrP was detected in the
white pulp in a proportion of macrophage-like cells
with open nuclei containing little nuclear chromatin,
and these had multiple intense puncta of staining
adjacent to the nucleus (Figure 1(a)). These cells were
located throughout the white pulp and occasionally in
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Figure I. (a) One micrometre thick plastic embedded spleen from a terminally ill mouse showing immunostaining for PrP.
Macrophage-like cells with punctate perinuclear immunoreactivity (arrow) are present. Other attenuated cell processes and larger
areas of immunoreactivity are also immunostained. Peroxidase-anti-peroxidase (PAP) staining for PrP. (b) One micrometre thick
plastic embedded spleen from a 70 dpi mouse immunostaining for PrP in a similar but less intense pattern than in terminally diseased
mice. PAP staining for PrP
red pulp immediately surrounding white pulp, in the
mantle zones, and in both the dark and light zones of
germinal centres. They were provisionally interpreted
as tingible body macrophages [25]. All germinal centres
were affected.
A further cell type, also with marginated nuclear
chromatin and presumptively identified as the FDC
[26], showed a diffuse pattern of staining throughout
the perikaryonal cytoplasm and in association with
cytoplasmic processes which extended for considerable
distances from the cell body (Figure 1(a)).
At 70 days post inoculation (dpi) the amount
of immunostaining was considerably lower and not
all follicles showed evidence of PrP accumulation.
Although more subtle in amount, the patterns of
staining at 70 dpi was essentially the same as that
described above (Figure 1(b)).
No immunostaining was seen in the red or white
pulp of age matched normal brain inoculated controls.
Electron microscopy
Control tissues did not show any immunostaining
when examined by electron microscopy. The white
Published by John Wiley & Sons, Ltd.
pulp adjacent to red pulp contained small lymphocytes,
between which were small filiform dendritic processes
of FDCs. At the centre of some foci of white pulp,
secondary lymph follicles could be identified, in part of
these follicles lymphocytes were large (the germinal
centre light zone) and between them, arranged in
small knots, were more complex branching processes
(labyrinthine glomerular complexes) of FDCs. At the
plasmalemma of these dendrites was electron-dense
material. Tingible body macrophages were identified in
white pulp and less frequently in red pulp.
In tissues obtained from ME7 infected mice at 70 dpi
and at terminal disease, a proportion of tingible body
macrophages, identified by their frequent lysosomes,
abundant rough endoplasmic reticulum and open
nuclei containing mainly euchromatin with a pe¬
ripheral margin of heterochromatin, showed marked
immunogold affinity for PrP within lysosome-like
structures (Figures 3, 4 and 9). In some of these
lysosomes, immunogold deposits were concentrated at
one particular pole, associated with a more electron-
dense floccular material. A minority of tingible body
macrophages showed immunogold affinity for fibrillar
J Pathol 2000; 191: 323-332.
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Figure 2. Terminal disease. Foci of immunoreactivity are
present between lymphocyte cell nuclei in association with an
FDC labyrinthine glomerular complex containing highly con¬
voluted dendrites. Bar= 1.63 pm
structures within a lysosome (Figure 4). Only a
proportion of tingible body macrophages was so
stained. Some macrophages were found at sites
Figure 3. Terminal disease. Tingible body macrophage showing
intra-lysosomal PrP accumulation. Bar= 0.45 pm
Figure 4. Terminal disease. Tingible body macrophage showing
intra-lysosomal immunostaining. There are short linear filamen¬
tous structures within one lysosome (asterisk) which arc cloScly
associated with the reaction product. Bar = 0.34 pm
apparently distant from FDCs, whilst others were
in close proximity to FDC-associated immunogold
staining.
Immunogold/silver complex labelling was also asso¬
ciated with a second population of cells, characterized
by a nucleus containing abundant eucluoniatin and
marginal heterochromatin and complex branching
processes (dendrites) which identified them as follicular
dendritic cells (FDC?) (Figure? ? and 5), Tn the light
zone of lollicl03 obtained from spleens ot clinically
affected mice, the FDC dendrites invariably formed
large and complex labyrinthine glomeruli (Figures 5
and 6) [27], indicating a highly reactive response
to stimulation. Around each dendrite, a significant
margin of amorphous electron-dense material was
present (Figures 5 and 6). Immunogold staining wuo
seen in the extracellular space surrounding the den¬
dritic processes of FDCs and was associated with the
electron-dense deposit. The immunogold staining
intensity and the complexity of branching of dendritic
processes within the glomeruli increased in proportion
to the amount of electron-dense material within the
extracellular space (Figures b and 6). In some areas,
abundant short fibrillar forms were present within
the extracellular space and were associated with the
electron-dense deposit (Figure 6). Fibrils were of
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Figure 5. Terminal disease. Labyrinthine glomerulus with
reactive FDC dendritic processes is present. The immunogold/
silver reaction is associated with an electron-dense deposit at
the plasmalemma of these dendrites. Bar = 0.8 pm
approximately 20 nm diameter and from 40 to 300 nm
long. Immunogold localization was seen in coated pits
at the surface of FDC dendrites. Rarely, coated pits at
the surface of lymphocytes adjacent to labyrinthine
complexes also contained immunoreactive products
(Figure 7). Immunogold reaction was present in elec¬
tron-dense material associated with FDC dendrites
surrounding (emperipolesing) plasmablasts with dilated
endoplasmic reticulum containing globulins (Figure 8).
In terminally affected mice, FDCs were recognized
by electron microscopy in areas lacking PrP immuno-
staining at light microscopy (the dark zone and
periarteriolar sheath). FDCs in this region had few
filiform dendrites and did not show immunogold
staining.
At 70 dpi most FDCs in the follicular light zones
had relatively inconspicuous dendrites which formed
small knots of labyrinthine complexes interspersed
between lymphocytes and thus were similar to controls.
Any such processes had no obvious amorphous
electron-dense deposit at the plasmalemma although
some electron dense material was present around the
FDC dendrites of a minority of cells (Figure 9).
Although the immunostaining was weaker than at
terminal disease, nevertheless PrP accumulation was
present at the plasmalemma of these FDC dendrites.
FDCs with large labyrinthine glomerular complexes
Figure 6. Terminal disease. FDC processes associated with
intense immunogold reaction. There are frequent short fila¬
ments (arrowheads) present within the extracellular space.
Bar = 0.28 pm
similar to those found in terminally affected mice were
occasionally detected and invariably associated with
intense immunogold staining. PrP immunoreactive
fibrils were sometimes found in the extracellular space
around these large labyrinthine complexes.
Discussion
These results confirm previous light microscopy studies
showing that disease specific accumulations of PrP
occur in white pulp of spleen. Although the antibody
used does not distinguish between the protease
sensitive and protease resistant isoforms of PrP, we
would anticipate that at least some of the excess PrP
accumulations, particularly those in fibrillar forms,
would be protease resistant. In agreement with
transmission and light microscopy studies of Brown
et al. [18] our observations do not suggest that PrP
accumulation occurs within B-lymphocytes in ME7
scrapie affected spleens.
Secondary follicles have at least three major mor¬
phological subdivisions. A peripheral circumferential
Published by John Wiley & Sons, Ltd. J Pathol 2000; 191: 323-332.
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Figure 8. Terminal disease. Plasmablast (asterisk) with dilated
(globulin containing) endoplasmic reticulum surrounded by
immunoreacLive dendrites of an FDC. Bar— 1.7 pm
Figure 7. Terminal disease. Detail of convoluted dendrites of an
FDC in association with frequent coated pits (arrowheads). A
lymphocyte adjacent to the immunogold reaction shows PrP
within a coated pit near the cell surface (arrow). Bar = 0.36 pm
arrangement of small recirculating lymphocytes forms
the mantle zone around the dark and light zones of
germinal centres [28]. The dark zone contains larger
and more closely packed lymphocytes (centroblasts)
and FDCs with poorly developed cytoplasmic exten¬
sions. In the light zone there are yet larger lymphoid
cells (centrocytes) and FDCs with extensive cytoplas¬
mic extensions. During the development of germinal
centres, FDCs lose the capacity to synthesize matrix
elements and begin to produce specific surface anti¬
gens. As increasing quantities of immune complexes
are retained, imported by lymphoid cells or by other
means, the surfaces of FDCs enlarge, form plicae and
dendrites develop [24]. Immune complexes are bound
to the cytoplasmic extensions (dendrites) of FDCs,
where they may remain for weeks or months. These
complexes are not endocytosed but are held at the
surface of the dendrite by C3b or Fc receptors [27,29].
Free antigens are not bound to the surface of
FDCs. Antigen-antibody complexes serve periodically
to restimulate B and perhaps T cells, although many of
the complexes are deep within the cytoplasmic invagi¬
nations of FDCs and not readily revealed to other
cells.
In so far as we are able to determine the localization
of FDCs within follicles, immature FDCs correspond¬
ing to those found in the dark zone were similar in
controls and in infected mice. However, in presumed
light zones, all FDCs at terminal stages of disease and
a proportion of FDCs at 70 dpi had large and highly
complex labyrinthine glomeruli. This appears to rep¬
resent an abnormal reactive or hyperplastic change of
FDCs compared with controls.
Transmission studies using chimeric mice [ 18] in which
some immune system cells carry the PrP gene and some
do not, and light microscopy immunocytochemical
studies of spleen and lymph nodes, suggest that mature
FDCs accumulate PrP [12,13,18]. The subcellular loca¬
lization of PrP described above confirms that FDCs are
associated with PrP accumulation. However, the PrP
accumulation appears to be found at the cell surface of
FDCs and not within the cytoplasm. This is similar to
the extracellular localization of PrP around neurons in
Figure 9. (a) 70 dpi. An area of intense PrP labelling is present which extends over much of the upper portion of the field. Two FDC
nuclei, one with only light staining (asterisk) of the adjacent parenchyma and one where the adjacent parenchyma is unstained
(arrow), are also in the field. Arrowhead indicates a PrP containing tingible body macrophage. Bar = 4.5 pm. (b) Detail near tingible
body macrophage at arrowhead in (a). An intense immunogold reaction is associated with the electron-dense deposit overlying
complex labyrinthine convolutions of FDCs similar to those seen in terminal mice. Bar = 0.53 pm. (c) Detail near FDC at asterisk
in (a). FDC processes extending between lymphocytes are simple and do not have conspicuous electron-dense deposits at the
plasmalemma. Bar = 0.39 pm
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the brains of scrapie infected mice [30,31]- As is also
found in brain, continued accumulation of PrP appears
to lead to the formation of amyloid fibrils within the
extracellular space [30,31]. Immature FDCs with poorly
developed processes do not contain immunoreactive PrP
in association with dendrites.
1 he observations presented in this study indicate that
there is a proportionality of electron-dense deposits at
the FDC dendrite plasmalemma, complexity of FDC
dendritic branching and accumulation of excess or
abnormal PrP. As attachment of immune complexes is
the trigger for a marked increase in the complexity of
dendritic processes [27,28], the pattern of dendritic
branching and distribution of immunogold deposit in
terminally diseased mice indicates that the FDCs were
highly stimulated by either (or both) of the abundant or
abnormal PrP, or by excess trapping of immune
complexes. These findings suggest that PrP is involved
in dendritic process elongation or in the process of
trapping immune complexes. We suggest that this may
reflect the normal function of PrPsen. In support of this
hypothesis we have also observed that disease specific
accumulations of PrP in scrapie infected sheep lymph
nodes and spleen are co-localized with the cell surface
marker CD 21 and are confined to the light zone of
germinal centres (M. Jeffrey, S. Martin, personal
observations). Only fully mature process bearing FDCs
posses CD21 in the light zone. In the present study, the
uncomplicated nature of most FDC dendrites at 70 dpi
and the paucity of plasmalemma associated electron-
dense deposits suggest that early disease-specific PrP
accumulation may occur initially in the absence of
antigen-antibody complex trapping.
PrP immunostaining in FDC plasmalemma asso¬
ciated electron-dense material could also be interpreted
as possible trapped antibody-PrP complexes. However,
antibodies to PrPsen would not be anticipated. Anti¬
bodies to PrP are not detected in TSE infected hosts,
although infection does cause an immunological
response in PrP null mice. PrP-antibody complexes
would not therefore be expected at 70 dpi, but it is
possible that low levels of antibodies may be formed to
abnormal PrPres as a result of structural changes,
aggregation and fibrillization. Recent evidence using
chimeric SCID-PrP null mice, irradiated and then
reconstituted with either PrP null or PrP+/+ bone
marrow, indicate that scrapie replication and accumu¬
lation of PrP on FDCs [18] depends on PrPsen
expressing FDCs. These findings would suggest that
most of the PrP detected at the cell surface of FDCs
and within electron-dense material at the cell surface
was initially expressed at the FDC surface and then
released into the extracellular space.
If increased cell surface expression of PrP was
involved in increased ability to scavenge non-specific
antigen-antibody complex, then a breakdown in
antibody homeostasis and a heightened non-specific
polyclonal antibody response might be anticipated.
Alterations in immunoglobulin levels have indeed been
described in some scrapie-host model systems
[11,32,33], including natural scrapie of sheep [33], but
they are clearly not an essential aspect of disease, as
most models do not exhibit changes in immunoglobu¬
lin levels. In some models, immunoglobulin levels may
be altered at early stages of infection. The hyperplastic
form of FDCs, evidence of emperipolesis associated
plasinablast transformation, and marked increase in
PrP associated antigen-antibody complexes suggests
that scrapie infection may induce an enhanced pre¬
sentation of immune complexes to B-lymphocytes. If,
as suggested above, PrP is involved in non-specific
binding of antigen-antibody complexes, then increased
trapping of complexes may elicit alterations in homeo¬
stasis of antibody responses and an increased host
polyclonal antibody response. These observations
might suggest that the immunological response in
scrapie is more complex than previously supposed.
Further investigation of the immune system inter¬
actions with PrP may be of interest, not least as
a potential for disease intervention strategies and
diagnosis.
Tingible body macrophages ingest apoptotic cells,
mostly B cells that are not selected to form clones of
globulin producing cells. However, they also scavenge
the ends of FDC processes and perhaps effete FDCs
themselves [34,35]. Tingible body macrophages con¬
taining intra-lysosomal PrP were found adjacent to
PrP accumulation associated with FDCs and as
individual stained cells distant from other foci of
immunostaining.
Intra-lysosomal PrP accumulation has also been
seen within phagocytic cells of the CNS, including
microglia, astroglia [30] and Kohler cells. We suggest
that tingible body macrophages are ingesting excess or
abnormal PrP. It is unclear whether this occurs as a
result of phagocytosis of entire degenerate FDCs,
or their processes, or merely by scavenging the
extracellular space. All known amyloids are formed
within the extracellular space from precursor proteins
and therefore, as some macrophages possess intra-
lysosomal filaments consistent with amyloid, these at
least would presumably have been internalized to the
macrophage from the extracellular space.
Scrapie associated fibrils are abnormal filamentous
structures, which can be seen by negative stain electron
microscopy following detergent extraction of brain [36]
and spleen [4]. They are composed of PrP [37] and arc
observed only in the TSEs. Morphologically similar
amyloid fibrils containing full length PrP are found in
vivo in the brains of scrapie infected animals [31,38].
Although scrapie associated fibrils can be demon¬
strated in many of the TSEs, amyloid fibrils are not
always seen in the brains of scrapie-infected animals
and are in fact rare in scrapie of sheep and in BSE
(M. Jeffrey, personal observations). In spleen, previous
studies have shown that scrapie-associated fibrils may
be found at early stages of disease and their numbers
increase in correlation with infectious titre [4].
Although the inconsistent occurrence of PrP positive
amyloid fibrils in the CNS suggests that the scrapie
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associated fibrils seen by negative stain electron
microscopy are an artefact of the tissue preparation
process, nevertheless the similarity between scrapie
associated fibrils and amyloid fibrils suggests that full
length excess PrP has a propensity to form fibrils both
in vivo and in vitro. It is possible that this propensity to
aggregate carries with it the likelihood to acquire
protease resistance, as with other amyloid proteins.
Western blot analyses have demonstrated that PrPres
may be detected in ME7 infected spleens at very early
stages of infection [24]. Our ultrastructural studies
show that fibrillar forms of PrP may be detected deep
in the folds of FDC dendrites even at early (70 dpi)
stages of infection. We suggest therefore that western
blots demonstrating PrPres may be detecting these
extracellular, fibrillar PrP aggregates and not necessa¬
rily the earlier, non-fibrillar disease specific accumula¬
tions of PrP.
In the light of recent reports indicating that PrP
accumulates within the tonsil of clinical [15] and the
appendix of preclinical vCJD patients [39], the impor¬
tance of understanding the role of the lymphoreticular
system in TSE pathogenesis has greatly increased. The
present study provides an insight into the cellular and
subcellular involvement of FDCs in the peripheral
pathogenesis of scrapie and also suggests possible
functions of PrPsen
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Cellular and sub-cellular localisation of PrP in the lymphoreticular
system of mice and sheep
M. Jeffrey, G. McGovern, S. Martin, C. M. Goodsir, and K. L. Brown
Lasswade Veterinary Laboratory, Penicuik, Scotland, U.K.
Summary. Using immunocytochemistry or immunogold electron micros¬
copy, abnormal PrP accumulation was found in lymphoreticular tissues of
Suffolk sheep naturally exposed to scrapie and in the spleens of ME7 in¬
fected C57 BL mice at 70 days after infection and at the terminal stage of
disease at 170 days. Clinically diseased scrapie affected sheep show wide¬
spread PrP accumulation within tingible body macrophages (TBMs) and
follicular dendritic cells (FDCs) of secondary lymphoid follicles. Serial *
tonsillar biopsies taken from 171ARQ/ARQ sheep at 4 months of age did
not contain abnormal PrP accumulations but 80% of biopsies were positive
by 14 months. In contrast, whole body necropsies of sheep not previously
biopsied failed to detect PrP in the tonsil of sheep at 4, 8, 12 or 16 months of
age. These findings suggest that the biopsy procedure of susceptible sheep
but not resistant sheep may induce tonsillar infection. In spleen ofmice both
at 70 and 170 dpi, accumulations of PrP were found within lysosomes of
TBMs and also at the plasma-lemma of FDCs. In the light zone of follicles
of terminally diseased mice, all FDC dendrites were arranged in the form of
highly reactive or hyperplastic labrynthine glomerular complexes. PrP was
consistently seen between FDC dendrites in association with abundant
electron dense antigen-antibody complexes. At 70 days after challenge,
labrynthine complexes were rare and invariably labelled for PrP. However,
sparse PrP labelling was also seen on simple FDC dendrites at this stage.
These observations suggests that scrapie infected FDCs continually release
PrP from the cell surface where it accumulates in excess in association with
trapped immune complexes and dendritic extension. It is likely that TBMs
acquire lysosomal PrP following phagocytosis of effete FDC processes or
from the extracellular space. We suggest that the normal function of PrP
may involve cell process extern-' n or immune complex trapping.
Introduction
Many stu5 „ indicate that the lymphoreticular system is important
for sr ^ie pathogenesis. Within a few weeks of scrapie infection, agent
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replication can be detected in a variety of lymphoid tissues [27] and, initial
neuroinvasion is thought to occur following retrograde transportation of
infectivity to the spinal cord via splanchnic nerves which innervate the
spleen [20].
Studies employing a variety of experimental approaches, including the
use of cell fractionation techniques, severe combined immunodeficient
(SCID) mice and whole body y irradiation, suggest that the follicular
dendritic cell (FDC) is important for scrapie pathogenesis [6, 7, 12, 13, 24].
Procedures which deplete mitotic cells, such as y irradiation as well as
genetic athymia or surgical thymectomy do not significantly alter incuba¬
tion periods [12, 13] suggesting that scrapie replication does not depend
upon T cells but requires radioresistant mitotically inactive cells. Disease
specific accumulations of PrP are also seen in association with FDCs of
TSE infected mice, sheep and human beings [16, 22, 27, 33]. PrPsen can be
detected in association with FDCs of the murine spleen [27],
SCID mice lack B and T cells and FDCs fail to mature [2], They are
relatively resistant to scrapie challenge by peripheral routes and fail to
replicate infectivity in their spleens [4, 6], Following reconstitution by bone
marrow grafting these mice become fully susceptible to peripheral challenge
and capable of supporting replication in their spleens. In further .studies,
chimaeric mice have been produced by bone marrow grafting either SCID
or y-irradiated mice, which express PrP in FDCs but not lymphocytes, and
vice versa. This has been possible because, in adult mice, FDCs probably
derive from a stromal cell within the lymphoreticular system and are not
replaced significantly from the bone marrow. Following ME7 scrapie in¬
fection, replication has been shown in the spleens of mice with a functional
PrP gene (PrP + / + ) reconstituted with PrP + /+ or PrP null (PrP_/_) bone
marrow but not in the spleens of PrP-/_ mice reconstituted with either
PrP+,/+ or PrP_/,_ bone marrow [4, 5], These observations indicate that
mature PrP expressing FDCs are necessary for scrapie replication. How¬
ever, other studies using a different murine scrapie strain have suggested
that B cells may be involved [1] although this now appears to be in some
doubt [23], Nevertheless, it has been clearlyd shown that some lymphocytes
express PrPsen on their cell surface [8, 25].
These studies were undertaken to try and better understand the role of
the LRS in the peripheral pathogenesis of scrapie.
Materials and methods
Animals
Sequential tonsillar biopsies or necropsies were performed on lambs taken from a
flock of Suhoik sheep which had experienced frequent cases of scrapie over a period of
sew years. All but 2 of 106 scrapie cases examined between 1990 and 1996 in this
^cK were homozygous for glutamine at codon 171 of the PrP gene with a mean age to
clinical disease of 30 months. Clinically affected sheep had widespread PrP










Fig. 1. a Numbers of positive and negative tonsillar biopsies by age and genotype; b
numbers of positive necropsies with positive or negative immunostaining in viscera by
genotype and age of sheep
accumulation in the lymphoreticular system and peripheral ganglia. Lambs born in
Spring of 1998 were serially biopsied from tonsils or were subjected to whole body
necropsy at selected time intervals (Fig. 1).
C57 BL mice infected with the ME7 scrapie strain by intracerebral injection of
20 pi of a 1% brain homogenate were available for electron microscopy studies. Forty-
seven spleen tissue blocks were taken from two scrapie infected mice at 70 days after
infection and 33 spleen tissue blocks were taken from three mice at terminal stages of
the disease (mean incubation period approximately 170 days). From five age matched
normal brain inoculated control mice, 70 blocks of spleen tissue were available for
examination.
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Light and electron microscopical immunohistochemical staining procedure
Details of light and electron microscopical techniques for immunostaining are as
previously described [20]. Spleens were immersion fixed in 2% PLP, 0.5% paraform¬
aldehyde/0.5% gluteraldehyde or in a variety of concentrations of paraformaldehyde/
glutaraldehyde for 24 h at 4 °C. Primary antibody (1A8) at a 1:500 dilution in
incubation buffer or pre-immune serum were then applied for 15 h. After rinsing
extensively, sections were incubated with Auroprobe 1 nm colloidal gold diluted 1:50
in incubation buffer for 2 hours.
Tonsillar biopsies were prepared as described by van Keulen et al. [33] and stained
using both the 521.2 antibody (kindly supplied by Dr. van Keulen) and a polyclonal
rabbit anti-sheep PrP peptide antibody R482. None of the above antibodies can
distinguish between PrPsen and PrPres. However, under the conditions of fixation and
embedding employed in this study no staining was seen in control tissues. Immuno-
cytochemically detected PrP therefore represents accumulation of abnormal amounts




Clinically affected sheep showed PrP accumulation in virtually all follicles
of all lymph nodes. The numbers of secondary lymphoid follicles appeared
to be more frequent than in controls and often penetrated into the medulla
of the node. PrP was found in cells of the light zone which resembled
mature FDCs and in serial sections co-localised with CD21 staining. Other
cells which resembled TBMs were also immunostained and were found in
light zone, dark zone, mantle zone and, in smaller numbers in the para¬
cortex.
Serial tonsillar biopsies taken from lambs at 4, 8 and 14 months of age
did not show any PrP accumulation in germinal centres of two ARR/ARR
or four ARQ/ARR sheep. In serial biopsies from ARQ/ARQ lambs disease
specific PrP accumulation was not seen in 20 lambs at 4 months of age, but
was found in 2 of 10 lambs at 8 months and in 7 of 10 lambs at 14 months
(Figs. 1 and 2). Initially, the earliest disease specific PrP accumulation seen
was in TBMs within germinal centres and only later was it detected in a
reticular pattern in the light zone of germinal centres. As in clinically dis¬
eased sheep, the latter staining was found to co-localise with CD21 sug¬
gesting that PrP was present in FDCs. At 12 months some immunostained
TBMs were found in paracortical areas.
Eight ARQ/ARQ-lambs necropsied at 3 or 8 months of age had no
visceral PrP accumulations but at 12 months of age two of four ARQ/ARQ
lambs had PrP accumulation in mesenteric lymph nodes alone. Other
hmphoreticular tissues including tonsil were not affected. The remaining
two 12-month-old ARQ/ARQ and two ARQ/ARQ sheep at 16 months had
no CNS or visceral PrP (Fig. 1).
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Fig. 2. Tonsillar biopsy of a 14-month-old sheep. The follicle shows marked
immunostaining of cells with intense granular intracytoplasmic staining (Tingible
body macrophages) throughout all regions of the follicle and diffuse punctate staining
within the light zone (presumed FDCs). ABC staining for PrP
Murine scrapie infected spleen: light microscopy
In 1 pm thick sections of the spleens of mice at terminal stages of disease,
PrP was detected in the white pulp in a proportion of macrophage like cells
as multiple intense puncta of intracytoplasmic staining as described in
sheep. These cells were located throughout the white pulp and occasionally
in red pulp in the mantle zones and in both the dark and light zones of
secondary lymphoid follicles and were provisionally interpreted as TBMs.
All germinal centres were affected, A further cell type presumptively
identified as the FDC, showed a diffuse pattern of staining in association
with cytoplasmic processes which extended for considerable distances from
the cell body.
At 70 days post inoculation (dpi) the overall amount of immunostain¬
ing was considerably lower and not all follicles showed evidence of PrP
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Fig. 3. Murine spleen. 70 days postinoculation showing staining of cells and processes.
1 grn thick section PAP for PrP
accumulation. Although more subtle in amount, the patterns of staining at
70 days post inoculation was essentially the same as in terminal diseased
mice (Fig. 3). No immunostaining was seen in the red or white pulp of age
matched normal brain inoculated controls.
Electron microscopy
Control tissues did not show any immunostaining when examined by
electron microscopy. The dark zones of germinal centres contained lym¬
phocytes between which were small filiform dendritic processes of FDCs.
At the centre of some foci of white pulp, secondary lymph follicles could be
identified. Tr: part of these follicles lymphocytes were large often with in¬
dented nuclei, (the germinal centre light zone) and between them, arranged
h: small knots were more complex branching processes (labyrinthine
glomerular complexes) of FDCs. At the plasmalemma of these dendrites
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was electron dense material. TBMs were identified in white pulp and less
frequently in red pulp.
In tissues obtained from ME7 infected mice at 70 dpi and at terminal
disease, a proportion of TBMs showed marked immunogold affinity for
PrP within membrane bound electron dense structures resembling lyso-
somes (Fig. 4). Only a proportion of TBMs showed immunogold staining.
Immunogold labelling was also associated with a second population of
cells found only in the light zone and characterised by complex branching
processes (dendrites), sometimes containing desmosome-like membrane
specialisations, which identified them as FDCs (Fig. 5). In the light zone of
follicles examined from the spleens of 170 dpi mice, the FDC dendrites
invariably formed large and complex labyrinthine glomeruli (Figs. 5 and 6)
[31] indicating a highly reactive response to stimulation. At the plasma-
lemma of dendrites there was an amorphous electron dense material (Figs.
5 and 6). Immunogold staining was seen in the extracellular space sur¬
rounding the dendritic processes of FDCs and was associated with the
electron dense deposit. The immunogold staining intensity and the com¬
plexity of branching of dendritic processes within the glomeruli increased in
Fig. 4. Murine spleen. 70 days postinoculation. Tingible body macrophage showing
intra-lysosomal PrP accumulation. Bar: 0.75 pm
Fig. 5. Murine spleen. Terminal disease. Foci of immunoreactivity are present between
lymphocyte cell nuclei in association with a FDC labyrinthine glomerular complex
containing highly convoluted dendrites. Bar: 0.45 pm
proportion to the amount of electron dense material within the extracel¬
lular space (Figs. 5 and 6). In some areas amyloid fibrils were present within
the extracellular space and were associated with the electron dense deposit
(Fig. 6). Immunogold reaction was present in electron dense material as¬
sociated with FDC dendrites surrounding (emperipolesis) plasmablasts
with dilated endoplasmic reticulum. When compared with control material
the frequency of plasmablast transformation within germinal centres was
increased. Degenerate FDCs with condensation and fragmentation of nu¬
clear chromatin and cytoplasmic vacuolation were also found in germinal
centres of scrapie infected tissues but not in controls.
In terminal disease affected mice, most or all germinal centres in light
zones were characterised by frequent reactive FDCs with highly complex
labyrinthine glomeruli. FDCs were recognised by electron microscopy in
areas lacking FrP immunostaining at light microscopy (the dark zone
and perh rteriolar sheath). FDCs in this region had a primitive mor¬
phology with few filiform dendrites and did not show immunogold
staining.
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Fig. 6. Murine spleen. Terminal disease. FDC processes associated with intense im-
munogold reaction. There are frequent short filaments present within the extracellular
space. Bar: 0.28 pm
At 70 days post inoculation most FDCs in the follicular light zones had
relatively inconspicuous dendrites that formed small knots of labyrinthine
complexes interspersed between lymphocytes and thus were similar to
controls. Relatively smaller amounts of amorphous electron dense deposit
were present at the plasmalemma. Weak immunostaining was seen within
electron dense material around some mildly reactive FDC dendrites of a
minority of cells (Fig. 7). FDCs with large labyrinthine glomerular com¬
plexes similar to those found in terminal diseased mice were occasionally
detected and invariably associated with intense immunogold staining
(Fig. 8). Some such areas showed amyloid fibril formation with increased
numbers of coated pits.
Discussion
Although the study i sequential tonsillar biopsies and necropsies within
our Suffolk f k are still incomplete, abnormal PrP accumulation has
not bee'- detected in tissues of sheep with ARR/ARR or ARQ/ARR
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Fig. 7. Murine spleen. 70 days postinoculation. Small areas of immunogold reaction
are present. These are located at the surface of FDC processes extending between
lymphocytes. The dendrites are simple and do not have conspicuous electron dense
deposits at the plasmalemma. Bar: 0.63 pm
genotypes. In contrast to the results of Dutch Texel and Swifter sheep
reported by Schreuder and others [34], susceptible sheep upto 16 months
of age have only low levels of immunohistochemically detectable PrP. This
may reflect lower levels of susceptibility in Suffolk sheep generally when
compared with Texel and Swifter sheep, or lower levels of infection within
this flock compared to those studied by van Keulen et al. [33]. The dis¬
parity between abnormal PrP detection in tonsils at necropsy and fol¬
lowing multiple tonsil biopsy is interesting. The results suggest that
the biopsy procedure of susceptible sheep but not resistant sheep may
increase susceptibility of FDCs within the remainder of the tonsil to in¬
fection.
The studies of murine spleen confirms previous light microscopy studies
showing that disease specific accumulations of PrP occur in secondary
follicles of spleen . Although the antibodies used do not distinguish between
the protease sensitive and protease resistant isoforms of PrP, we would
anticipate that at least some of the excess PrP accumulations, particular'-
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Fig. 8. Murine spleen. 70 days postinoculation. An intense immunogold reaction
associated with the electron dense deposit overlying complex labrynthine convolutions
of FDCs similar to those seen in terminal mice. Frequent fibrils are present in the
extracellular space. Frequent coated pits are also present in association with these
fibrils. Bar: 0.53 pm
those in fibrillar forms, would be protease resistant. In agreement with
transmission and light microscopy studies of Brown et al. [5], our obser¬
vations do not suggest that PrP accumulation occurs within B lymphocytes
in ME7 scrapie affected spleens. Rather, the presence of PrP within TBMs
in the paracortical zone or peri-follicular areas in spleen suggests that these
cells or dendritic cells rather than plasma cells may possibly be responsible
for transporting infection throughout the LRS.
Secondary follicles are divided into a mantle zone of small re-circulating
lymphocytes surrounding the dark and light zones of germinal centres [15],
In the light zone there are large lymphoid cells (centrocytes) and FDCs with
extensive cytoplasmic extensions. FDCs in the dark zone have immature
processes. During the development of germinal centres, FDCs produce
specific surface antige:, As increasing quantities of immune complexes are
retained, the surfices of FDCs enlarge, form plicae and dendrites de¬
velop [15] Immune complexes are bound to the cytoplasmic extensions
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(dendrites) of FDCs where they may remain for weeks or months. These
complexes are not endocytosed but are held at the surface of the dendrite
by C3b or Fc receptors [3, 31]. Free antigens are not bound to the surface of
FDCs. Antigen-antibody complexes serve to periodically restimulate B and
perhaps T cells.
Immature FDCs corresponding to those found in the dark zone were
morphologically similar in controls and in infected mice. However, in light
zones, all FDCs at terminal stages of disease and a proportion of FDCs at
70 dpi had large and highly complex labyrinthine glomeruli. This appears
to represent an abnormal reactive or hyperplastic change of FDCs com¬
pared to controls. In addition, excess plasmablast differentiation and FDC
degeneration were abnormal. These features show that pathological re¬
sponses to scrapie infection are not confined to the CNS.
Transmission studies using chimaeric mice [5] in which some immune
system cells carry the PrP gene and some do not, and light microscopy
immunocytochemical studies of spleen and lymph nodes, suggest that
mature FDCs accumulate PrP [5, 22, 27]. The sub-cellular localisation of
disease specific PrP accumulations described above confirms that mature
FDCs are associated with this accumulation. Outwith the light zone of the
follicle, immature FDCs with poorly developed processes do not contain
immunoreactive PrP. The disease specific PrP accumulation is not in-
tracytoplasmic but is found at the cell surface of FDCs. This is similar to
the plasmalemmal and extracellular localisation of PrP around neurons in
the brains of scrapie infected mice [17, 18]. The continued accumulation of
PrP both in brain and in spleen appears to lead to the formation of amyloid
fibrils within the extracellular space [17-19], a feature consistent with other
conventional amyloid diseases.
In this study, an increase in the complexity of FDC dendritic branching
was associated with both an increase in the amount of electrondense de¬
posit at the FDC dendrite plasmalemma and the intensity of immuno-
staining for PrP. As attachment of immune complexes are the trigger for a
marked increase in the complexity of dendritic processes [14, 31], the pat¬
tern of dendritic branching and distribution of immunogold deposit in
terminally diseased mice indicates that the FDCs were highly stimulated by
abundant or abnormal PrP, or by excess trapping of immune complexes. In
scrapie infected sheep tonsil and lymph nodes, PrP co-localised with CD 21,
a marker confined to fully mature FDCs with well developed processes. The
sites of accumulation of excess disease specific PrP and the morphological
responses of the FDCs may reflect the normal function of PrPsen . We
suggest that PrPsen is involved in dendritic process elongation or assisting in
the adhesion of immune complexes to the cell surface. In the present study,
the uncomplicated nature of most FDC dendrites at 70 dpi and the paucity
of plasma-lemma associated electron dense deposits suggest that early dis¬
ease, specific PrP accumulation may occur initially in the absence of anti¬
gen-antibody complex trapping.
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PrP immunostaining in FDC plasmalemma associated electrondense
material could also be interpreted as possible trapped antibody-PrP com¬
plexes. However, host antibodies to PrPsen would not be anticipated. An¬
tibodies to PrP are not detected in TSE infected animals although
parenteral injection does cause an immunological response in PrP null
mice. It is therefore possible that low levels of antibodies may be formed to
abnormal PrPres as a result of structural changes, aggregation and fibrilli-
sation. Recent evidence using chimaeric SCID-PrP null mice irradiated and
then re-constituted with either PrP null or PrP ' ^ bone marrow, indicate
that scrapie replication and accumulation of PrP on FDCs [5] depends on
PrPsen expressing FDCs. These findings would suggest that most of the PrP
detected at the cell surface of FDCs and within electron dense material at
the cell surface, was initially expressed at the surface of FDCs and then
released into the extracellular space to aggregate and form fibrils.
If increased surface expression of PrP increases the ability of FDCs to
scavenge circulating immune complexes, then a breakdown in antibody
homeostasis and a heightened non-specific polyclonal antibody response
might be anticipated. The large number of lymphoid follicles with some
penetrating into the medullary zones of lymph nodes in clinically diseased
sheep 1 suggests an abnormal response of lymph nodes to scrapie infec¬
tion. Sub-cellular pathology 2 including FDC degeneration, plasmablast
differentiation, magnitude and ubiquity of labyrinthine glomerular com¬
plexes of FDCs in light zones of terminally diseased ME7 infected mice 3
further indicate an altered immunological response. Alterations in im¬
munoglobulin levels have been described in some scrapie-host model sys¬
tems [7, 9, 10] including natural scrapie of sheep [10] but they are clearly
not an essential aspect of disease as most models do not exhibit changes in
immunoglobulin levels. In some models immunoglobulin levels may be
altered at early stages of infection. The widespread distribution of the
hyperplastic form of FDCs with emperipolesis, and the marked increase in
amounts of immunecomplexes suggests that scrapie infection may induce
an enhanced trapping capacity of immunecomplexes. PrP may therefore
be involved in non-specific binding of antigen-antibody complexes. In¬
creased trapping of immune complexes caused by excess PrP at the FDC
dendritic plasmalemma may elicit alterations in homeostasis of antibody
responses and an increased host polyclonal antibody response. These
observations suggest that the immunological response in scrapie is more
complex than previously supposed and further investigation of the im¬
mune system interactions with PrP may be of interest, not least as a
potential for disease intervention strategies and diagnosis.
TBMs ingest apoptotic cells, mostly B cells which are not selected to
form clones of globulin producing eells. However, they also scavenge the
ends of FDC processes and perhaps effete FDCs themselves [28, 30]. TBMs
containing intra-lysosornai PrP were found adjacent to PrP accumulation
associated with ^ Js and as individual stained cells distant from other foci
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of immunostaining. Intra-lysosomal PrP accumulation has also been seen
within phagocytic cells of the CNS, including microglia [16], astroglia [16]
and Kohler cells (unpubl. obs.). We suggest that TBMs ingest excess or
abnormal PrP following phagocytosis of entire degenerate FDCs or their
processes or by scavenging the extracellular space.
In the light of recent reports indicating that PrP accumulates within the
tonsil of clinical [16] and pre-clinical CJD patients, the importance in un¬
derstanding the role of the lymphoreticular system in TSE pathogenesis has
been greatly increased. The present study indicates that natural and ex¬
perimental scrapie induced pathological changes are not confined to the
CNS. It also provides an insight into the cellular and sub-cellular in¬
volvement of FDCs in the peripheral pathogenesis of scrapie and also
suggests possible functions of PrPsen.
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Temporary Blockade of the Tumor Necrosis Factor Receptor Signaling
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Although the transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases, their
agents usually replicate and accumulate in lymphoid tissues long before infection spreads to the central
nervous system (CNS). Studies of a mouse scrapie model have shown that mature follicular dendritic cells
(FDCs), which express the host prion protein (PrPc), are critical for replication of infection in lymphoid
tissues. In the absence of mature FDCs, the spread of infection to the CNS is significantly impaired. Tumor
necrosis factor alpha (TNF-a) secretion by lymphocytes is important for maintaining FDC networks, and
signaling is mediated through TNF receptor 1 (TNFR-1) expressed on FDCs and/or their precursors. A
treatment that blocks TNFR signaling leads to the temporary dedilferentiation of mature FDCs, raising the
hypothesis that a similar treatment would significantly delay the peripheral pathogenesis of scrapie. Here,
specific neutralization of the TNFR signaling pathway was achieved through treatment with a fusion protein
consisting of two soluble human TNFR (huTNFR) (p80) domains linked to the Fc portion of human immu¬
noglobulin G1 (huTNFR:Fc). A single treatment of mice with huTNFR:Fc before or shortly after intraperito¬
neal injection with the ME7 scrapie strain significantly delayed the onset of disease in the CNS and reduced
the early accumulation of disease-specific PrP in the spleen. These effects coincided with a temporary dedif-
ferentiation of mature FDCs within 5 days of huTNFR:Fc treatment. We conclude that treatments that
specifically inhibit the TNFR signaling pathway may present an opportunity for early intervention in periph¬
erally transmitted TSEs.
The transmissible spongiform encephalopathies (TSEs), or
"prion diseases," are infectious neurodegenerative diseases
that affect humans and both wild and domestic animals. The
host prion protein (PrPc) is critical for TSE agent replication
(8) and accumulates in diseased tissues as an abnormal, deter¬
gent-insoluble, relatively proteinase-resistant isoform, PrPSc
(4). Although the precise nature of the TSE agent is uncertain
(13), PrPSc copurifies with infectivity and is considered to be a
major component of the infectious agent (41).
Natural TSEs, including sheep scrapie, bovine spongiform
encephalopathy (BSE), chronic wasting disease in mule deer
and elk, and variant Creutzfeldt-Jakob disease (vCJD) in hu¬
mans, are considered to be acquired peripherally. For example,
the emergence of vCJD in the United Kingdom population is
almost certainly due to consumption of BSE-contaminated
tissues (7). Following peripheral exposure, TSE agents usually
accumulate in lymphoid tissues long before infection spreads
to the central nervous system (CNS). For example, after intra¬
gastric or oral challenge of rodents with scrapie, the infectious
agent first accumulates in Peyer's patches and gut-associated
lymphoid tissues (2, 24). The detection of PrPSc in Peyer's
patches and gut-associated lymphoid tissues of sheep with nat¬
ural scrapie (1, 20) prior to detection in other lymphoid tissues
and the CNS (46) implies that this disease is also acquired
orally. Lymphoid tissues play an important role in transmission
in some TSE models (17), but this tissue tropism may be agent
strain dependent. Although acquired peripherally, BSE in cat-
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5204. Fax: 44 131 668 3872. E-mail: neil.mabbott@bbsrc.ac.uk.
tie (43) and iatrogenic Creutzfeldt-Jakob disease in humans
(21) appear to be confined to nervous tissues. However, within
the lymphoid tissues of patients with vCJD (21) and most
sheep with natural scrapie (45) or following experimental pe¬
ripheral infection of rodents with scrapie (5, 29, 30, 33), early
PrPSo accumulation takes place on follicular dendritic cells
(FDCs). Studies of mouse scrapie models have shown that
mature FDCs are critical for replication in lymphoid tissues
and that in their absence, neuroinvasion following peripheral
challenge is significantly impaired (5, 29, 30, 35). From the
lymphoid tissues, infectious agents spread to the CNS via pe¬
ripheral nerves (19).
The FDC therefore presents a potential target for therapeu¬
tic intervention in peripherally acquired TSEs such as natural
sheep scrapie and vCJD. Indeed, recent studies have demon¬
strated that treatments that temporarily interfere with the in¬
tegrity (29, 35) or function (28) of FDCs also interfere with
TSE pathogenesis. Signaling through lymphocyte-derived tu¬
mor necrosis factor alpha (TNF-a) is critical for FDC devel¬
opment, as mice deficient in TNF-a (TNF-a mice) lack
mature FDCs in lymphoid tissues (38). The effects of TNF-a
on FDC development are mediated via signaling through TNF
receptor 1 (TNFR-1) expressed on FDCs and/or their precur¬
sors (44). Specific neutralization of the TNF-a signaling path¬
way leads to the temporary inactivation of FDCs (31), suggest¬
ing that FDCs require constant stimulation from this cytokine
to maintain their differentiated state. It has previously been
shown that in the absence of mature FDCs in the lymphoid
tissues of TNF-a~/~ mice, susceptibility to peripheral chal¬
lenge with scrapie is reduced (30). Therefore, in this study we
sought to determine whether a treatment that temporarily
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blocks the TNF-a signaling pathway would delay the spread of
scrapie to the CNS.
MATERIALS AND METHODS
huTNFR:Fc treatment. At the times indicated, C57BL mice (8 to 12 weeks
old) were given a single intraperitoneal (i.p.) injection of 100 pg of a dimeric
fusion protein containing the soluble human TNFR (huTNFR) (p80) domain
linked to the Fc portion of human immunoglobulin G1 (huTNFR:Fc; Immunex
Corp., Seattle, Wash.) (34) or 100 p.g of polyclonal human immunoglobulin G
(hu-Ig) (Sandoglobulin; provided by J. Browning, Biogen Inc., Cambridge,
Mass.) as a control. To monitor the effects of treatment on FDC status, at the
times indicated following treatment, two spleens were taken from each group
and halved. One half was fixed in periodate-lysine-paraformaldehyde and em¬
bedded in paraffin wax for immunocytochemical detection of PrP (33) with the
PrP-specific antiserum 1B3 (15). The other half was snap-frozen at the temper¬
ature of liquid nitrogen, and 6-p.m-thick sections were cut on a cryostat. FDCs
were visualized by staining with the FDC-specific monoclonal antiserum
FDC-M2 (27) or 8C12 monoclonal antiserum to detect CD35 (Pharmingen, San
Diego, Calif.). Immunolabeling was carried out with alkaline phosphatase cou¬
pled to the avidin-biotin complex (Vector Laboratories Inc., Burlingame, Calif.).
Vector Red (Vector Laboratories) was used as a substrate.
Scrapie infection. At the times indicated relative to treatment, mice were
injected intracerebrally (i.e.) or i.p. with 20 pi of a 1.0, 0.1, or 0.01% (wt/vol)
dilution of unspun brain homogenate from C57BL mice terminally affected with
ME7 scrapie (20 pi of a 1.0% homogenate represents a dose of approximately 1
X 104'5 i.e. 50% infectious dose [ID50] units). Following challenge, animals were
coded and assessed weekly for signs of clinical disease and killed at a standard
clinical end point (16). Scrapie diagnosis was confirmed by histopathological
assessment of vacuolation in the brain. Where indicated, some mice were sacri¬
ficed 70 days postchallenge, and their spleens were taken for further analysis. For
the bioassay of scrapie infectivity, individual half spleens were prepared as 10%
(wt/vol) homogenates in physiological saline and 20 p.1 was injected i.e. into
groups of 12 C57BL indicator mice. The scrapie titer in each spleen was deter¬
mined from the mean incubation period for the assay mice with reference to
established dose-incubation period response curves for scrapie-infected spleen
tissue (11).
Immunoblot detection of PrPSc. The remaining half of each spleen collected 70
days postchallenge was prepared as previously described (12, 28, 30). In brief,
before immunoblot analysis, spleen tissue homogenates were treated with 20 pg
of proteinase K (to confirm the presence of PrPSc) and subsequently partially
purified by treatment with 2% (wt/vol) AMauroylsarcosine (in 0.1 M Tris [pH
7.4]), allowing sedimentation of only the proteinase-K-resistant, detergent-insol¬
uble fraction of PrP (PrPSc). Samples were subjected to electrophoresis through
sodium dodecyl sulfate-12% polyacrylamide gels (Bio-Rad, Hemel Hempstead,
United Kingdom) and transferred to polyvinylidene difluoride membranes (Bio-
Rad) by semidry blotting. PrP was detected with the PrP-specific rabbit poly¬
clonal antiserum 1B3 (15) followed by alkaline phosphatase-conjugated goat
anti-rabbit antiserum (Jackson ImmunoResearch Laboratories Inc., West Grove,
Pa.), and bound alkaline phosphatase activity was detected with SigmaFast NBT/
BCIP solution (Sigma, Poole, Dorset, United Kingdom).
Ultrastructural immunohistochemistry. Spleen fragments were immersion
fixed in 0.5% paraformaldehyde-0.5% glutaraldehyde for 24 h at 4°C, postfixed
in osmium tetroxide, dehydrated, and embedded in araldite. Serial 65-nm-thick
sections were then placed on 300-mesh nickel grids and prepared as previously
described (23). Briefly, PrP was detected by staining with the PrP-specific rabbit
polyclonal antiserum 1A8 (14) followed by Auroprobe 1-nm colloidal gold.
Sections were then postfixed in 2.5% glutaraldehyde in phosphate-buffered sa¬
line, and staining was enhanced with immunogold silver stain. The grids were
then counterstained with uranyl acetate and lead citrate.
Previous studies have shown that the combination of fixatives and pretreat-
ments required for the preparation of tissue for electron microscopy by this
method destroys PrP° immunoreactivity and reveals only disease-specific PrP
accumulations (23).
Statistical analysis. Incubation period data are expressed as means ± standard
errors of the mean, and significant differences between incubation periods were
sought by one-way analysis of variance with Minitab for Windows (Minitab Inc.,
State College, Pa.).
RESULTS
Effect of huTNFR:Fc treatment on FDC status. A blockade
of the TNF-a signaling pathway was achieved by a single i.p.
injection of 100 pg of huTNFR:Fc (34). This fusion protein
binds TNF-a with high affinity and acts as an antagonist of
TNF-a biological activity in in vivo assays in mice (34, 47).
Here, within 2 days of treatment of mice with huTNFR:Fc, a
significant reduction in staining for the FDC markers FDC-M2
and CD35 was observed in lymphoid follicles of the spleen
(Fig. 1). Furthermore, FDC-M2 and CD35 expression was
absent 5 (data not shown) and 7 (Fig. 1) days after treatment
with huTNFR:Fc. The cellular isomer of the prion protein,
PrPc, is expressed by FDCs in uninfected mice (Fig. 1) (5, 29,
33). Likewise, PrPc expression was also markedly reduced
within 2 days of treatment and undetectable 5 (data not shown)
and 7 (Fig. 1) days after treatment with huTNFR:Fc. The
effects of huTNFR:Fc treatment on FDC status were tempo¬
rary, as PrP-expressing FDC networks were detected in the
spleen 14 days after treatment (Fig. 1). Treatment of mice with
100 pg of polyclonal hu-Ig as a control had no adverse effect on
FDC status (Fig. 1). In some follicles from hu-Ig-treated mice,
there appeared to be increases in the size of the FDC network
and the level of PrPc expression 14 days after treatment com¬
pared to values for follicles analyzed 2 and 7 days after treat¬
ment (Fig. 1). This may be indicative of a germinal-center
response to hu-Ig.
Ultrastructural analysis of the effect of huTNFR:Fc treat¬
ment on FDC status. Mice were treated with huTNFR:Fc or
hu-Ig 38 days after i.p. injection with scrapie, and PrP deposi¬
tion in the spleen was analyzed 7 days later by light-microscop¬
ical and ultrastructural immunohistochemical methods. As
expected, in spleens of control-treated mice, abundant disease-
specific PrP staining in association with FDCs was detected by
light microscopy (Fig. 2a and c). Immunoelectron microscopic
analysis confirmed that these PrP accumulations were disease
specific and were found in association with electron-dense ma¬
terial at the surface of highly convoluted FDC dendrites (Fig.
2e and f), as previously reported (23). In some follicles, indi¬
vidual fibrils consistent with the dimensions of amyloid fibrils
were present in association with FDCs (data not shown). Dis¬
ease-specific PrP accumulations were also detected within sec¬
ondary lysosomes of tingible body macrophages (Fig. 2e).
Mice were treated with huTNFR:Fc 38 days after scrapie
injection, and abundant PrP labeling was still apparent in the
spleen 7 days after treatment (Fig. 2d) despite a temporary
absence of mature FDCs (Fig. 2b). Ultrastructural analysis
revealed that the centers of secondary lymphoid follicles in
spleens from huTNFR:Fc-treated mice showed marked degen¬
erative changes compared with those from hu-Ig-treated con¬
trol mice. Severe and extensive lymphocyte apoptosis was
noted (Fig. 2g), and large numbers of highly reactive macro¬
phages containing degenerative cellular material were also
present in these sites (Fig. 2h). In many cases, whole apoptotic
B lymphocytes could also be identified within these macro¬
phages. At the ultrastructural level, FDC networks were iden¬
tified but their processes appeared immature (Fig. 2i) and
lacked the highly convoluted characteristics observed for those
of hu-Ig-treated control mice (Fig. 2f). The immature nature of
these FDC dendrites was consistent with the loss of expression
of FDC-specific markers following huTNFR:Fc treatment
(Fig. 1 and 2). Although a few mature FDC processes were
identified at the ultrastructural level, it was not possible to
























FIG. t. Effect of huTNFR:Fc treatment on FDC status in spleens of uninfected mice. Tissues were taken on the indicated days postinjection
(d.p.i.) with hu-lg (control) or huTNFR:Fc, and adjacent frozen sections were stained with FDC-M2 monoclonal antiserum to detect FDCs (upper
row; red) or with 8C12 monoclonal antiserum to detect CD35 (middle row; red). PrP was detected on paraffin-embedded sections with the
PrP-specific polyclonal antiserum 1B3 (bottom row; red). Expression of FDC-M2, CD35, and PrP in the spleen was undetectable 7 days after
treatment with huTNFRTc. Original magnification, X400.
determine whether these were regenerating FDCs or mature
FDCs unaffected by the TNFR signaling blockade (31).
Effect of huTNFR:Fc treatment on scrapie pathogenesis.
Mice were given a single i.p. injection of huTNFR:Fc (or hu-lg
as a control) at one of three different times relative to scrapie
challenge; 5 days before sciapie injection, so mature FDCs
would he absent in lymphoid tissues at the time of scrapie
injection; 14 days after scrapie injection, soon after the onset of
scrapie replication in lymphoid tissues; or 38 days after scrapie
injection, when high levels of scrapie infectivity are present in
lymphoid tissues (5. 30). When groups of six mice were chal¬
lenged with the ME7 scrapie strain by direct i.e. injection into
the CNS, treatment with huTNFR:Fc 5 days before or 14 days
after scrapie challenge had no effect on the incubation period
of the disease (— 164 to 172 days; Fig 3a) or pathology within
the brain (data not shown) compared with those of controls.
These findings demonstrate that the blockade of the TNFR
signaling pathway did not affect scrapie pathogenesis once
disease was established in the CNS.
When treated with huTNFR:Fc before or shortly after pe¬
ripheral (i.p.) injection with scrapie, mice developed neurolog¬
ical disease much later than did the hu-Ig-treated controls. The
most significant effect was observed when mice were treated 5
days before i.p. scrapie injection (Fig. 3b). For example, fol¬
lowing injection with a moderate dose of scrapie (20 p.1 of a
1.0% scrapie brain homogenate), all control-treated mice suc¬
cumbed to disease, with a mean incubation period of 255 ± 15
days (n = 8), whereas those treated with huTNFR:Fc devel¬
oped disease 47 days later, with a mean incubation period of
302 ± 7 tlays (P < 0.01; n - 8; Fig. 3b). Likewise, when treated
with huTNFR:Fc before injection with a 10-fold-lower scrapie
dose (20 p.1 of a 0.1% scrapie brain homogenate), mice devel¬
oped neurological disease with a mean incubation period of
353 ± 4 days (n = 0). which was 38 days longer than the mean
incubation period of the hu-Ig-treated controls (315 ± 7 days;
/' < O.OOI; n - 0; Fig. 3b). Despite these highly significant
prolongations of the incubation period, little effect on disease
susceptibility was observed following treatment with hu-
TNFR:Fc prior to injection with a low dose of scrapie (20 p.1 of
a 0.01% scrapie brain homogenate): 7 of 9 huTNFR:Fc-treated
mice remained free of scrapie disease 500 days after inocula¬
tion, compared to 5 of 9 control mice (Fig. 3b).
An increase in survival time was also observed when treat¬
ment with huTNFR:Fc was delayed until 14 days after i.p.
injection with a moderate dose of scrapie (Fig. 3c). In this
instance, mice developed neurological disease with a mean
incubation period of 281 ± 7 days (n = 8), which was 19 days
longer than the mean incubation period of the hu-Ig-treated
controls (262 ± 8.0 days; n = 8). However, treatment with
huTNFR:Fc 38 days after injection, a time when high levels of
infectivity agents have already accumulated in the spleen (5,
;r.«xv'si . - w *>>£ ■ .
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FIG. 2. Immunohistological analysis of the effects of huTNFR:Fc treatment on FDC status and PrP labeling in spleens of mice already
incubating scrapie, (a to d) Light-microscopical analysis. Mice were injected i.p. with scrapie and 38 days later given a single i.p. injection of
huTNFR:Fc (b and d) or hu-lg as a control (a and c). Spleens were obtained 7 days later; frozen sections were stained for FDCs with FDC-M2
monoclonal antiserum (a and b; red), and PrP was detected on paraffin-embedded sections with the PrP-specific polyclonal antiserum 1B3 (c and
d; red). Abundant abnormal PrP was detected in association with FDCs in the spleens of control mice 45 days after scrapie injection. However,
when mice were treated with huTNFR:Fc 38 days after scrapie injection, heavy PrP labeling was still apparent in the spleen 7 days after treatment
despite a temporary absence of FDC-M2 expression. The arrow in panel D indicates a tingible body macrophage containing apoptotic B
lymphocytes. Magnification, X400. (e to i) Ultrastructural analysis. Mice were injected i.p. with scrapie and 38 days later given a single i.p. injection
of huTNFR:Fc (g to i) or hu-lg as a control (e and f). Spleens were obtained 7 days later, and araldite sections were immunostained with the
PrP-specific polyclonal antiserum 1A8. (e) An area of immunogold reactivity (indicated with an asterisk) is present between lymphocytes in the
germinal center of a scrapie-injected, hu-Ig-treated control mouse. This focal immunoreaction is associated with a complex knot of mature FDC
processes. Part of a tingible body macrophage is present at the bottom left (arrow). Bar = 1.76 p.m. (f) High magnification of the FDC complex
indicated with an asterisk in panel e. Highly convoluted FDC processes are associated with the immunogold reaction. Many short linear and
curvilinear structures are immunolabeled. Bar = 0.35 (im. (g) Edge of a germinal center showing marked apoptosis (black arrows) in the spleen
of a scrapie-injected, huTNFR:Fc-treated mouse. Immature FDC dendritic processes surround the germinal center (white arrows). Bar = 1.87 p.m.
(h) Tingible body macrophage (arrow) in the spleen of a scrapie-injected, huTNFR:Fc-treated mouse showing intralysosomal PrP accumulation.
Moderately reactive FDC dendrites lie adjacent to the macrophage. Bar — 1.31 (im. (i) Foci of immunoreactivity associated with immature FDC
dendritic processes in the spleen of a scrapie-injected, huTNFR:Fc-treated mouse. The immunogold reaction is associated with electron-dense
material in the extracellular space surrounding FDC dendrites. Bar = 0.56 p.m.
30), had no effect on the incubation period compared with that
of control-treated mice (Fig. 3c).
Scrapie infectivity and PrPSc accumulation in the spleen.
Within 70 days of a peripheral injection of untreated mice with
the ME7 scrapie strain, high levels of infectivity and the dis¬
ease-specific isomer of the prion protein, PrPSc, accumulate
within lymphoid tissues (5, 12, 28, 30). In this study, spleens
were taken from each control and huTNFR:Fc treatment
group 70 days after i.p. injection with a moderate dose of
scrapie and halved. PrPSc accumulation was determined in one
half by immunoblot analysis, while the scrapie infectivity titer
was estimated in the other half by bioassay in groups of indi¬
cator mice. As expected, all spleens from control mice treated
with hu-lg 5 days before or 14 or 38 days after scrapie chal¬
lenge contained high infectivity titers (5.0 to 5.3 log i.e. IDS0/g,
as estimated by incubation period assay; Fig. 4) and abundant
detergent-insoluble, relatively proteinase-K-resistant PrPSc
(Fig. 4). However, following treatment of mice with huTN-
FR:Fc 5 days before scrapie challenge, PrPSc was less abundant
in the spleen 70 days postinfection (Fig. 4a, lanes 4 and 6). In
contrast, the infectivity titers were as high as those detected in
spleens from hu-Ig-treated controls, suggesting that the accu¬
mulation of PrPSc in the spleen lags behind replication of
infectivity during the early stages of infection, as observed in
previous studies (12, 28).
When treatment was delayed until 14 or 38 days after scrapie
challenge, no differences in the accumulation of infectivity or
abundance of PrPSc in the spleen were detected between con¬
trol- and huTNFR:Fc-treated mice when measured 70 days
after scrapie challenge (Fig. 4b and c).
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FIG. 3. Blockade of the TNFR signaling pathway significantly extends the incubation period of disease following peripheral injection with ME7
scrapie, (a) Mice were treated with huTNFR:Fc (□) or hu-Ig as a control (■) 5 days before or 14 days after i.e. injection with a moderate dose
of scrapie (1.0% [wt/vol] scrapie brain homogenate). (b) Mice were treated with huTNFR:Fc (□) or hu-Ig as a control (■) 5 days before i.p.
injection with a moderate (1.0%) or limiting (0.1% or 0.01%) dose of scrapie. O, incubation periods for individual mice, (c) Mice were treated with
huTNFR:Fc (□) or hu-Ig (■) 5 days before or 14 or 38 days after i.p. injection with a moderate dose of scrapie. Each bar represents a mean ±
standard error of the mean for six to nine mice. The vertical broken line represents the time at which two spleens were taken from each treatment










Here we have shown that a single treatment of mice with
huTNFR:Fc before or shortly after a peripheral scrapie injec¬
tion significantly extended survival time compared to that of
control-treated mice. Our studies also demonstrated that treat¬
ment prior to peripheral exposure decreased the early accu¬
mulation of disease-specific PrPSc within the spleen. These
effects coincided with a temporary dedifferentiation of mature
PrP-expressing FDCs in the spleen following treatment with
huTNFR:Fc. Taken together, these results are consistent with
previous findings that in the absence of mature FDCs in lym¬
phoid tissues, neuroinvasion following peripheral injection
with scrapie is impaired (5, 29, 30). Surprisingly, a single treat¬
ment with huTNFR:Fc had little influence on disease suscep¬
tibility following low-dose scrapie challenge. Nevertheless,
TNF-a blockade over longer periods may present a potential
strategy for intervention in peripherally acquired TSEs.
Secretion of TNF-a has been implicated in the development
of neuropathology in several human inflammatory, infectious,
and autoimmune disorders (40). Although TNF-a expression
has been reported to occur in the brains of mice showing
clinical signs of scrapie (9), studies using TNF-a_/_ mice (30)
and TNFR-l-deficient mice (25) suggest that this cytokine
signaling pathway alone is not directly involved in the devel¬
opment of neuropathology in TSEs. Due to its high molecular
weight, huTNFR:Fc would be unlikely to cross the blood-brain
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Treatment hu-lg huTNFR:Fc hu-lg huTNFR:Fc hu-lg huTNFR:Fc
Timing (d) -5 -5 +14 +14 +38 +38
Lane 1 23456 12M3456 123456
42.4 _
kDa
32.6 _ ' f§ -ife
PK - +- + -+ -+ . + .+ .+ . + .+
Infectivity 5.0 5.0 4.9 5.3 4.9 5.0 5.0 5.2 5.0
FIG. 4. PrPSo accumulation and infectivity titers in the spleen 70 days after i.p. injection with scrapie. Immunoblots show the accumulation of
detergent-insoluble, relatively proteinase-K-resistant PrPSo. Treatment of tissue in the presence ( + ) or absence (-) of proteinase K before
electrophoresis is indicated. Following proteinase K treatment, a typical three-band pattern was observed between molecular mass values of 20 and
30 kDa, representing unglycosylated, monoglycosylated, and diglycosylated isomers of PrP (in order of increasing molecular mass). Scrapie
infectivity titers are expressed as log i.e. ID50 units per gram. Mice were treated with hu-lg (control) or huTNFR:Fc 5 days before (a) or 14 (b) or
38 (c) days after scrapie injection. Lane M contained molecular mass markers, d, days; PK, proteinase K.
barrier and inhibit TNF-a signaling within the brain. Treat¬
ment with huTNFR:Fc in this study had no effect on survival
time or neuropathology when mice were injected with scrapie
directly into the CNS, confirming that the effects of treatment
on TSE pathogenesis operate at a peripheral stage prior to
neuroinvasion. Our studies suggest this is most likely due to a
temporary interference with the integrity of FDCs, although
effects of huTNFR:Fc treatment on other cell types in the
spleen cannot be entirely excluded. However, the increased
survival time following treatment with huTNFR:Fc 14 days
after scrapie injection (Fig. 3b) and the recent demonstration
that membrane lymphotoxin, not TNF-a, regulates the migra¬
tion of dendritic cells in the spleen (48) suggest that it is
unlikely that the effects of huTNFR:Fc treatment on scrapie
pathogenesis are due to impaired cell trafficking from the site
of scrapie challenge to the spleen.
Light-microscopical analysis demonstrated that mature PrP-
expressing FDCs were temporarily absent in the spleen soon
after treatment with huTNFR:Fc. Several hypotheses could
explain the fate of FDCs following huTNFR:Fc treatment: (i)
FDCs temporarily revert to an immature state that affects their
function and phenotype; (ii) the chemokine gradients respon¬
sible for the organization of cell populations within the germi¬
nal center are altered (36), and as a consequence the FDCs
disperse; or (iii) in the absence of stimulation from TNF-a,
FDCs undergo apoptosis. We consider the first hypothesis
most likely, as despite a temporary absence of FDC-M2, CD35,
and PrPc expression by FDCs, immature FDC processes were
detected at the ultrastructural level, suggesting that these cells
had reverted to a dedifferentiated state. Antigens are trapped
and retained on the surface of FDCs through interactions
between complement components and cellular complement
receptors (37, 39). The loss of expression of complement re¬
ceptor 1 (CD35; Fig. 1) and substantially decreased abundance
of complement component C3 (data not shown) in lymphoid
follicles of treated mice implied that these immature FDC
processes had an impaired ability to retain antigens (31). Re¬
cent studies have demonstrated that Clq, C3, and complement
receptors play an important role in the localization of TSE
infectious agents to FDCs (26, 28). Therefore, it is unlikely that
during the period of dedifferentiation following treatment with
huTNFR:Fc, these immature FDC processes would have the
potential to acquire TSE infectivity. Occasionally a few mature
FDC processes were detected in the spleen by ultrastructural
analysis 7 days after treatment (data not shown). These may
represent FDCs in the process of regeneration, but it is also
plausible that these were FDCs that were participating in
strong antigenic responses and whose state of differentiation
was unaffected by treatments which inhibit the TNFR signaling
pathway (31).
Ultrastructural analysis of secondary lymphoid follicles from
huTNFR:Fc-treated mice revealed other associated degenera¬
tive changes. FDCs provide important costimulatory factors
which prevent B lymphocytes from undergoing apoptosis (18).
Therefore, the detection of severe and extensive lymphocyte
apoptosis following treatment with huTNFR:Fc suggested that
this was most likely due to a loss of mature FDCs. Many of
these apoptotic B lymphocytes were identified whole within
tingible body macrophages which scavenge apoptotic lympho¬
cytes and are considered to regulate the germinal-center reac¬
tion (42). The increased survival time following treatment with
huTNFR:Fc is unlikely to be directly related to a loss of B
lymphocytes by apoptosis, as ME7 scrapie pathogenesis is un¬
affected in mice with impaired germinal-center B-lymphocyte
development (30). However, the effects of treatment on dis¬
ease susceptibility could be indirectly related to a loss of cyto¬
kine stimuli from B lymphocytes, which leads to FDC dedif¬
ferentiation.
Within 70 days of a peripheral injection of immunocompe¬
tent mice with the ME7 scrapie strain, high levels of infectivity
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titers and abundant PrPSc are detected in the spleen (5, 12, 28,
30). Here, when mice were given huTNFR:Fc before scrapie
challenge, low levels of PrPSc were detected in the spleen 70
days postinoculation, approximately 50 days after the expected
reappearance ofmature FDCs. In the absence ofmature FDCs
at the time of scrapie challenge, it is likely that PrPSc and
infectivity from the inoculum persist in the spleen but that a
significant proportion is destroyed, for example by macro¬
phages (3, 10). This effect would significantly delay both the
onset of replication when the FDCs reappear within 14 days of
treatment and the subsequent transfer of infectivity via periph¬
eral nerves (19) into the CNS. Interestingly, infectivity titers in
spleens from huTNFR:Fc-treated mice were the same as those
from hu-Ig-treated controls, implying that the accumulation of
PrpSc jn the Spieen lags behind the replication of infectivity
during the early stages of infection (28). These experiments
also suggest that the time interval during which the FDCs were
unable to acquire and replicate scrapie was insufficient to allow
macrophages adequate time to destroy most of the infectious
agents, as huTNFR:Fc treatment had little, if any, effect on
disease susceptibility.
Further experiments will show whether it is possible to ex¬
tend the period of FDC dedifferentiation beyond that de¬
scribed in this report through prolonged treatment with mul¬
tiple doses of huTNFR:Fc. Such an approach may reduce the
accumulation of scrapie infectivity in the spleen and further
delay or prevent the development of disease in the CNS. How¬
ever, a prolonged blockade of proinflammatory cytokines such
as TNF-a may cause serious side effects, including increased
susceptibility to other infectious microorganisms, increased in¬
cidence of malignancies, or induction of autoimmune disease.
A therapeutic blockade ofTNF-a has been used to successfully
treat rheumatoid arthritis and Crohn's disease in humans,
where this cytokine plays a critical role in mediating inflam¬
mation (22, 32). The experience of long-term treatment of
human rheumatoid arthritis patients with TNF-a antagonists
suggests that they are safe and well tolerated (22, 32).
The detection of infectivity in lymphoid tissues and of PrPSc
in association with FDCs from patients with vCJD (6, 21) and
sheep with natural scrapie (1, 20, 45) suggests that these TSEs
also share a similar requirement for FDCs. Therefore, the
experiments described in this report and those of others sug¬
gest that treatments which temporarily interfere with the in¬
tegrity (29, 35) or immune complex trapping function (28) of
FDCs offer a potential approach for early intervention in pe¬
ripherally acquired TSEs.
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Summary
Follicular dendritic cells (FDCs) of the lymphoreticular system play a role in the peripheral replication of
prion proteins in some transmissible spongiform encephalopathies (TSEs), including experimental
murine scrapie models. Disease-specific PrP (PrPd) accumulation occurs in association with the
plasmalemma and extracellular space around FDC dendrites, but no specific immunological response has
yet been reported in animals affected by TSEs. In the present study, morphology (light microscopical and
ultrastructural) of secondary lymphoid follicles of the spleen were examined in mice infected with the
ME7 strain of scrapie and in uninfected control mice, with or without immunological stimulation with
sheep red blood cells (SRBCs), at 70 days post-inoculation or at the terminal stage of disease (268 days).
Scrapie infection was associated with hypertrophy ofFDC dendrites, increased retention of electron-dense
material at the FDC plasma membrane, and increased maturation and numbers of B lymphocytes within
secondary follicles. FDC hypertrophy was particularly conspicuous in immune-stimulated ME7-infected
mice. The electron-dense material was associated with PrPd accumulation, as determined by immunogold
labelling. We hypothesize that immune system changes are associated with increased immune complex
trapping by hypertrophic FDCs expressing PrPd molecules at the plasmalemma of dendrites, and that this
process is exaggerated by immune system stimulation. Contrary to previous dogma, these results show that
a pathological response within the immune system follows scrapie infection.
Crown Copyright © 2004 Published by Elsevier Ltd. All rights reserved.




(TSEs) are a family of slowly progressive neurode¬
generative disorders, consisting of infectious,
familial and sporadic forms of disease in both
animals and man. The TSEs include bovine spongi¬
form encephalopathy (BSE) of cattle and exotic
ungulates, scrapie of sheep and goats, and Creutz-
feldt-Jakob disease (CJD), kuru and Gertsmann-
Straiissler syndrome (GSS) of human beings. TSEs
can be naturally, experimentally or iatrogenically
transmitted to several mammalian species and are
Correspondence to: G. McGovern.
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doi: 10.1016/j.jcpa.2003.11.001
characterized by the accumulation of an abnormal
disease-specific isoform of a host-encoded cell
surface glycoprotein called prion protein (PrPd).
The normal PrP molecule (PrPc) is expressed
abundantly in the central nervous system (CNS)
(Manson et al., 1992; Ford et al, 2002) and less
abundantly in many other tissues (Oesch et al.,
1985), while PrPd accumulates in the CNS in many
of the TSEs and also in the peripheral nervous
system and lymphoreticular tissues in most exper¬
imental animal models.
The role of the lymphoreticular system (LRS) in
the pathogenesis of TSEs has been extensively
studied (Fraser and Dickinson, 1970; Mabbott and
Bruce, 2001). Initial investigations into which cells
Crown Copyright © 2004 Published by Elsevier Ltd. All rights reserved.
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within the LRS permit prion replication demon¬
strated that T-cell depletion by adult or neonatal
thymectomy had no effect on scrapie pathogenesis,
suggesting that T cells were not critical for scrapie
pathogenesis. However, surgical or genetic sple¬
nectomy prolonged the incubation period in
several scrapie models (Kimberlin and Walker,
1989), demonstrating the pathogenetic import¬
ance of the spleen and its cellular components.
Further studies revealed that exposure of scrapie-
infected mice to lethal doses of gamma irradiation
had no effect on pathogenesis, or on prion
replication in the spleen, suggesting that a long-
lived radiation-resistant cell was important for
neuroinvasion and replication of the infective
agent (Fraser and Dickinson, 1978; Fraser and
Farquhar, 1987).
Genetically immunodeficient (SCID) mice lack
functional B and T lymphocytes, and follicular
dendritic cells (FDCs) in such mice remain
immature due to lack of stimulation from B cells
(Bosma et al., 1983; Kapasi et al., 1993). SCID mice
are also relatively resistant to peripheral (i.e., non-
CNS) inoculation with scrapie (Kitamoto et al.,
1991; O'Rourke et al., 1994; Brown et al., 1997). The
lymphocyte population in SCID mice can be
restored with bone marrow from immunocompe¬
tent donors, enabling FDCs to mature (Kapasi et al.,
1993). Lymphocyte-reconstituted SCID mice
infected peripherally with scrapie develop the
disease after incubation periods comparable with
those of immunocompetent mice, confirming that
cells of the immune system play a significant role in
the peripheral pathogenesis of the disease (Fraser
et al., 1996; Lasmezas et al., 1996).
While studies with SCID mice produced strong
evidence in favour of a critical role for FDCs in
pathogenesis, the possible role of lymphoid cells
could not be excluded. A more conclusive role for
FDCs in scrapie replication was provided by studies
in chimaeric mice, in which PrP was expressed on
FDCs but not on lymphocytes, and vice versa. In
these models, replication of infectivity and pro¬
gression of infection to the CNS depended upon
the presence of mature PrP-expressing FDCs, and
were independent of the expression of PrP on
lymphocytes (Brown et al., 1999, 2000).
FDCs are accessory cells that occur only in
lymphoid follicles, where they are tightly sur¬
rounded by lymphocytes (Tew et al., 1982). During
germinal centre reactions, the function and mor¬
phology of FDCs change markedly. On stimulation,
FDC processes elongate and make contact with
numerous lymphocytes, while their surface recep¬
tors allow them to trap immune complexes which
can be retained for extended periods. The immune
complexes are then presented to, and processed by,
B lymphocytes. Within the spleen, FDCs, unstimu¬
lated B cells and some macrophage populations are
contained in the primary follicle of the white pulp
region. This region is characterized by closely
packed lymphocytes and is divided into two zones,
namely, the follicle itself and the surrounding
periarteriolar lymphoid sheath (PALS), which
contains the arteriole, T cells and macrophages.
The marginal zone tightly surrounds the PALS and
merges into the highly vascularized red pulp.
In previous morphological studies of spleens
from mice terminally affected by scrapie, FDCs
formed highly convoluted labyrinthine structures,
with irregular, often abundant, electron-dense
deposits associated with cell dendrites (Jeffrey
et al., 2000). These deposits occasionally contained
PrPd -associated amyloid fibrils, which were seen to
a lesser extent in tissues obtained from mice at pre¬
clinical stages of disease. Immunogold labelling was
associated with plasmablast emperipolesis by FDC
dendrites (i.e., FDC dendrite-encircled plasma-
blasts), and with the extracellular space surround¬
ing FDC dendritic processes. Coated pits were more
abundant on the surface of FDCs from scrapie-
infected animals than from normal control ani¬
mals; PrPd labelling, however, was not associated
with these structures. In the spleens of pre-clinically
and terminally affected animals, immunogold
labelling was also associated with tingible body
macrophage (TBM) lysosomes. Immunolabelling
within these lysosomal compartments is predomi¬
nantly associated with the more electron-dense
areas. This lysosomal PrPd is probably scavenged
from the extracellular space or from FDC processes
(Jeffrey et al., 2000). In sheep TBMs, PrPd lacks the
N terminus of the PrP, which further supports the
suggestion that TBMs internalize and digest extra¬
cellular PrP (Jeffrey et al., 2000). The aims of the
present study were (1) to characterize the morpho¬
logical response of the secondary follicle to scrapie
infection, and (2) to determine whether this
response was normal as compared with other
forms of exogenous antigenic stimulation.
Materials and Methods
Animals and Experimental Procedure
C57BL mice of either sex (n= 16) were inoculated
intraperitoneally with a 10-2 dilution of either ME7
(Brown et al., 1997) scrapie brain homogenate, or
normal brain (NB) homogenate. At 42 and 63 days
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post-inoculation (dpi), two of the ME7-infected
mice received intraperitoneally 0.1 ml of a sheep
red blood cell (SRBC) suspension (107 SRBCs),
and a further two received 0.1 ml of saline; similar
injections were given to four of the NB-treated
mice. These eight mice were all killed by cervical
dislocation at 70 dpi. At 240 and 261 dpi, the
remaining four ME7-infected and four NB-treated
mice received injections exacdy as described above.
These eight mice were killed by cervical dislocation
at 268 dpi, at which time the ME7-infected animals
were in the terminal stage of disease.
The spleens of all mice, obtained at necropsy,
were fixed in a solution containing paraformalde¬
hyde 0.5% and glutaraldehyde 0.5%. Between 25
and 30 cubes (1 mm3) of tissue, taken from each
spleen, were then post-fixed in osmium tetroxide,
dehydrated and embedded in araldite (Hayat,
1989).
Light Microscopy
Thick (1 pm) sections were stained by toluidine
blue or were 'etched' (deplasticized) with saturated
sodium ethoxide for up to 30 min. Endogenous
peroxidase was blocked and sections were 'de-
osmicated' with hydrogen peroxide 6% in metha¬
nol for 10 min, followed by pre-treatmentwith neat
formic acid for 5 min (Jeffrey and Goodsir, 1996).
Normal serum was then applied for 1 h to block
non-specific labelling. The avidin-biotin complex
method was used for immunohistochemical label¬
ling, with 1A8 anti-PrP serum (Farquhar el al.,
1993) at a dilution of 1 in 3000, or pre-immune
serum. The primary antibody was applied to the
etched and pre-treated sections and incubated at
4 °C for 15 h. All other treatments were undertaken
at room temperature. Reaction product was devel¬
oped with 3-3'diaminobenzidine. Blocks (4-7 per
animal) with appropriate immunolabelled areas
and large areas ofwhite pulp were then selected for
ultrastructural studies from ME7-infected and
uninfected groups.
Ultrastructural Immunohistochemistry
Serial 55-nm sections were taken from blocks
previously identified as containing secondary fol¬
licles, which in the case ofME7-infected mice were
also immunolabelled for PrPd. These sections were
placed on 400-mesh gold grids and etched in
sodium periodate for 60 min. Endogenous peroxi¬
dase was blocked and sections were de-osmicated
with hydrogen peroxide 3% in methanol for
10 min, followed by enhancement of antigen
expression with neat formic acid for 10 min.
Residual aldehyde groups were quenched with
0.2 M glycine in phosphate-buffered saline (PBS),
pH 7.4 for 3 min. Primary antibody (1A8) at a 1 in
500 dilution in incubation buffer or pre-immune
serum was then applied for 15 h at 4 °C. After
thorough rinsing, sections were incubated for 2 h
with Auroprobe 1-nm colloidal gold (Amersham
Ltd, Amersham, UK), diluted 1 in 50 in incubation
buffer. Sections were then post-fixed with
glutaraldehyde 2.5% in PBS and labelling was
enhanced with immunogold silver stain (IGSS)
(Amersham Ltd) for 4 min. Grids were counter-
stained with uranyl acetate and lead citrate, and




At both 70 dpi and during terminal stages of
disease (268 dpi), single or multiple reactive
germinal centres were identified in all blocks of
spleen tissue from ME7-infected mice. Approxi¬
mately twice as many germinal centres were present
in scrapie-infected spleens as in the corresponding
uninfected spleens. The splenic germinal centres
from scrapie-infected mice showed PrPd labelling
mainly within secondary follicles; some TBM
labelling, however, was seen at the periphery of
follicles. The intensity of immunolabelling in the
spleens from terminally diseased animals was
considerably greater than in those from mice killed
at 70 dpi, with most follicles showing extensive PrPd
accumulations (Fig. 1).
Immunolabelling of PrP , provisionally ident¬
ified as TBM labelling, was also detected in the red
pulp, mantle zones and periarteriolar sheaths of
ME7- infected mice. No immunolabelling of PrPd
was seen in the spleens of age-matched uninfected
mice, inoculated with normal brain.
Electron Microscopy (EM)
Morphology and immunolabelling of uninfected splenic
tissue. No morphological difference was seen
between spleens from NB-treated mice and
spleens from NB-treated mice that also were
immunized with SRBCs. Electron microscopy
showed that follicles of tissues from uninfected
mice contained FDCs at various stages of matu¬
ration. Mature FDCs were confined to the second¬
ary follicles, had highly irregular nuclei and were
184 G. McGovern et al.
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Fig. 1. Resin-embedded spleen (1 |xm thick) from a terminally affected mouse. The germinal centre shows two types of PrPc
labelling. There is an interrupted linear pattern (oval) and condensed granular pattern (square). PrPd immunolabelling.
Bar, 17.36 p-m.
often binucleate and occasionally multi-nucleate.
The nucleus was clear, with abundant euchromatin
and a distinctive band of heterochromatin adja¬
cent to the nuclear membrane. The perikaryonal
cytoplasm was relatively slight and contained
moderate numbers of cell organelles. Dendritic
processes of mature FDCs ran between the
lymphoid cells of germinal centres. These pro¬
cesses were often extensive and sometimes formed
small knots; occasionally more complex arrange¬
ments of dendrites (labyrinthine glomerular com¬
plexes) were present. Where several processes ran
between cells they usually ran in parallel straight
or curved lines. No visible structural features were
present between the plasmalemmae of adjacent
dendrites. Occasionally, two processes were joined
by desmosomes. Where processes formed knots
and labyrinthine glomerular complexes, curvi¬
linear electron-dense material could be seen
between the plasmalemmae of adjacent FDC
dendrites (Fig. 2a). This electron-dense deposit
formed a dense line (on average 0.18 pm in
diameter), intermediate between dendrites and
consistently located 0.15 pm from each dendritic
process (Fig. 2b). FDCs of a similar size and
complexity were present in all uninfected spleens,
regardless of SRBC immune stimulation.
Within the secondary follicles, some FDCs
appeared less mature, with more rounded, single
nuclei and poorly developed processes. Unlike
human or ovine secondary follicles, the murine
secondary follicles showed little variation in lym¬
phocyte nuclear size. As a result, dark and light
zones could not be distinguished. Consequently,
the location of the immature FDCs in relation to
the dark and light zones was not determined.
Numerous TBMs, with phagocytosed nuclear
remnants and abundant lysosomes in their cyto¬
plasm, were present within the secondary follicle.
Occasionally whole degenerate cells (presumed to
be apoptotic lymphocytes) were found within the
cytoplasm of these macrophages. Most lymphocytes
showed little or no evidence of differentiation
within the light zone of the secondary follicle.
Rarely, some lymphocytes showed evidence of early
B cell differentiation. These cells had dilated, oval
or rough endoplasmic reticulum (RER) containing
floccular material. In the mantle and PALS,
occasional lymphocytes showed even more recog¬
nizable differentiation towards plasma cells. Such
cells had numerous cisternae ofwidely dilated RER
containing an amorphous electron-dense material
(presumed to be globulins). No PrPd immunola¬
belling was detected in these tissues.
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Fig. 2a,b. (a) FDC dendrite processes from an uninfected mouse spleen. Simple FDC processes run between lymphocytes. The
associated electron-dense deposit is uniform and linear. Ultrastructural counterstain. Bar, 1.22 |im. (b) Detail of
labyrinthine glomerular complex from the spleen of an uninfected mouse treated with SRBC. The extracellular space
surrounding dendritic process plasmalemmae consists of an intermediate dense lamina (arrows), bound on either side
by two less electron-dense zones. This assembly is of a consistent width. Ultrastructural counterstain. Bar, 0.11 p.m.
Morphology of infected splenic tissue. In tissues
obtained from all terminally affected ME7-infected
mice, regardless of SRBC immune stimulation, the
majority of dendritic processes of FDCs within
secondary follicles formed large labyrinthine glo¬
merular structures. The area occupied by these
structures was estimated to be 10-20 times larger in
diameter than those of control tissues, with more
elaborate branching and interweaving of dendritic
processes. The space between the convoluted
dendritic extensions within these glomerular struc¬
tures was often markedly greater than in unin¬
fected mice, and contained uniformly opaque,
electron-dense material associated with the den¬
dritic membrane. The intermediate electron-dense
lamina, present in uninfected tissues, was absent. In
other areas of hypertrophic labyrinthine glomeru¬
lar complexes, the membrane-associated electron-
dense deposit was sparse or absent. In these areas,
the space between adjacent dendritic processes
remained relatively constant, and an intermediate
electron-dense line could clearly be seen. In yet
other FDC dendritic complexes there was no
abnormal accumulation of electron-dense deposit,
and the size and frequency of occurrence of
branching of dendrites was similar to that in
uninfected mice. This pattern was seen with
particular frequency in infected mice killed at
70 dpi. The complexity of branching of dendritic
processes and the abundance of extracellular
electron-dense material were directly related, i.e.,
the less complex the branching of dendrites, the
less electron-dense material was seen. In some of
the highly hypertrophic labyrinthine glomerular
complexes there was a reduction in electron
density of the material in the extracellular space
around the dendrites. Within these areas were
short, usually single, fibrillar structures; occasion¬
ally, however, small groups of randomly oriented
fibrils were also seen (Fig. 3).
By comparison with unimmunized terminally
diseased mice, SRBC-immunized terminally dis¬
eased mice showed larger hypertrophic labyr¬
inthine glomerular complexes and greater
amounts of extracellular material between them
(Fig. 4).
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Fig. 3. Spleen from a terminally affected mouse treated with SRBC. Note fibrillar structures (arrows) in the expanded extracellular
space surrounding mature FDC dendritic profiles. Ultrastructural counterstain. Bar, 0.34 p,m.
In all terminally diseased animals, regardless of
SRBC immunization, TBMs of secondary follicles
contained abundant lysosomal compartments.
Apoptotic cells were occasionally seen within
these compartments, including B lymphocytes
with dilated RER. Similarly sized TBMs were
observed in mice killed at 70 dpi.
Well differentiated plasmablasts with distended
RER, presumably containing globulins, were pre¬
sent in the secondary follicles of ME7-infected
mice, regardless of SRBC stimulation. They were
frequently surrounded (or emperipolesed) by FDC
dendritic processes, as shown in Fig. 4. Less mature
B cells, still with dilated RER, were found in the
secondary follicles of both uninfected and infected
animals; differentiated B cells were, however,
generally more abundant in the latter.
Coated pits and vesicles were observed in all
experimental groups, including the uninfected
controls, but these structures were much more
numerous in the infected mice. Increased numbers
of coated pits were observed mainly at the
plasmalemma of reactive FDC dendrites; less
commonly they were observed at the cell surface
of lymphocytes adjacent to FDCs of infected mice.
The increased number of coated pits in infected
mice killed at 70 dpi was similar to that in
terminally diseased mice at 268 dpi.
Immunogold labelling ofPrP1 in infected splenic tissue. In
splenic tissue from both immune stimulated and
unstimulated ME7-infected mice, this was associ¬
ated with FDC dendritic plasmalemmae of both
immature extended linear processes and mature
labyrinthine glomerular complexes. The smaller
particles of immunogold/silver reaction product
demonstrated that labelling was generally associ¬
ated with the plasma membrane itself. Only a small
proportion of the reaction product was found
within the electron-dense material of the extra¬
cellular space. This was conspicuous in the SRBC-
stimulated animals, in which the extracellular
electron-dense material was particularly abundant
between separated FDC dendrites, making the
distinction between plasmalemma-associated PrPd
and PrPd accumulation in electron-dense material
more readily apparent (Fig. 5). Within the extra¬
cellular space surrounding some FDC labyrinthine
glomerular complexes, PrPd-immunolabelled short
fibrillar forms were observed.
Immunolabelling of hypertrophic labyrinthine
glomerular complexes was indistinguishable in
infected mice killed at 70 and 268 dpi. Subtle
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Fig. 5. Immunolabelled spleen from a terminally affected
mouse treated with SRBC. Detail of a hypertrophic
FDC complex. Immunogold PrPd labelling is primarily
associated with the plasmalemma of dendrites and not
the adjacent electron-dense deposit. The abundant
amorphous electron-dense material is unstructured
and lacks an intermediate dense lamina. PrPd immu¬
nogold labelling. Bar, 0.65 pm.
Large TBMs containing many apoptotic bodies
were observed more frequendywithin the secondary
follicles of infected groups than in the correspond¬
ing uninfected groups. In addition to TBM
labelling of secondary follicles, intra-lysosomal
PrPd labelling of TBMs was seen in the red pulp,
mantle zone and periarteriolar sheath of both
SRBC-stimulated and unstimulated terminally dis¬
eased mice (Fig. 9). In some cases, PrPd accumu¬
lations appeared to be associated with dense
floccular material within lysosomes. Intralysosomal
PrPd labelling of TBMs was not seen outside the
secondary follicles in infected mice killed at 70 dpi.
Immunolabelling demonstrated that the trans¬
formation of B lymphoblasts into plasmablasts
and differentiated plasma cells was associated
with FDC dendrites showing emperipolesis and
PrPd expression. An association between lym¬
phocyte emperipolesis and PrPd immunolabelling
could also be seen within areas of the follicle
in which labyrinthine glomerular complexes
Fig. 4. Spleen from a terminally affected mouse treated with
SRBC. A markedly hypertrophic FDC labyrinthine
complex with highly convoluted dendrites and abun¬
dant associated electron-dense deposit is shown.
Embedded within the hypertrophic dendrites is a
differentiating plasmablast (asterisk), which is dwarfed
by the hypertrophic FDC complex. Ultrastructural
counterstain. Bar, 1.41 p,m.
differences in the distribution of immunogold
labelling occurred, however, in respect of immature
FDCs and smaller groups of dendrites. At 70 dpi, all
PrPd accumulations were restricted to mature
hypertrophic FDC glomeruli, no PrPd accumu¬
lations being associated with smaller dendritic
knots. Where labelling occurred, it was invariably
associated with slight amounts of electron-dense
material. At the terminal stage of disease, very few
FDCs had not formed hypertrophic complexes.
However, immunolabelling was found at the
plasmalemma of dendrites of sparse, less mature
FDC dendrites in which no intermediate dense
lamina was present and no extracellular electron-
dense material was formed (Fig. 6). These obser¬
vations suggest a progression of events illustrated
schematically in Fig. 7.
As described above, coated vesicles and pits were
more abundant in infected than in uninfected
groups. However, immunolabelling was not con¬
spicuously associated with these structures (Fig. 8).
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Fig. 6. Immunolabelled spleen from a terminally affected mouse treated with SRBC. A lymphocyte emperipolesed by FDC
dendrites is shown (A). Immunolabelling is associated with the plasmalemma of dendritic processes. There is no electron-
dense material surrounding simple FDC dendrites. PrPd immunogold labelling. Bar, 0.75 pin.
were not observed. A full range of differentiating B
cells could be detected within the follicles of all
infected groups, from undifferentiated lymphocytes
(Fig. 10a) to fully mature plasma cells (Fig. 10b).
All the changes observed are summarized in
Table 1.
Discussion
Following on from our initial investigations (Jeffrey
et al., 2000), this study further confirmed that PrPd
is associated with the plasmalemma and adjacent
extracellular space of FDCs, and is localized
intralysosomally within macrophages.
All scrapie-infected splenic tissue, whether or
not from mice that subsequently received SRBC
immune stimulation, showed an exaggerated or
hypertrophic response of FDC dendrites within
germinal centres. Cell processes were elongated
and strikingly convoluted, forming large labyr¬
inthine glomerular structures within the secondary
follicle, while an electron-dense deposit accumu¬
lated around and between these processes. Both
the accumulated electron-dense material and the
hypertrophic FDC glomerular responses were more
conspicuous in the SRBC-stimulated animals than
in infected mice that did not receive such immune
stimulation.
In splenic tissue from uninfected mice, an
ordered electron-dense line or lamina, at a
constant distance from the FDC dendritic process
plasmalemmae, could be seen within the extra¬
cellular material. This line appeared as a tri-laminar
assembly in conjunction with two FDC plasmalem-
mal membranes. A previous report of FDC
antigen-antibody complex binding (Radoux et al.,
1985) described the binding of antibody/ferritin
complexes as a line, equidistant between adjacent
FDC membranes. The mechanism of antigen/
antibody complex attachment was later shown to
consist of fixation of the antigen in the extracellu¬
lar space to the adjacent FDC membranes via the
complexed antibody attaching to FDC C3b and Fc
receptors (Bosseloir et al., 1995). This would
suggest that the electron-dense lamina seen in the
detailed electron micrographs of the extracellular
space surrounding normal FDC dendritic processes
in uninfected mice is the site of normal
antigen-antibody complex binding. The extra¬
cellular space around hypertrophic FDCs from
mice inoculated with ME7 scrapie did not show the
tri-laminar assembly indicative of antigen-anti-
body complex binding, but demonstrated abun¬
dant electron-dense material within the
extracellular space. Because of its location and
the similarity of its electron density to that of the
intermediate dense line observed in association
with normal FDCs, we suggest that this represented
accumulated antigen-antibody complexes. Exces¬
sive trapping of antigen-antibody complex by FDC
dendrites, with a subsequent breakdown of the
normal binding and structural relationships
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Fig. 7a-c. Schematic diagram showing relationship between immune complexes and FDCs in uninfected and scrapie-infected
mice, (a) Antigen/antibody complexes (black circles) are held in the extracellular space at a regular interval between
FDC dendrites, (b) After infection with scrapie, abnormal PrP (PrPd) accumulates at the surface of FDC dendritic
plasmalemma. This is associated with increased extracellular electron-dense material (presumed to be immune
complexes) and FDC hypertrophy, (c) At early stages of infection, few FDCs within a germinal centre/secondary follicle
show evidence of PrPd accumulation. However, where PrPd accumulation is found, evidence of hypertrophy is present.
In contrast, at late stages of disease almost all FDCs show PrPd accumulation. Most are hypertrophic, but occasionally
PrPd can be found at the plasmalemma of unreactive FDCs.
between antigen-antibody complex receptors, is
therefore inferred by the presence of abnormal
amounts of this extracellular electron- dense
material.
The amount of FDC hypertrophy and extracellu¬
lar electron-dense material was greater in infected
animals that received SRBC immune stimulation
than in those that did not. The triggers for FDC
process extension are (1) an increased concen¬
tration of antigen-antibody complexes in the
extracellular space surrounding FDC dendrites,
and (2) the subsequent attachment of these
complexes to FDC plasmalemmae (Terashima
et al., 1992; Heinen et al., 1995). Therefore, the
increase in FDC hypertrophy and the assumed
immune complex attachment in spleens from
SRBC-immunized scrapie-infected mice may simply
have been due to an increase in available antigens
and complexes.
The present study revealed changes suggesting
that scrapie infection disturbs the processes of
B-cell maturation and development. Normally,
antigen-antibody complexes are retained at the
FDC surface, and the presence of CD4+T lympho¬
cytes is an initial requirement for the formation of a
germinal centre follicle (Steinman et al, 1997; Tew
et al, 1997). Where primed circulating B cells
recognize their cognate antigen held at the surface
of FDCs, they cease their cycle of recirculation,
proliferate and hypermutate. Many hypermutated
B cells (centrocytes) are immediately abolished by
apoptosis, but B cells with improved
antigen binding affinity of their surface immuno¬
globulins survive. Interaction with CD4+cells
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Fig. 8. Immunolabelled spleen from a terminally affected mouse treated with SRBC. Numerous coated pits are associated with FDC
dendritic profiles (arrows), but are not associated with immunogold labelling. Immunogold plasmalemmal PrPd labelling is
present in areas with or without excess electron-dense deposit. PrPd immunogold labelling. Bar, 0.52 p,m.
results in affinity maturation of the immunoglobu¬
lin produced by centrocytes (Stockinger et al.,
1996). Some centrocytes become memory B cells,
others join the pool of recirculating lymphocytes,
while others migrate into body tissues where they
further differentiate into long-lived antibody-secret¬
ing plasma cells (Takahashi et al, 1998).
Greater numbers of plasmablasts and morpho¬
logically mature plasma cells were observed within
the splenic germinal centres of scrapie-infected
mice than in uninfected controls. In addition,
there was an increase in the number of TBMs that
contained large amounts of apoptotic debris
(presumed apoptotic B cells). We suggest therefore
that scrapie infection leads to an increase in the
number of B cells that are selected for hypermuta-
tion. Although many of these will undergo apop-
tosis, many continue to survive and are retained
beyond the stage at which they would normally
migrate from the germinal centre. If scrapie
infection induces FDC hypertrophy and sub¬
sequent abnormal antigen-antibody trapping,
either by facilitating C3b or Fc receptor binding
or by impairing the release of transiently attached
immune complexes, the presentation of these
immune complexes to B cells may also occur
abnormally or in excess. Either this excess antigen
complex or PrPd itselfmay then induce a prolonged
retention of B cells within the secondary follicle.
Whether these morphologically mature B cells are
Fig. 9. Immunolabelled spleen from a terminally affected
mouse treated with SRBC. Lysosomal TBM labelling is
seen in the red pulp adjacent to a capillary containing
erythrocytes. PrPd immunogold labelling. Bar,
0.98 p,m.
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(b)
Fig. 10a,b. Immunolabelled spleen from a terminally affected mouse treated with SRBC. (a) PrPd-labelled FDC dendritic processes
are emperipolesing amaturing B cell (asterisk). PrPd immunogold labelling. Bar, 1.51 (xm. (b) Two differentiated B cells
emperipolesed by PrPd-accumulating FDC dendrites are shown. The B cell (asterisk) is terminally differentiated and
shows endoplasmic reticulum organized into globulin-producing compartments. The B cell (indicated by a cross) is less
mature, with dilated rough endoplasmic reticulum. PrPd immunogold labelling. Bar, 1.32 |xm.
in fact secreting antibody was not tested in the
present study.
In ME7-infected mice, at both 70 and 268 dpi
and regardless of SRBC immune stimulation,
increased numbers of coated pits and vesicles
were found in association with FDC hypertrophy.
The reason for this increase remains unclear.
Although the coated pits do not appear to be
directly associated with PrPd, they may still have an
indirect bearing on pathogenesis (Jeffrey el al.,
2000). Harris (1999) showed that in purified
preparations of coated pits from the brain, PrPc
co-localizes with these structures. In diseased
animals, normal PrP may be 'upregulated', result¬
ing in increased endocytic trafficking. Alternatively,
coated pits may have a role in the removal of, or
response to, PrPd from the cell surface or plasma-
lemma. Coated pits show an abnormal increase in
ovine (Ersdal et al, 2003) and murine (Jeffrey,
personal observation) scrapie-infected brain tissue.
Immunogold labelling of PrPd was found at the
plasmalemma of FDC dendrites, in the adjacent
extracellular space, on extracellular fibrils, and in
lysosomes of TBMs. As in an earlier study (Jeffrey
et al., 2000), the intensity of immunolabelling was
increased in proportion to the tortuosity of the
dendritic processes, the complexity ofbranching of
dendrites, and the amount of extracellular elec¬
tron-dense material. In the present study, a smaller
particle size of immunogold reaction product
revealed that FDC-associated PrPd was located on
the plasmalemma of dendrites within labyrinthine
glomerular complexes. That most immunogold-
labelled PrPd was associated with the plasmalemma
of dendritic processes and not with electron-dense
deposits suggests that PrPd remains membrane
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Table 1
Observed and subjectively assessed changes in the various experimental groups of mice
Degree (— to + ++ ) of change in groups *
killed at 70 dpi killed at 26S dpi
Type of change U U/S I I/S U U/S I I/S
FDC Hypertrophy —
Increased electron- dense deposit accumulation —
PrPd labelling of immature FDCs —
Coated pit activity +
Lysosomal TBM labelling —
Increased follicular B cell maturity —
++ ++ - - +++ +++
++ ++ - - ++ +++
- - - - +++ +++
++ ++ + ++ +++ +++
++ ++ - - +++ +++
++ ++ - - +++ ++ +
*U, uninfected; U/S, uninfected and SRBC-stimulated; I, ME7-infected; I/S, ME7-infected and SRBC-stimulated.
bound and is not released into the extracellular
space. A small amount of extracellular PrPd was
located within the extracellular space around FDC
dendrites, mainly on fibrils. These FDCs were made
conspicuous, not only by the increased number of
fibrils within the extracellular space, but also by the
lack ofmembrane-associated electron-dense depos¬
its and highly convoluted dendritic profiles. FDCs
of this type were found in all scrapie-infected
spleens at both 70 dpi and during the terminal
stages of disease; they were also observed by
Mabbott et al. (2002) at 42 dpi. The mechanism
or sequence of events leading to PrPd aggregation,
complex release and increase in dendrite complex¬
ity remains unclear. However, these findings
suggest that PrPd is initially attached to the FDC
membrane until released or otherwise stimulated
to aggregate and form fibrils (Jeffrey et al, 2000).
The amounts of extracellular electron-dense
material and plasmalemmal PrPd, and the degree
of dendritic hypertrophy and tortuosity, were
directly proportional to each other. However, in
terminally diseased mice, some immature FDCs
which lacked any intermediate dense line between
FDC dendrites, or in some cases lacked any
extracellular structure, showed PrPd accumulation
at the plasmalemma. As both the accumulation of
electron-dense material and hypertrophy of FDCs
are considered to be the sequel to increased
immune complex trapping, we suggest that excess
PrPd retained at the FDC dendritic plasmalemma
may enhance capacity to trap complexes via C3b or
Fc receptors. PrPd accumulation at the plasma¬
lemma of immature FDCs suggests that PrP
accumulation at the cell surface is the primary
event in the chain of pathological events described
above (Fig. 7).
In this and previous studies of sheep and mice
infected with scrapie, we found that all, or virtually
all, follicles at the terminal stage of disease were
scrapie-infected, as shown by the accumulation of
PrP (Fig. 7b). This further suggests that follicles
do not regress but are stimulated to continue to
produce antibody. The presence of excess numbers
of mature plasma cells was also consistent with
delayed or impeded B cell migration from the
follicle and delayed involution of secondary
follicles.
In terminally diseased animals, the presence of
intralysosomal PrPd labelling of macrophages out¬
side the germinal centre suggests that these cells
play an important role in the transportation of
infectivity away from the secondary follicle.
In conclusion, several novel morphological
changes were identified in the spleens of scrapie-
infected mice. Taken together, the loss of the
intermediate electron-dense line between FDC
dendrites, FDC hypertrophy and increased plasma
cell retention within the secondary follicle all
suggest the occurrence of functional abnormalities
within the spleen as a result of scrapie infection.
The nature of these changes suggests that there is a
change in immune complex binding mechanisms,
and associated changes in the responses of FDCs
and plasma cell maturation. We speculate that
these changes are due to the presence of abnormal
PrPd at the surface of FDCs and that this PrPd
retains a functional role in facilitating immune
complex trapping. The progression of events
suggests that PrPd accumulation precedes func¬
tional immunopathological changes; PrPd may be
transported from the germinal centre in macro¬
phage lysosomal compartments. While the exact
mechanisms for the delayed release of B cells from
the secondary follicle and increase in coated pit
expression are unknown, these changes are also
scrapie-associated.
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